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For Jacqueline
I do not know what I may appear to 
the world, but to myself I seem to have 
been only l ik e  a boy playing on the sea-shore, 
and diverting myself in now and then finding  
a smoother pebble or a p re t t ie r  shell than 
ordinary, whilst the great ocean of truth lay 
a ll  undiscovered before me.
Sir Isaac Newton
A short time before his death
SUMMARY
Tne metabolic fate of shikimic acid has been investigated 
in the ra t .  Shikiinic acid was not observed to be metabolised by 
mammalian tissues, instead the compound appears to be metabolised 
via a m u lt ip lic ity  of microbial-dependent pathways in the gastro­
in testinal t ra c t .  Products of microbial metabolism were excreted 
unchanged or subsequent to further biotransformation in the 
tissues.
Both in v itro  and in vivo^shikimic acid was shown to be 
converted to cyclohexanecarboxylic acid by gastrointestinal 
microorganisms. The formation, absorption and further metabolism 
of the la t te r  accounted for the observed urinary excretion of 
hippuric acid, hexahydrohippuric acid and 3 ,4 ,5 ,6 -te trahydro-  
hippuric acid a fte r  oral administration of shikimic acid. Liver 
perfusion studies confirmed that the l iv e r  is one of the major 
organs responsible for the metabolism of cyclohexanecarboxylic 
acid in the ra t.
Additional microbial pathways gave rise to the production of 
both c is - and trans- 3,4-dihydroxycyclohexanecarboxylic acids 
and a urinary conjugate of catechol.
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Of the great variety of naturally occurring acidic  
compounds the close relatives shikimic acid and qui n ic acid 
are of particu lar importance because of th e ir  involvement 
in the biosynthesis of essential amino acids. Whereas amino 
acids such as L-phenylalanine, L-tyrosine and L-tryptophan 
cannot be produced by de novo synthesis in animals, in plants 
and microorganisms they are formed by a process known as 
the shikimate pathway (Davis 1955). Since shikimic acid 
is so widely distributed in the plant kingdom the possible 
to x ic ity  of such compounds has received l i t t l e  attention  
except until recently (Evans and Osman 1974) when shikimic 
acid was claimed to be one of the mutagenic or possibly 
carcinogenic toxins.present in the Bracken fern (Pteridium 
Aquilinum). This observation has awakened new in terest in
COOH COOH
HO'
OHOH
Shikimic acid Q uinic acid
the subject (Stavric and Stoltz 1976, Brewster et ^  1976).
Shikimic acid does not readily f a l l  into any of the common 
groups of chemical carcinogens such as aromatic amines, azo- 
dyes, nitrosamines and polycyclic hydrocarbons nor into the 
well known groups of highly reactive biological a lkylating  
agents such as epoxides, lactones, or the precursors of various
carbonium ions, free radicals, carbenes and the l ik e .
Shikimic acid is a very polar stable compound and would appear 
to require metabolic activation for any such toxic action.
Very l i t t l e  is known of the metabolic fate of polyhydroxy- 
lated cyclohexane derivatives such as shikimic or quinic acids 
in animals and therefore together with the possible toxicological 
in terest outlined above a study of the metabolism of shikimic 
acid represents a very important and challenging investigation. 
Since microorganisms as well as plants incorporate shikimate 
into various metabolic pathways, the role of gastrointestinal 
microorganisms in the biotransformation of shikimic acid in vivo 
is to be given considerable attention.
SHIKIMIC ACID
Occurrence
Shikimic acid is widespread throughout the plant kingdom.
I t  is diverse throughout a multitude of species and indeed 
between sections of individual species. Some of the more 
fam ilia r  plants and f ru its  reported to contain shikimic acid 
are given below.
Plant or f r u i t section amount
(mg/lOOg)
reference
Il l is iu m  anisatum leaves 10 Hasegawa et al (1957)
Apple peel 5 - 8 Hulme (1956a)
Pear pulp 6 - 8 Hulme (1956b)
Wheat Coic (1961)
Coconut milk Tulecke (1961)
Banana pulp Steward (1960)
Tea shoots 35 Zaprometov (1961)
Asparagus Johnson (1968)
Corn Johnson (1968)
Lettuce Johnson (1968)
Tomato f r u i t Johnson (1968)
Cherry f r u i t 3 -  4 Hulme (1956p^)
Strawberry f r u i t 1 -  2 Hulme (1956ol)
Gooseberry fru i t 105 Johnson (1958 )
Ferns 0 . 1-6 Minamikawa (1972)
Old wine Carles (1960)
Biochemistry
The significance of the involvement of shikimic acid in important 
biochemical pathways leading to the formation of aromatic amino 
acids was f i r s t  described by Davis (1955). Since then numerous 
contributions to an understanding of the shikimate pathway have been 
presented and these have been adequately reviewed (Bohm 1965,
Haslam 1974).
Metabolism of shikimic acid in animals
L i t t le  is known of the metabolic fate  of shikimic and 
quinic acid in animals but the metabolism which has been 
observed appears to be dependent upon the action of gastro­
in testinal microorganisms. Administration of shikimic or 
quinic acid to animals results in a degree of aromatisation to 
hippuric acid which is excreted in the urine but in animals 
pretreated with antib iotics  to suppress the gut f lo ra  no such 
metabolism is observed (Adamson et ^  1970, Asatoor 1965, Cotran 
et ^  1960). The general opinion as to the mechanism of 
hippurate excretion is that shikimate or quinate are aromatised 
to benzoic acid by gastrointestinal microorganisms and then 
conjugated with glycine in the mammalian tissues. This appeared 
to be substantiated by the claim that quinic acid was converted 
to benzoic acid on incubation with rat caecal microorganisms 
in v itro  (Scheline and Indahl 1973). An unidentified urinary  
conjugate of catechol has been observed as a minor metabolic 
product (Booth et ^  1960, Scheline and Indahl 1973).
The conversion to hippuric acid shows considerable 
species variation (Adamson ejL ^  1970), in lower laboratory  
animals this represented a very minor pathway whereas in 
Man and Old World Monkeys a considerable degree of conversion 
was observed. Species variation in the extent of aromatisation 
has been attributed to differences in the microbial f lo ra  of 
the animals examined (Adamson et al 1970).
COOH COOH
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NATURALLY OCCURRING CARCINOGENS
Although the hazards presented by synthetic chemical 
carcinogens is increasing, there are many naturally  occurring 
toxic agents present in plants or fungi. Some of the most 
potent carcinogens of a l l  belong to the group c o llec tive ly  
known as the aflatoxins. Serious outbreaks of livestock  
poisoning in 1961 were eventually attributed to a fungal 
infection of Brazilian groundnuts (peanuts) (Lancaster et al 
1961) soon iden tif ied  as the fungus Aspergillus flavus 
(Sargeant £ t  ^  1963). The causative agents have been id en tif ied  
as a group of highly carcinogenic lactones (Butler and Barnes 
1963, Lancaster £ t  ^  1961). Concern is mounting over the 
sporadic outbursts of aflatoxins in food for both livestock  
and human consumption. Many other fungal toxins are known.
Thus carcinogenic metabolic products of the rice fungus 
Pénicillium islandicum have been characterised, the carcinogen 
hatulin (Dickens and Jones 1961) is produced by Pénicillium  
urticae and griseofulvin is produced by P,griseofulvum.
Various plants and ferns are known to be responsible 
for toxic reactions in humans and animals. The to x ic ity  of
bracken (Evans and Mason 1965) toward various animal species 
is p articu larly  disturbing in view cf the amount of bracken 
infested land that exists throughout the world. Cycad nuts 
contain certain glycoside derivatives of azoxy compounds such as 
cycasin (methyazoxymethanol-g-D-glucoside) and amygdalin 
(a mandelonitrile glycoside) is present in b i t te r  almonds.
Both cycasin and amygdalin give rise to toxic metabolites 
(carcinogenic in the case of cycasin) upon hydrolysis 
and w ill  be discussed la te r .  Safrole (p-allylmethylenedioxy- 
benzene) is a chief constituent of o il of sassafras but also 
occurs in certain spices and has been shown to produce hepatomas 
in rats (Homburger et ^  1962, Long ejL ^  1963). The activated  
carcinogenic agent responsible is probably the corresponding 
epoxide produced by the l iv e r ,  substantiated by the fac t that 
dihydrosafrole is not a hepatocarcinogen (Long and Jenner 1963). 
Parasorbic acid is a further example of a naturally  occurring 
carcinogenic lactone,being found in the ripe berries of the 
mountain ash Sorbus aucuparia (Dickens 1964). The possible 
mechanism of lactone induced carcinogenesis w ill  be described 
shortly but i t  is generally found that the more potent carcino­
genic lactones are those in which the carbonyl function is  
a , 3-unsaturated. Some of the more well known naturally  occurring 
carcinogenic compounds are shown in Fig. 1.1.
OMe OCH
MeO
Cl
CH3 -  N = N
CHgO-g-D-glucose 
Cycasin
Griseofulvi n
Patulin
Me
Parasorbic acid
0 0
OMe
Safrole Aflatoxin G
Fig. 1.1 Some naturally occurring carcinogens
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DRUG METABOLISM AND CHEMICAL CARCINOGENESIS
Drug metabolism may be broadly defined as the biological 
fate of a drug o*^  xenobiotic in terms of i ts  absorbtion, 
d istr ib u tio n , biotransformation and f in a l ly  i ts  excretion.
The metabolism of xenobiotics usually results in the formation 
of more polar and water-soluble derivatives which are conducive 
to a rapid excretion of the products and a reduction in 
biological a c t iv i ty .  As a consequence, the process of xenobiotic 
metabolism has been regarded as a detoxicative sequence of 
events. In the majority of cases the above reactions occur 
in the hepatic endoplasmic reticulum by means of a haemo- 
protein termed cytochrome P-450 (Coon et a^ 1973, Estabrook e t al 
1973). The general pattern of drug metabolism is common to a lV  
species and is usually biphasic, consisting of an in i t ia l  
oxidation (e.g. hydroxylation), reduction or hydrolysis followed 
by a second synthetic phase (conjugation) with hydrophilic 
derivatives. The result is usually an increased p o la r ity ,  
hydrophilicity and therefore rapid excretion.
The process of chemical biotransformation however may 
lead to increased pharmacological a c t iv ity  and often to increased 
to x ic ity ,  even carcinogenicity, mutagenicity or teratogenic ity .  
The mechanism of activation of the parent compound is often due 
to intermediates on route to the fina l excretion of inactive ,  
hydrophilic derivatives e.g. the epoxidation of o le fins , f in a l ly  
excreted as dihydrodiols. Further assignment of the actual 
toxic agents is therefore necessary, thus cycasin a pre­
carcinogen is hydrolysed to methylazoxymethanol (proximate
carcinogen) which f in a l ly  yields diazomethane the ultimate  
hepato carcinogen.
I t  is now believed that the important event a f te r  the 
administration of any carcinogen is the conversion of the 
compound to an e lectrophilic  species (Garner 1976). The 
formation of this ultimate (M il le r  1970) carcinogen may occur 
in several stages and normally results in the alkylation or 
arylation of cell constituents. Whether the target of such 
covalent attachment is a nucleic acid or a protein remains 
uncertain but the reactive a lkylation sites in nucleic acids 
such as the nitrogen 7 of guanine or nitrogen 3 of adenine 
seem to be the most susceptible points of attack (Harbers 
1968).
Epoxides There are many examples (Garner 1976) of the 
biological formation of these reactive intermediates and i t  
is probably true to say that most of them are more toxic than 
the parent molecule. I t  is l ik e ly  that the formation of epoxides 
is important in the to x ic ity  of various olefins (e.g. safrole  
and afla toxins) and polycyclic hydrocarbons (Garner 1976). Certain 
epoxides are almost certa in ly  the 'u ltim ate ' carcinogenic 
form of the parent compound and would seem to owe th e ir  
re a c t iv ity  to the e lectrophilic  nature of the strained oxirane 
system.
r :N  - Hc ?
R -  CH - CH - R  R - CH - CHR
OH
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N may be one of many nucleophilic centres eg Ny of 
purine or N3 of adenine bases of nucleic acids.
The epoxidation of o le f in ic  drugs and xenobiotics often 
represents a detoxicative mechanism since the epoxide may 
be converted to the trans-diol by epoxide hydrase or 
conjugated with glutathione. Both mechanisms w il l  f a c i l i t a t e  
excretion.
Lactones Many synthetic or naturally  occurring carcinogenic 
lactones are known and re ac tiv ity  toward nucj^ophiles is assisted 
by the strained system present in the smaller rings such as in  
g-propiolactone. The a lkylation of nucleic acids in the manner 
by which certain epoxides appear to act may explain the a c t iv i ty  
of such lactones. The My alkylation of guanine by g-propiolactone 
has been demonstrated (Dickens 1964) but the manner by which 
the highly potent aflatoxins are activated remains in some doubt. 
The extreme potency of the afla toxin  group of lactones and th e ir
CHg 0
CH2
3-propiolactone
0 0
OMe
Aflatoxin B
observed contamination of certain foods infected with the fungus 
Aspergillus flavus is most concerning and has prompted major 
reviews of the compounds (Goldblatt, 1969, Detroy e t al 1971),
13
Amines Certain aromatic amines were f i r s t  discovered to be
carcinogenic in man as a result of industrial exposure. Studies 
on the induction of bladder cancers by aromatic amines have shown 
how differences in metabolic pathways may a ffec t carcinogenicity 
and i t  is quite clear that aromatic amines themselves are not 
carcinogenic. The to x ic ity  of aryl amines has been attributed  
to e ither ortho-hydroxyl ation or N-hydroxylation with the
h/metabolism of 2-napjthylamine providing an ideal example. Thus
2-napghylamine is transformed in the l iv e r  to both ortho-ami no­
phenol and N-hydroxy-2-nap^hylamine. Both metabolic products 
are potent bladder carcinogens when administered by d irect implantation 
whereas the parent amine is not (Clayson 1964, Bonser e t al_ 1958).
P - H
NH - PNH ^ 
-------
P - H = protein or nucleic
acid
The above schemes indicate possible pathways leading to the
L
covalent interaction of napjthylamine with cell consituents 
through quinone-imine intermediates (Clayson 1964).
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Certain endogenous amines may be responsible for the 
production of spontaneous bladder tumours in man. Thus 
tryptophan is metabolised in vivo to ortho-ami nophenol 
derivatives one of which (3-hydroxyanthranilic acid) is 
carcinogenic i f  implanted in the mouse bladder and has 
been found in greater than normal levels in patients with 
spontaneous bladder cancer (Boyland 1958).
tryptophan
CHgCHCOOH
3-hydroxyanthranilic acid
Polycyclic hydrocarbons Numerous investigations into
the carcinogenic components of coal ta r  led to the recognition 
of 3,4-benzpyrene as the major carcinogen and to the synthesis 
and evaluation of s im ilarly  related compounds. The mechanism 
of activation of polycyclic hydrocarbons has not been f u l ly  
resolved (Garner 1976) but the possession of a region of high 
electron density or o le f in ic  character (designated the K region) 
is important. In some cases, the formation of reactive epoxide 
intermediates at the K region may precede the binding to ce ll  
constituents . An example would be the metabolic conversion 
of 1 , 2-benzanthracene to the corresponding epoxide capable of 
arylation of macromolecules (Boyland 1964).
15
K-region
3,4-benzpyrene epoxide of 1 , 2-benzanthracene
Azo-dyes The to x ic ity  of certain azo-dyes was f i r s t  high­
lighted when they were found to produce l iv e r  cancers in ra ts .  
Until recently the relationship of the azo-dyes to other carcino­
genic amines had been obscure. I t  now appears that the amino 
function (e.g. in butter yellow) may undergo N-hydroxylation and 
the resulting derivative act as an arylating agent in a manner 
sim ilar to that described for aromatic amines (M il le r  and 
M il le r  1966).
A Wide range of azo compounds undergo reductive fission
H = N N Me,
4-dimethylaminoazobenzene (Butter Yellow)
through metabolism by members of the gastrointestinal microflora  
(Walker 1970) and the resulting substituted aromatic amines may 
be responsible for the observed carcinogenicity.
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Nitrosamines Nitrosamines are a group of very 
potent carcinogens which are activated by conversion to 
powerful a lkylating agents (Magee and Schoental 1964).
These are probably produced via the formation of unstable 
diazo hydroxides which give rise to diazo alkanes, diazonium 
salts and f in a l ly  carbonium ions (Brooks 1966). In the case 
of dimethyl n i trosamine the fina l product is diazomethane which 
has been shown to alkylate the Ny position of nucleic acid 
guanine.
CH3
dimethyl n itrosamine
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THE ROLE OF GASTROINTESTINAL MICROORGANISMS IN THE METABOLISM 
OF FOREIGN COMPOUNDS
An examination of the history of foreign compound metabolism 
shows that in terest in such metabolic processes has until recently  
been almost exclusively devoted to those which occur in the 
tissues. Investigations in the whole animal have predominated 
with excellent reviews being available (Williams, 1959; G i l le t te ,  
1966; Parke, 1968; Williams and Parke, 1964) although in more 
recent decades, the use of various tissue preparations, in 
particu lar those of the l iv e r ,  have been extensively studied and 
reviewed (G i l le t te  e t a^ 1969). However, research workers in the 
past appear to have been slow to take in terest in the fac t that  
drugs, endogenous anutrients and the l ik e  w i l l  often come into  
contact with the micro-organisms harboured in the gastrointestinal 
t ra c t .  The meeting of foreign compounds with the so called  
gastrointestinal f lo ra  is a common occurrence since so many 
foreign compounds enter the organism with the d iet and the vast 
majority of s e lf  administered drugs are taken by oral means.
In addition, this exposure w ill  be aided when absorption is delayed 
due to factors such as poor l ip id  s o lu b il i ty  (Williams e t ^  1971; 
Scheline 1968a) or when faecal excretion is delayed due fo r  example 
to conditions of gastrointestinal stasis when i t  is known that 
such changes in in testina l m o ti l i ty  commonly leads to greatly  
increased bacterial populations (Drasar and H il l  1974). Foreign 
compounds in these conditions w il l  also be exposed to metabolising 
conditions for longer durations. Foreign compounds may s t i l l  meet 
the gastrointestinal f lo ra  via other routes such as diffusion or
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secretion into the in testinal lumen or more commonly via  
b i l ia r y  excretion by the l iv e r .  Although fa i lu re  to appreciate 
the possible importance of this area of metabolism is often 
evident, the past decade has witnessed a rapidly growing 
in terest in this f ie ld  of foreign compound metabolism, and the 
work of very recent years has shown an increasing awareness 
and acceptance of the possible effects of bacterial metabolism 
on the fate and biological properties of foreign compounds.
The metabolic a c t iv i ty  of the gut microflora is now 
considered po ten tia lly  equal to that of the l iv e r  and possibly 
greater than the l iv e r  in certain adaptive capacities (Drasar 
et a^ 1970).
Nature and Distribution of the Flora within the Gastrointestinal 
Tract
Nature of the F lora: The normal occupants of the gastrointestinal
t rac t  of man and animals have not been extensively studied in the 
past. The main reasons for such neglect are two-fold. F i r s t ly ,  
many of the normal f lo ra  especially the aerobic components are 
d i f f i c u l t  to cu ltivate  and secondly, the subject has largely  
been ignored because of the apparently stable and symbionic 
relationship between host and f lo ra .  Emphasis has therefore been 
centred more on the pathogenic microorganisms which may reside 
in the tra c t  especially in times of disease. I t  has been shown 
(Spears et al_ 1967) that the predominant and s t r ic t ly  anaerobic 
bacteria of the f lo ra  are sensitive to even transient contact with 
oxygen. This is clear warning that our knowledge of the f lo ra
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may be inaccurate and greatly dependent upon the methodology 
used in the ir  iso la tion . Such findings should be born in mind 
when attempting to correlate the in v itro  metabolism of foreign  
compounds by gut microorganisms with the in vivo s ituation . The 
more typical components of the gastrointestinal microflora are 
l is ted  in Table 1 .1 .
The distr ibution of microorganisms varies considerably 
throughout the G .I .  t ra c t .  As already indicated aerobic f lo ra  
of human faeces consisting of coliforms, streptococci and lacto-  
b a c i l l i  may account for 5% of the population whilst anaerobic 
microorganisms (predominantly bacteriodes and bifidobacteria ) may 
in certain regions of the trac t out number aerobic members of the 
f lo ra  by factors of 10^ to 10^ (Gorbach 1971). These differences  
are best i l lu s tra te d  by a b r ie f  comparison of the bacterial 
populations in the main regions of the gastrointestinal t ra c t .
A more detailed description of the flo ra  already mentioned 
and th e ir  d is tr ibution in man, rabbit, guinea pig, ra t  and mouse 
is available elsewhere (Drasar, et al_ 1970; Williams ^  ^  1971). 
particu la r ly  in the case of the human flo ra  (Drasar and H i l l ,  1974). 
The results are summarised in Table 1.1 and 1 .2 .
1. The mouth: From a metabolic point of view, the f lo ra  of 
the mouth is probably unimportant. In man the flo ra  probably r e f le c t  
the d iffe r in g  micro-environments available with the bacteria reaching 
the stomach mainly using the saliva as a vehicle.
2. The stomach: The bacterial count of the stomach is dependent 
upon the time of sampling since the source of bacteria is normally
20
Table 1.1 -  compiled from Scheline, 1973; Drasar and H i l l ,  1974.
Mi cro-organisms Description
Bacteriodes S tr ic t ly  anaerobic gram -ve b a c i l l i .
None spore forming rods. Most numerous organism 
in the in testina l trac t .
Lactobacilli Facultatively anaerobic gram +ve rods.
Bi fidobacteri a S tr ic t ly  anaerobic gram +ve rods v. common.
Fusobacterium S tr ic t ly  anaerobic gram -ve rods.
Enterobacteria Facultatively anaerobic gram -ve rods.
(a) E. Coli
(b) Aerobacter
(c) Klebsiella
(d) Proteus.
Often termed Coli forms.
Clostridi a S tr ic t ly  anaerobic gram +ve spore forming b a c i l l i .  
Do not occur in large numbers.
Streptococci Mainly facu lta tive ly  anaerobic gram +ve cocci.
Pseudomonads S tr ic t ly  aerobic gram -ve motile rods.
Usually in small numbers, eg. Ps. Aeruginosa about 
50 per g faeces.
Staphylococci Aerobic or facu lta tive ly  anaerobic gram +ve cocci.
Ve il lone lla Anaerobic gram - ve cocci.
Yeasts
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the food. In man the stomach contents are often s te r i le  
(Dick, 1941; Drasar et ^  1969). Even a f te r  a meal, human 
stomach contents contain a hundred-fold less bacteria per 
unit sample weight than in the mouse, ra t or guinea pig. This 
difference may be due in part to the fact that animals tend 
to eat continually, though i t  is more l ik e ly  that gastric  
acid in man eliminates bacteria. This view is supported by 
the fact that the rabb it , another good producer of gastric  
acid possesses very few stomach bacteria. In some animals 
there are additional sources of bacteria. The r a t ,  mouse 
and occasionally the guinea pig are coprophagic and the mouse 
has in the stomach a non-secretory area of epithelium that  
is permanently colonised with bacteria (Williams et al_ 1971).
3. Proximal small in tes tin e : Stomach contents may
begin passage into the duodenum before gastric acid reaches 
bactericidal levels again thereby populating the small in tes tin e .  
The fac t that animals feed continuously w i l l  aid this transfer  
of bacteria and may explain the higher population in the proximal 
small intestine in animals than man, assuming that this is not 
due to differences in m ultip lication rates (Williams e t al
1971). In the ra t  and mouse lactobaciH i,bacteriodes and 
bifidobacteria predominate as they do throughout the t ra c t .
4. The distal small in tes t in e : In the rabb it, guinea pig 
and especially in man, the bacterial population of the lower 
small intestine is in marked contrast to the upper regions, 
housing a considerable f lo ra  (Cregan and Hayward, 1953; Drasar 
et al 1970). In man, the numbers of bacteria increase rapidly
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towards the terminal regions of the ileum (Drasar, et al_, 1969) 
where a t  this point the flo ra  of man closely resembles that of 
laboratory animals.
Table 1.2 Distribution of the gut f lo ra  between species^.
Region of 
. G . I .  trac t
log-|Q viabl e counts/g wet sample
Man Rabbit Guinea
Pig
Rat Mouse
2mouth 5-7 _3 - - -
stomach 0t5 0-6 5-6 7-9 7-9
prox.s .intestine 0-5 0-5 5-6 6-8 7-9
D is t .s .in tes t in e 6-7 6-7 6-7 7-8 7-8
L. intestine 7-10 8-9 8-9 8-9 8-9
Rectum & Faeces 10-11 9-10 9-10 9-10 9-10
1 . Drasar ejt ^  1970
2. Drasar and H i l l ,  1974
3. No evidence available
5. The large in tes tine , rectum and faeces: L i t t l e  information 
is available concerning the f lo ra  of the large in testine but i t  has 
been said that the d istr ibution of bacteria in the faeces should be 
a close re flection  of the contents of the large in testine and rectum 
(Williams ^  1971). Results in man (Seèliger and Werner, 1963) 
and in the rabbit, guinea pig, ra t  and mouse (Drasar e t al_ 1970)
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suggest quite a close resemblance in the numbers of the more
common members of the flo ra  in the large in tes tine . In the
faeces, bacterial counts are at a maximum with figures of 
9 10between 10 and 10 counts per gram wet sample for common 
laboratory animals. In man, the d istribution  is very s im ila r ,  
bacteriodes and bifidobacteria predominating in approximately 
equal amounts although the total count is now of the order of 
ten times the count per unit sample weight in laboratory 
animals. There are more lactobac iH i and streptococci in the 
faeces of rats and mice than in man who shows fa r  more 
enterobacteria than in rabbits and guinea pigs (Drasar, 
et al 1970).
The d istr ibution  of the f lo ra  in the G .I .  t ra c t  shows 
quantitative differences between man and rabbit and the other 
common laboratory animals. In the ra t  and mouse, large bacterial 
populations occur at a fa r  e a r l ie r  stage and this may give r ise  
to important species variations in the metabolism of foreign  
compounds. Such variations are feasible with compounds which 
are normally absorbed before reaching the d ista l small in testine  
and therefore metabolism in the ra t and mouse is possible but 
in man and the rabbit i t  is most unlikely.
Further details  of the d istr ibution and id en tit ie s  of the 
gastrointestinal f lo ra  are available elsewhere (Smith 1965; 
Williams et al 1971; Drasar et al 1970; Drasar and H i l l , 1974).
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Metabolic Reactions of Gastrointestinal Microorganisms
Of the great variety  of types of metabolic transformations 
possible by in testinal microorganisms, the majority may be 
c lassified  under two main groupings, namely:-
1. Hydrolytic processes
2. Reductive processes
1. Hydrolytic processes
(a) Hydrolysis of Glycosides: Glycosides entering the body
are usually of three main orig ins, the d ie t ,  therapeutic glycosides 
and glucuronides b i l ia r y  excreted by the l iv e r .  The bacterial 
glycosidases especially 3-glucuronidase of the G . I .  t rac t  have 
been well described (Drasar and H il l  1974).
( i )  Glucuronide hydrolysis: The hydrolysis of glucuronides is
one of the most common of the metabolic reactions of microorganisms 
of the G . I .  t ra c t .  What is so interesting about this reaction  
is that although the associated aglycone may be of diverse o r ig in ,  
the conjugate is so often produced endogenously. Transport of 
the conjugate to the in testinal lumen is essential for  bacterial 
attack and in the majority of cases this occurs via b i l ia r y  
excretion of the conjugate by the l iv e r .  Upon hydrolysis, the 
liberated aglycone may be reabsorbed from the in tes tina l lumen 
to be reconjugated by the l iv e r  and thereby establish an entero- 
hepatic c ircu lation of the compound. This subject has been
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reviewed (Smith 1966).
( i i )  Other glycosides: The majority of plant glycosides are 
glucosides in which the sugar moiety may be a or 3 linked in 
contrast to the specific 3-linkage of glucuronides. Many 
examples of the hydrolysis of a or 3 glycosidic linkages ex is t  
but an example worth special attention is the case of cycasin 
(methylazoxymethyl glucoside). This compound, a constituent 
of cycad nuts is carcinogenic by mouth but not by i .p .  in jec tion .  
An explanation for this observation is that the glucoside is  
hydrolysed by members of the in testinal f lo ra  to the aglycone 
(methylazoxymethanol) which may be then further metabolised 
by the tissues to diazomethane the proximate carcinogen 
(Laqueur, 1964; Kobayashi and Matsumoto 1965). Glycoside 
hydrolysis is important in the metabolism of cardiac glycosides 
(e .g. Lauterbach and Repke, 1960).
(b) Hydrolysis of sulphate esters: Gut sulphatase a c t iv i ty
has been shown to be mainly of microbial orig in (Eriksson and 
Gustafsson, 1970) but few examples of sulphate hydrolysis ex is t  
and the reaction appears to be uncommon. The majority of 
sulphates examined appear to undergo l i t t l e  or no hydrolysis by 
the gut microflora (Scheline 1968a; Garton and Williams, 1949; 
Hawkins and Young, 1954).
(c) Hydrolysis of glycine conjugates: Glycinase a c t iv i ty  
is present in the gut and has been shown in the case of several 
b ile  acids to be of mainly bacterial orig in (Norman and Grubb 
1965; Drasar, 1967). Hippuric acid (Norman and Grubb, 1955) and
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aminohippuric acids (Hulsmann et ^  1967) are examples of simpler 
glycine conjugates readily  hydrolysed by gut bacteria.
(d) Other hydrolytic reactions: The hydrolytic v e rs a t i l i ty
of gut microorganisms is further i l lu s tra te d  by b r ie f  reference 
to other types of hydrolysis that have been reported. Amides 
may be hydrolysed by gut bacteria, a good example being the 
formation of sulphathiazole ( I I )  the active metabolite of 
the antiseptic succinyl sulphathiazole ( I )  (Winstein 1970). 
Carboxylic acid esters are occasionally hydrolysed by gut 
microorganisms. The hydrolysis of chlorogenic acid ( I I I )  to 
quinic and dihydroxycinnamic acids and the hydrolysis of the 
lactone dihydro coumarin (IV) to m e ll i lo t ie  acid (V) (Scheline, 
1968c) are good examples. The la t te r  reaction has also been 
regarded as an example of ring fission (Williams, 1972). Ester 
hydrolysis a f te r  oral administration does not necessarily 
indicate bacterial a c t iv ity  since esterases are normally present 
in the in testinal mucosa or i ts  secretions. The cases of 
aspirin (Levy and Angelino, 1968) and reserpine (Glazko, e t  al 
1956) are typical examples of the la t t e r .  ,
moc-cH^ cH^ -comy ^
(I)
( I I )
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CH = CH
HO
( I I I ) ( I V )
0 ^ 0
u S O g H
(VI) (V I I )
Sulphamate and n itra te  hydrolysis by in testinal microorganisms 
have been reported but examples are few. In the case of 
sulphamates only one well documented example exists but is of 
great in teres t. The a r t i f i c ia l  sweetener cyclamate (N-cyclo- 
hexyl sulphamate,VI) has been shown to be p a r t ia l ly  converted 
to the potentia lly  toxic cyclohexylamine (V I I )  by 'tra ined ' 
bacteria and w il l  be discussed la te r  although the history has 
been reviewed (Anon, 1972). The hydrolysis of pentaerythritol 
te tra n itra te  by in testinal bacteria has been proposed but not 
confirmed (Di Carlo et al 1967).
2. Reductive Reactions:
The dominant organisms in the intestine are anaerobic and 
therefore the more important reactions for which the gut micro- 
f lo ra  are responsible are l ik e ly  to be of a reductive nature 
(Williams 1972). This is supported by the fac t that the oxidation  
or redox potential (Eh) of the normal mouse caecum is about 
-200 mV but a fte r  reducing the population of the f lo ra  by
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treatment with a n tib io t ics , the Eh rises to about + 200 mV 
(Meynell, 1963). I t  is interesting to note how the role of 
the f lo ra  is therefore often in d irect opposition to the 
usual tissue metabolic processes of the body. The metabolism 
of foreign compounds by the tissues usually consists of an 
i n i t i a l  phase I oxidation step to compounds of a more 
polar and hydrophilic nature thereby fa c i l i ta t in g  urinary  
excretion. A subsequent phase I I  conjugation step may 
improve upon the la t te r .  However the reductive nature of 
the gastrointestinal f lo ra  often leads to a reduction in 
polarity  and hydrophilic character and therefore a retaining  
action upon the compound rather than a rapid excretion.
The retaining action w ill  often be in the form of an entero- 
hepatic circulation of the compound and increases the p o ss ib il i ty  
of toxicological actions.
Although almost a l l  bacterial transformations can be 
argued to be of a reductive nature the more obvious examples are 
those of azo reduction, o le f in  reduction, decarboxylation, 
reduction of aldehydes, ketones and nitro  compounds and the 
reduction of N-oxides and arsonic acids.
( i )  Azo reduction: The observations that azo compounds are
s p l i t  by gut microorganisms has led to considerable attention  
being devoted to the subject in recent years since the metabolic 
products of these water soluble dyes (so widely used as food 
colouring agents) are usually aromatic amines (Daniel, 1962).
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More is known of the bacterial metabolism of azo compounds than 
any other group of xenobiotics and much of this has been reviewed 
(Walker, 1970).
( i i )  Olefin reduction: The reduction of double bonds by gut 
microorganisms appears to be a f a i r ly  common reaction. This is  
much more so in the case of a,g-unsaturated carboxylic acids 
and esters. Thus caffe ic  acid ( V I I I )  is ,  in part, reduced to 
phenyl propionic acid derivatives by various in testina l  
bacteria (Peppercorn and Goldman 1971) and by monkey faecal 
bacteria (Hanson and Crawford, 1968). The a,g-unsaturated 
system in indoyl-3-acry lic  acid (IX) is s im ilarly  reduced
when incubated with monkey faeces (Hanson and Crawford,
1968) as is the a,g-unsaturated lactone system in the conversion 
of coumarin (X) to dihydrocoumarin (IV) by ra t  caecal contents 
(Scheline, 1968c).
( i i i )  Nitro reduction: One of the e a r l ie s t  and most interesting  
examples of n itro  reduction was described for the a n t ib io t ic  
chloramphenicol (X I) .  Although in man, 90% of the drug suffered 
urinary excretion, extensive b i l ia ry  excretion occurred in lower 
animals resulting in the formation of large amounts of aryl 
amines which were excreted in the faeces (Glazko, ^  1949). I t  
was subsequently shown that the reduction was a ttr ib u tab le  to
gut microorganisms (Smith and Worrel, 1950). Nitro reduction 
by in testinal bacteria has also been reported for the herbicide 
t r i f lu r a l i n  in the rat and dog (Emmerson and Anderson, 1966) and
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in rumens (Golab, £ t  ^  1969) and extensive studies of 
simpler aromatic n itro compounds have also been described 
(Bray et ^  1953).
( iv )  Reduction of aldehydes, Ketones and alcohols: The
l i te ra tu re  does not contain many examples of such reductions 
by in testinal bacteria although these reactions are fa r  from 
being unknown. Benzaldehyde derivatives are reduced to 
benzyl alcohols by ra t  caecal contents (Scheline 1972) and 
certain Keto steroids including estrone derivatives have 
been reduced to the corresponding carbinols with various 
faecal incubates (Stimmel 1954; Gustafsson £ t  al_ 1966). Non­
steroidal ketone reductions are also known as in the case of the 
complete reduction of the a,g-unsaturated system in daidzein 
(7,4'-dihydroxyisoflavone (X I I )  by rat caecal contents 
(G r if f i th s  and Smith, 1972).
CH = C H -C O g H
( V I I I )
CH = C H .C O g H
NHCOCH-  
/  ^
H-CH 
OH ^ CHgOH
( X I )
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Aliphatic alcohols may be reduced to the parent hydrocarbons 
thus in the case of various benzaldehyde derivatives, the 
f in a l products of incubation with rat caecal bacteria were 
often toluene derivatives as well as benzyl alcohols (Scheline 
1972, 1975).
(v) Reduction of arsonic acids and N-oxides: Gut bacteria
are capable of reducing arsonic acids and N-oxides. Thus ( - )  
nicotine-1'-N-oxide is reduced by in testinal microorganisms 
in man and the ra t  to free nicotine (Beckett et ^  1970; Dajani 
ËÎ. i L  1972) and the poultry growth promoter 4-nitrophenyl 
arsonic acid is reduced to the arsenoxide when incubated with 
hen faecal bacteria (Moody and Williams 1964).
3. Other Reactions of the Gastrointestinal Flora:
Many other types of bacterial transformations ex is t and are 
best l is ted  in table form - Table 1.3. The dealkylation  
reaction in Table 1.3 is beautifu lly  i l lu s tra te d  by the removal 
of the C-jQ methyl substituents of certain steroids which in  
the case of 1 ,4-diene-3-one systems results in aromatisation 
of ring A upon énolisation. The dehydrogenation and subsequent
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aromatisation of 4-androste n -3 ,17-dione by certain human 
c los tr id ia  is an excellent example (Goddard and H i l l ,  1971,
1972).
Table 1.3
metabolic reaction abundance Reference example
Decarboxylation V.common Scheline (1973)
Dealkylation V.common Scheline (1966a)
Dehalogenation q.common Scheline (1968a)
Deamination q.common Booth & Williams (1963)
Dehydroxylation q.common Dacre et ^  (1968)
Ring Fission q.common Scheline (1973)
Nitrosamine
formation
f.common Klubes and Jondorf
(1971)
Isomérisation uncommon Kemp & Dawson (1968)
Hydroxylation rare Thomas (1970)
E stérif ica tion v.rare Rosenfield e t (1967)
Acétylation one example 
only
Sjaastad (1966)
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Factors which may influence the Bacterial Metabolism of Foreign 
Compounds in the Gastrointestinal T ract:
Although in the past the tissues were usually considered 
to be the major sites of foreign compound metabolism, i t  is now 
quite certain that in testinal microorganisms are responsible 
for  many metabolic changes that can occur when foreign 
compounds enter the gastrointestinal t ra c t .  Furthermore, 
ju s t as a great variety of factors may influence the way in 
which foreign compounds are metabolised by the tissues, a 
variety  of circumstances may a ffec t the bacterial metabolism 
of these compounds.
1. Site of absorption: The subject of gut absorption
has been well described (Smyth, 1970; Crampton, 1970). In 
short, the l ip id  membrane of the cells  lin ing the gut wall is  
permeable throughout its  length to l ip id  soluble compounds. 
Generally, the absorption is a passive process although some 
compounds such as vitamins, nucleotides, glucose and amino 
acids may be actively  transported. Compounds with high l ip id  
s o lu b il i ty  and present in a non-ionic form w ill  suffer absorption 
towards the extreme proximal end of the small in testine  unless 
administered in large saturating doses. Thus the rate of absorption 
of a foreign compound w ill  determine the extent to which metabolic 
degradation by in testinal microorganisms w il l  occur. In man and 
the rabbit the weakly colonised nature of the upper small in testine  
enables the more easily absorbed compounds to escape extensive 
bacterial action. However, in the case of the ra t  and mouse, 
extensive metabolism even of l ip id  soluble foreign compounds may
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occur due to the fact that the upper reaches of the gastro­
in testinal tra c t  in these animals usually harbours a 
re la t iv e ly  rich and permanent f lo ra .  Indeed, in the mouse, 
metabolism may occur as early as the stomach. These facts  
indicate how species differences between the ra t and mouse 
and the group comprising man, rabbit and guinea pig may 
arise and therefore how variations in pharmacological and 
toxicological a c t iv i ty  are possible. Compounds which are 
poorly absorbed w il l  reach the heavily populated regions 
o f the lower ileum and the colon in which case the nature of 
the anima Vs microflora w i l l  influence the metabolic fa te .
2. Species variations: The subject of how species
variations in the d istr ibution of the f lo ra  (e.g. due to 
copraphagy) may give rise to species differences in metabolism 
has been covered in the previous section. However, there are 
other ways in which species variations in bacterial metabolism 
may arise. Variations in the populations of particu lar strains  
of bacteria between various species may account for observed 
differences in metabolism. Studies using specific members of 
the f lo ra  have shown some members to be more important than 
others between d if fe re n t  animalSo Thus in the case of cyclamate 
i t  has been shown that enterococci in man and c lo s tr id ia  
and enterobacteria in rats and rabbits were mainly responsible 
for the formation of cyclohexylamine (Drasar, e t al_ 1971, 1972).
In addition, studies of the levels of various microbial 
glycosidases has shown that there is less g-glucuronidase a c t iv i ty  
in the small in testine of man, rabbit and guinea pig than in the 
mouse and rat (Hawksworth et 1971) and probably re flects  the
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degree of colonisation of this area of the gastrointestinal 
t rac t between these species. The microbial-dependent metabolism 
of quinic acid shows considerable species variation and has 
been attributed to differences in the gut f lo ra  (Adamson e t al
1970).
3. Effect of d ie t : The d ie t may have a considerable
e ffec t  on the nature of the gastrointestinal f lo ra  and the 
subject has been reviewed (Donaldson 1964). Clearly  
therefore, the d ie t may have an important influence on the 
metabolism of certain compounds merely by affecting the 
population of the strains of bacteria responsible. Thus the 
in testina l hydrolysis of the glycoside hesperidin to i ts  
aglycone (hesperitin) occurs in rabbits fed a purified d ie t  
but not when maintained on a commercial p e lle t  food (Booth 
e t£ l_  1958). Also the 4-dimethyl ami no-azobenzene azo reductase 
a c t iv ity  of caecal incubates is lowered in rats fed low r ibo­
f la v in  levels (Williams et ^  1970).
4. Effects of starvation: The e ffec t of starvation may, 
l ik e  the d ie t ,  a l te r  the re la tive  abundance of many members of 
the gastrointestinal f lo ra  and thereby a l te r  i ts  metabolic 
p ro f i le .  At a time when experiments using fasted animals is so 
common, i t  is important to appreciate the possible consequences 
starvation may have on gastrointestinal metabolism. Thus the 
glycoside amygdalin is toxic o ra lly  due to the release of 
hydrolytic enzymes by the gastrointestinal f lo ra ,  but is fa r  
less toxic in animals fasted for 48 hrs (Smith, 1971).
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5. Effect of coprophagy: Many of the lower species of
the common laboratory animals especially rats and mice are 
coprophagic and therefore the e a r l ie r  regions of the gastro­
in testinal t rac t  in these animals may be heavily populated 
by comparison because of this action. For compounds normally 
absorbed in these regions this may be an important consideration 
when explaining species differences in metabolism between for  
example man and the ra t .  Furthermore, in coprophagic animals 
faecal metabolites are l ia b le  to suffer further metabolic 
transformation due to re -in jes t io n .
6 . Effect of age: L i t t l e  information is available on the 
e ffec t of age upon metabolism by the in testinal microflora.
However, i t  is important to note that the gastrointestinal tracts  
of the new born are i n i t i a l l y  s te r i le .  The trac t soon becomes 
populated upon feeding and the nature of the flo ra  w i l l  to some 
extent be diet-dependent. Thus the enterohepatic recirculation  
of d ie th y ls t i lb o e s tro l, which occurs via bacterial hydrolysis
of the glucuronide conjugate followed by reabsorption, is v ir tu a l ly  
absent in 0-5 day old rats (Fischer and Weissinger 1972). I t  
may well be that the absence of an in testinal f lo ra  a t th is  age 
is important in that unnecessary exposure of the l iv e r  to such 
deconjugated foreign compounds is avoided.
7. Effect of drugs and an tib ac te r ia ls : Drugs having an 
antibacteria l e ffec t  profoundly a ffec t the nature and d is tr ib u tio n  
of the flo ra  within the gastrointestinal t rac t (Luckey, 1959). 
Examination of the effects of a variety of antibacteria l  
substances has shown that at least in man, selective modifications
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in the nature and d istr ibution  of the gastrointestinal f lo ra  
is possible (Fingold 1970). Thus kanamycin w ill  largely  
eliminate aerobic and linomycin anaerobic bacteria and a n t i ­
biotics such as p e n ic i l l in  may eliminate la c to b a c il l i  but 
yet greatly increase counts of enterococci and gram negative 
bacteria (Dubos ^  1963). Clearly the use of 'germ free '  
animals (via suitable antibacteria l treatment) is useful 
in determining i f  bacterial metabolism is occurring. In 
addition i t  may also be useful to use various selective  
modifications to the flo ra  as an aid to identify ing the ; 
species responsible for particu lar processes. During the 
c lin ic a l use of a n tib io t ics , the consequences of a lte r ing  
the metabolic p ro fi le  of the gastrointestinal trac t should 
be given consideration. F ina lly  in work with germ free animals, 
i t  should be noted that hepatic enzyme levels may also have 
been modified (Luckey, 1963).
8 c Generation of an enterohepatic c irc u la t io n : The l iv e r
conjugates (usually glucuronides) of foreign compounds or 
th e ir  phase I metabolites may be excreted in the b i le  i f  the 
resulting conjugate has a molecular weight in excess of about 
300 (Milburn, 1970). Thus as opposed to urinary metabolites 
which are usually rapidly excreted from the body, such b i l ia r y  
metabolites may be held for long periods since these compounds 
w il l  come into contact with hydrolytic enzymes notably 
g-glucuronidase supplied by the in testinal m icroflora. Hydrolysis 
of such conjugates may lead to reabsorption of the aglycone from 
the in testinal lumen resulting in the generation of an entero-
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hepatic c irculation of the compound. Retention of foreign 
compounds by these means may have serious toxicological 
implications since the compound w il l  have a longer time in 
which to exert i ts  biological action. The metabolism of 
stilboestrol is a good example of the la t te r  phenomenon. When 
given o ra lly  or by in jection , stilboestrol glucuronide is 
excreted to a s ign ificant extent in the b i le ,  upon contact 
with the gastrointestinal f lo ra  the conjugate is hydrolysed 
and readily  reabsorbed resulting in a considerable delay in 
the excretion of this compound. Gastrointestinal microorganisms 
and the enterohepatic c ircu lation of foreign compounds has been 
the subject of considerable discussion (Smith, 1966, 1970;
Drasar and H i l l ,  1974).
9. Metabolic adaption to foreign compounds: As already
described, many compounds especially antib iotics  may have 
profound effects upon the nature and d istr ibution of the 
gastrointestinal f lo ra .  However, in some cases a compound 
may modify the flo ra  only to the extent that i ts  own metabolism 
is affected. Few cases of such a metabolic adaption have been 
described one of best examples, however, being the conversion of 
cyclamate to cyclohexylamine which is described la te r .  Orotic 
acid is a further example in that this compound on feeding to 
naive rats is excreted unchanged in the faeces. Continuous 
feeding for 5 days, however, results in the disappearance of this  
compound from the faeces. Further experiments indicated that  
in testinal microorganisms were involved (Windmueller et £]_ 1965).
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Although apparently uncommon, the metabolic adaption of in testina l  
microorganisms to foreign compounds raises an important consideration 
in that the to x ic ity  of o ra lly  ingested foreign compounds may only 
arise a f te r  continued exposure.
Pharmacological and Toxicological Significance of Metabolism by 
Gastroi ntesti nal Microorganisms
Pharmacological implications: Oral administration of drugs
usually results in the drug being exposed to the metabolising 
capacity of the gastrointestinal f lo ra .  Consequently, ju s t  
as the tissues frequently metabolise drugs to compounds which 
are responsible for the drugs action i t  is possible fo r such 
active metabolites to be generated by the gastrointestinal 
f lo ra .  In addition, drugs given by in jection may s t i l l  form 
active metabolites through bacterial degradation i f  the 
compound is b i l ia r y  excreted to any appreciable extent (Smith,
1966). Thus i t  has been shown that imipramine is demethylated 
to the active metabolite desmethylimipramine by microorganisms 
in the gastrointestinal trac t  as well as by the l iv e r  (Minder 
Ê l  1971). The sulphonamides succinyl and phthalyl sulpha­
thiazole have been shown to be hydrolysed to the active  
metabolite of these antibacteria ls  (sulphathiazole) by the 
gastrointestinal f lo ra  (Winstein, 1970), and many other examples 
have been compiled (Scheline 1973).
Toxicological s ignificance: The metabolism of foreign
compounds is not always a beneficial or detoxicative process.
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indeed metabolites of a more toxic nature can be released.
This is especially the case with bacterial metabolism since 
by the very nature of the Eh of the gastrointestinal t ra c t ,  
metabolic processes are usually reductive rather than oxidative  
and therefore do not usually afford read ily  excreted hydro­
p h ilic  materials. These processes may often be described 
as being in d irect opposition to the tissue processes.
Again, in contrast to tissue metabolism the metabolic reactions 
of the flo ra  w i l l  often lead to a retaining of the compound 
by the body, for example via an enterohepatic c ircu lation  
allowing the compound to exert i ts  toxic action for a longer 
period. Many examples of the potentia lly  toxic metabolic 
processes of the f lo ra  have been compiled (Scheline 1973;
Drasar and H i l l ,  1974; Williams,1972)«but of the more interesting  
and environmentally important examples are the cases of cyclamate, 
amygdalin and cycasin.
The sweetening agent cyclamate (N-cyclohexylsulphamate) 
is a highly polar compound and therefore poorly absorbed. When 
taken o ra lly  therefore cyclamate may be exposed to the f lo ra  
for some considerable time during which small quantities of 
cyclohexylamine (a possible carcinogen) may be formed, absorbed, 
and then excreted in the urine. Naive subjects do not metabolise 
cyclamate(Renwick and Williams , 1972a) e ither a f te r  oral or 
i .p .  administration. However, continued oral administration in 
man results in small amounts of urinary cyclohexylamine being
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formed in some subjects (Renwick and Williams 1972b). This 
observation has been proposed as being due to a metabolic 
adaption of the flo ra  in these individuals to the cyclamate 
which is not as yet understood. What is so interesting  
in cases of compounds such as cyclamate is that to some 
individuals only, certain foreign compounds may be 
toxic (possibly carcinogenic), p articu la rly  in the long term.
several minor
SO3H ^  including^^
N-cyclohexyl 
hydroxyl ami ne
(Drasar, e t ^  1970)
Amygdalin a glycoside of mandelonitrile is present in 
the seeds of b i t te r  almonds and is fa r  more toxic in the mouse 
by oral administration than by intraperitoneal in jection -  
LDgQ oral 300 mg/kg, i .p .  >5000 mg/kg (Williams 1972). I t  has 
been shown that the oral to x ic ity  of this compound may be 
attributed to the release of hydrogen cyanide following an 
i n i t i a l  hydrolysis of the glycoside to the unstable cyanhydrin 
of benzaldehyde (m andelonitrile), (Smith, 1971). Many other 
similar cyanhydrin conjugates are present in various plants 
used as food stuffs (Drasar and H i l l ,  1974) and are a potential 
source of cyanide release in the in testine .
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CH(CN)0-g-D-Glucose-g-D-Glucose
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CH(CN)OH CHO
+ HCN
A sim ilar toxic hydrolysis presents i t s e l f  in the 
case of cycasin (methylazoxymethyl glucoside) a component 
of cycad nuts, one of the principal sources of starch for  
people l iv in g  in South East Asia* The nuts are only 
suitable as food however a fte r  suitable processing since the 
nuts have been shown to be toxic to both man (Whiting 1963) 
and c a tt le  (Mason and Whiting, 1966) and have been shown to 
produce tumours of the gut, l iv e r  and kidney (Laquer and 
Spatz 1968). The oral to x ic ity  of cycad nuts is believed
0
t
CH.-N = N
\
CH3.N
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0
t
N
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\
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CHq-N = N - * 0
CHgOH
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to be due to the hydrolysis of the cycasin they contain by 
hydrolytic enzymes of the gastrointestinal f lo ra .  The 
liberated aglycone (methylazoxymethanol) is then probably 
metabolised further by the tissues, eventually yielding  
diazomethane which is believed to be the proximate carcinogen 
capable of methylating DNA and RNA (Williams ^  1971). The
fact that in testinal microorganisms are involved has been 
demonstrated by the fact that cycasin is non-toxic by in jection  
and is without to x ic ity  in germ free animals (Williams et al
1971).
Gastrointestinal Flora and Carcinogenesis
I t  has been suggested that upto 80-90% of cases of cancer 
in humans may be of environmental aetiology and therefore  
preventative measures should be possible (Drasar and H i l l  1974). 
Some of the carcinogens responsible may be formed as metabolites 
of dietary precursors rather than d irect carcinogens and the 
possible role of the gut flo ra  in such processes should not be 
ignored.
In the case of cancer of the colon i t  has already been 
shown (Drasar and H i l l ,  1972) that the disease is more prevalent 
in the developed nations of N*America and H.W. Europe than most 
of A frica , South America and Asia, although Japan is a major 
exception, having the lowest colon cancer incidence rate  
(Drasar and H i l l ,  1972). Furthermore, the rates have been found 
to correlate well with the metabolic a b i l i t y  of the f lo ra  and 
steroid content of the faeces as well as fa t  and protein intakes.
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Striking differences have been noted between the nature of the 
f lo ra  between the two groups of people (Drasar and H il l  1972).
Many examples of the production of possible carcinogens 
via metabolism by gastrointestinal microorganisms now existe  
Thus cycasin is converted to methylazoxymethanol (Williams 
et ^ 1 9 7 1 ) ,  7,12-dimethylbenz(a)anthracene is non-toxic to 
germ free C3H mice (Roe and Grant, 1970), cyclamate may be 
converted to cyclohexylamine (Drasar, et aj_ 1971) and the 
carcinogen ethionine is synthesised by Escherichia coli (Fischer 
and Mai l e t t e r , 1961). Furthermore, in testinal bacteria may 
metabolise b ile  salts (Norman and Grubb, 1955) and certain  
steroid hormones (Goddard and H i l l ,  1971) when i t  is known 
that a number of steroids, e.g. estradiol (Cutts, 1965) have 
been shown to be carcinogenic in animals. The bacterial conversion 
of b ile  salts and other steroids leading to cancer of the bowel 
(H il l  et £]_, 1971a; Renwick and Drasar 1976) and cancer of the 
breast (Hi 1 1 , ^ ^  1971b) has already been suggested and 
discussed. There is also considerable evidence to suggest that  
in testinal bacteria may have the a b i l i t y  to convert n itra te  
(via n i t r i t e )  and secondary amines to carcinogenic d ia lk y l-  
nitrosamines (Hawksworth and H il l  1971).
Carcinogens from steroids: As already stated the p o ss ib il i ty
that gut microorganisms may produce carcinogenic metabolites of 
certain steroids must not be overlooked. However, i t  is  also 
feasible that bacteria may be able to convert a suitable steroid
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nucleus into a polycyclic aromatic carcinogen by a series of 
aromatisation mechanisms known to be possible separately 
(Drasar and H il l  1974).
The following reactions of microorganisms upon steroid  
nuclei are known (Drasar and H i l l ,  1974):
1. Introduction of a double bond to conjugate with a 
ketone.
2c Déméthylation of C^q methyl group.
3. Dehydration.
4. Conjugative introduction of additional double bonds.
5. Oxidation of ring A hydroxyl.
Using these reactions a route from a typical b ile  acid to a 
substituted cyclopentaphenanthrene derivative with carcinogenic 
potential may be formulated as in Figure 1 . 2 .
Additional comprehensive information on the subject of 
in testinal bacteria and cancer has recently become available  
(Drasar and H i l l ,  1974).
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Fig. 1 .2 (Drasar and H i l l ,  1974)
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CHAPTER 2
The metabolism of shikimic acid by 
gastrointestinal microorganisms
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INTRODUCTION
Shikimic acid ( I )  is a highly polar compound with considerable 
hydrophilic character. As a resu lt the compound is poorly absorbed 
from the in testine (Chapter 5) and therefore l ia b le  to prolonged 
exposure to the gastrointestinal microflora. In addition, the 
compound contains features apparently suited to some of the more 
common metabolic reactions of the gut f lo ra  such as dehydroxylation 
(Dacre, 1968), decarboxylation (Scheline, 1966a, 1966b), reduction 
of a ,3 “Unsaturated carboxylic acids (Peppercorn and Goldman 1971, 
Hanson and Crawford 1968) and ring fission (Scheline 1968a).
COOH
HO., ^COOH
HO : ^  ho' ^  OH
OH
O^H
( I )  OH ( I I )
The claim that shikimic acid is carcinogenic in the mouse (Evans 
and Osman 1974) makes a study of the microbial metabolism of  
this compound desirable since an increasing number of compounds 
are being shown to be activated in this way. Thus cycasin is  
converted to methylazoxymethanol and possibly diazomethane by 
the gut f lo ra  (Williams ^  ^  1971), 7 ,12-dimethylbenz(a)antbracene 
is non-toxic to germ free mice (Roe and Grant 1970), cyclamate may 
be converted to cyclohexylamine (Renwick and Williams 1972), the 
carcinogen ethionine is synthesised by E.coli (Fischer and M alle tter  
1961) and the aromatisation of b i le  s a lts ,  or the re to x if ic a t io n  of 
l iv e r  metabolites of polycyclic aromatic hydrocarbons, may be
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important in the aetiology of colon cancer (H il l  £ t  ^  1971a, 
Aries ^  ^  1969, Renwick and Drasar 1976).
The oral administration of shikimic acid or qui n ic acid ( I I )  
to animals results in an increased urinary excretion of hippuric 
acid (Asatoor 1965, Booth et al_ 1960, Adamson e t ^  1970). I t  
has been proposed that the gut f lo ra  are responsible for the 
aromatisation since the metabolism is prevented in animals in 
which the f lo ra  has been suppressed with neomycin (Asatoor 1965, 
Adamson et ^  1970). An in i t ia l  microbial conversion to benzoic 
acid has been proposed since the conjugation of the la t t e r  with 
glycine in the mammalian tissues would account for the observed 
excretion of urinary hippuric acid (Asatoor 1965, Adamson e t  al 
1970, Cotran et ^  1960, Scheline and Indahi 1973).
A closer study of the metabolism of shikimic acid by gastro­
in testinal microorganisms has been carried out both with a view 
to establishing the mechanism by which shikimic acid is 
ultim ately excreted as hippuric acid and in an e f fo r t  to observe 
microbial metabolites which may support the po ss ib il i ty  of 
shikimate carcinogenicity.
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MATERIALS AND METHODS
Chemicals
Shikimic acid (m.p. 189-190°) was obtained from the 
Sigma Chemical Company, St. Louis, Minnesota, USA, [G-^^C]
-1shikimic acid (specific a c t iv i ty  20.7 mCi mmole )
from New England Nuclear Chemicals, Dreieichenhain, W. Germany 
and [r ing -U -^ \]benzo ic  acid (specific a c t iv i ty  108 mCi mmole’ ^) 
from the Radiochemical Centre, Amersham, Bucks, U.K. Yeast 
extract was obtained from the Difco Laboratories, D e tro it ,
Michigan, USA, and proteose peptone from Oxoid L td . ,  London,
All compounds used in isotope d ilu tion  studies or as chromatography 
standards were purchased from commercial sources. V a n il l ic  
acid was prepared by the method of Pearl (1963).
Animals
Male Wistar albino rats (220-250 g) were used as a source 
of caecal contents. Faeces or in testinal contents of a varie ty  
of animal species were collected from adult animals which had 
been resident in the animal un it for a period of a t least 5 days.
Measurement of rad ioactiv ity
Aqueous or non -aqueous samples (50 y l ) were dissolved in
0.5 ml of water and 4 ml of a Synperonic NXP-toluene-2,5-diphenyl-
14oxazole s c in t i l la n t  (Wood et ^  1975) and C determined in an 
LKB 1210 liqu id  s c in t i l la t io n  counter.
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Incubations with ra t  caecal contents
The in v itro  incubation of test compounds with samples of  
ra t  caecal contents was carried out using methods sim ilar to 
those described by Scheline (1966a). Caecal extracts were prepared 
by suspending the contents of a single caecum in 10 ml of 0.1 M 
phosphate buffer pH 7.4 and taking the supernatant obtained a f te r  
standing for 5 min. For incubation, a medium consisting of 0.5%
(w/v) each of D-glucose, peptone and yeast extract in 0.1 M 
phosphate buffer pH 7.4 was dispensed (10 ml aliquots) into 25 ml 
Thunberg tubes and the contents s te r i l ise d  by standing in boiling  
water for 20 min. When cool, test compound (1 -  10 mg) and caecal 
extract (0.5 ml) were added and the tubes evacuated (using a 
water pump) and r e f i l le d  with nitrogen 3-4 times before incubation 
at 37° for upto 48 h. Control incubations ( i )  without caecal 
extract, ( i i )  boiled before substrate addition, or ( i i i )  using 
a n tib io t ics , were employed to verify  the microbial orig in  of 
any metabolism occurring. Acidic substrates that were insoluble 
in water were dissolved in a minimum amount of 0.5M sodium bicarbonate 
solution before addition to the incubations. For incubations with 
animal faeces instead of ra t  caecal contents, faeces were converted 
to 10% (w/v) homogenates and 0.5 ml incubated in the manner 
described above.
Incubations using [^^CJshikimic acid or [^^C]benzoic acid were 
performed using 0.1 -  0.5 yCi of ^^C. The amount of ^^ C used in 
each incubation was obtained by counting an aliquot of the radio­
active dose.
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Solvent extraction of incubates
Incubates were ac id ified  to pH 1 with conc. HCl and extracted
with diethyl ether (3 x 10 ml). Extracts were combined, evaporated
under reduced pressure and the residues redissolved in methanol
(200-500 y l )  for analysis by t . l . c .  Incubations with [^^C]shikimic 
14acid or [ CJbenzoic acid were extracted as above, evaporated
14and acetone solutions of the residues counted for C. In the case 
of [^^CJshikimic acid incubations, rad ioactiv ity  extracted a f te r  
incubation was taken as being metabolised shikimic acid since the 
la t te r  does not extract from water under these conditions.
Chromatography
Thin-layer chromatography was carried out using 0.25 mm 
thick plates of s i l ic a  gel G.Fgg^ (Schleicher and Schlill L td . ,  
distributed by Anderman and Co. L td . ,  London) and preparative  
layer chromatography on s il ic a  gel GOFgg^  p lates .o f 2 mm 
thickness (E. Merck, Darmstadt, Germany). The solvent systems 
used were (a) acetone-petroleum ether (b.p. 40 -  60°) (1 : 2, 
by v o l . ) ,  (b) methanol-chloroform (1 : 6, by v o l . ) ,  (c) methanol-  
chloroform (1 : 20, by v o l . )  and (d) diethyl ether. Carboxylic 
acids were detected by spraying the developed chromatograms with
0.04% bromocresol green in ethanol (Lugg and Overall 1948).
Autoradiography
Autoradiograms of th in -layer chromatograms were developed 
on medical X-ray films (Kodak 'Blue Brand', BBg ,^ 18 x 24 cm).
After suitable contact exposure, the films were developed 
in Universal Developer (Kodak, diluted 1 + 7) for 3 min., rinsed
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in d i l .  acetic acid for several seconds and then fixed  
(KodafiXj 1+3 d ilu t io n ) for 3 - 4  minutes. The films were washed 
in moving water for at least 30 min and a i r  dried.
Contact prints of the developed autoradiograms were made 
on s tab il isa t io n  paper (Agfa Rapidoprint -  grade TP3 semimat 
f in is h )  and developed on an Agfa LD 37 Rapidoprinter. Permanently 
fixed copies were obtained by fix ing in Kodafix (diluted 1+3) for  
about 3 min before washing for 30 min.
Large-scale purif ication  of the shikimic acid metabolite produced 
by ra t  caecal microorganisms
600 ml of incubation medium prepared as described e a r l ie r  
was boiled gently for 15 min before use. The caecal contents 
of 7 male rats were suspended in 70 ml of the cooled medium and 
the suspension centrifuged for 15 s on the lowest speed of an 
MSE bench centrifuge to precipitate gross debris. 40 ml of the 
supernatant from this suspension was then added to a flask  
containing the described medium (400 ml) and shikimic acid 
(200 mg, 0.2 yC i). The flask was flushed with nitrogen, 
stoppered and incubated at 37° for 5 days. The incubate 
was adjusted to pH 2 using conc. HCl and then extracted with 
3 X 300 ml diethyl ether, separating the encountered emulsions 
by centrifugation (5,000 g for 10 min). The ether extracts  
were dried over anhydrous sodium sulphate, evaporated to dryness 
and diluted with 10 ml acetone.
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A chromatography column (60 cm x 45 mm internal diameter)
was packed with 35 cm of Merck Kieselgel 40 (70 -  230 mesh) and
wetted with acetone-petroleum ether (b.p. 40 -60°)(1 :2 , by v o l . ) ,
eluting and discarding the f i r s t  100 ml. The extract was applied
to the surface of the column and eluted in the usual manner
using the above solvent. A total of 700 ml was collected
14in 50 ml fractions which were counted for C. The rad ioac tiv ity  
was eluted over 3 fractions which were combined and evaporated, 
under reduced pressure to afford a yellow o il (1.290 g ). The
o il was redissolved in 15 ml diethyl ether and partitioned with
10 ml 0.5 M NaOH. The aqueous layer was separated, the pH adjusted
to pH 1 with conc. HCl and extracted with diethyl ether (3 x 15 m l).
Combined ether extracts were dried over anhydrous sodium sulphate 
and evaporated to y ie ld  a pale yellow o il (0.860 g ). The crude
011 was subjected to sequential, preparative t . l . c .  using systems 
(a ) ,  (b ), (c) and (d) respectively. The general method was as 
follows:
The crude o il was dissolved in acetone (1 ml) and applied to 
the orig in of the plate in the usual manner. After development, 
the radioactive band was located, the s il ic a  removed, powdered 
and transferred to a small glass column (25 cm x 12 mm internal 
diameter). I t  was found that the rad ioactiv ity  was read ily  
eluted from the column by acetone (35 ml). The solvent systems used, 
Rf of the metabolite and weight of recovered material are i l lu s tra te d  
below. Only solvents of AnalaR quality  were used for these stages.
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solvent system Rf weight recovered
(a) 0.65 0.410 g
(b) 0.60 0.164 g
(c) 0.25 0.141 g
(d) 0.75 0.134 g
The f in a l y ie ld  was 134 mg (67%) of a colourless o i l .
The material was apparently pure on a variety  of t . l . c .  systems 
and was only v is ib le  a fter  spraying with 0.04% ethanolic 
bromocresol green. The o il was dried under high vacuum (0.1 mm Hg) 
for  2 h. The n .m .r., i . r .  and mass spectra of the sample were 
obtained and an elemental analysis performed.
Spectroscopy
Infra-red spectra were recorded on a Perkin-Elmer 577 grating 
in fra-red spectrometer and mass spectra on an AEI MSI2 mass 
spectrometer equipped with temperature programming f a c i l i t y .
Nuclear magnetic resonance spectra were recorded on a 90 MH2 
Bruker WH-90 Fourier transform n.m.r. spectrometer operating a t  
ambient temperature and with deuterochloroform as solvent.
Metabolism of [^^C]shikimic acid in the isolated ra t  caecum
Male rats were k il le d  by cervical fracture and the intestines  
exposed by performing a midline incision. The caecae were located
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and ligatures applied to both the colon (2) and ileum (2 ) .  
[^^Cjshikimic acid (1 mgKg \  0.2yCi) in d is t i l le d  water (0.25 ml) 
was gassed with nitrogen and administered by syringe into the 
caecae via the ileo-caecal valve. The caecae were isolated by 
scission between the ligatures at the
colon and ileum and then incubated a t 37° in small, sealed glass 
via ls  for upto 4 h. The caecal contents were washed out with a 
minimum of water, ac id ified  to pH 1 with conc. HCl and extracted 
with diethyl ether (3 x 10 ml). Extracted was measured 
by s c in t i l la t io n  counting and the presence of cyclohexanecarboxylic 
acid in extracts determined by reverse isotope d ilu tion  analysis.
Isotope d ilu tion  for cyclohexanecarboxylic acid
Cyclohexanecarboxylic acid melts at 29 - 31°, i t  was decided 
therefore to perform the isotope d ilu tion  via the s-benzylthiuronium 
s a lt .
The ether extracts from incubations of [^^C]shikimic acid 
and in testinal contents were evaporated to dryness and redissolved 
in 5.00 ml acetone. 50 yl aliquots were counted to determine the 
content. An accurately weighed sample ('v 0.5 g) of authentic 
cyclohexanecarboxylic acid (Aldrich Chemical Company L td . ,  double 
d is t i l le d  before use) was added and the solution evaporated and 
resuspended in water (10 ml). Two drops of phenolphthalein were 
added and 1 M NaOH added until the solution was pink. 0.1 M HCl 
was then added dropwise until the solution was fa in t ly  pink. A 
solution of 2 g S-benzylthiuronium chloride in 10 ml water was
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added and the mixture cooled in ice. The precipitated solid 
was f i l t e r e d ,  washed with water and recrystalfised from ethanol 
(m.p. 155-7°) to constant specific rad ioactiv ity .
Isotope d ilu tion  analysis for other compounds was carried  
out using standard d ilu tion  techniques followed by recrysta lisa tion  
without derivatisation. Benzoic acid was purified to constant 
specific a c t iv i ty  by sublimation and phenol by recrystallisation  
of the p-toluenesulphonate ester from methanol*
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RESULTS
As a means of establishing the effectiveness of the incubation 
conditions described, a preliminary study of the metabolism of 
protocatechuic acid (3,4-dihydroxybenzoic ac id), v a n i l l ic  acid 
(4-hydroxy-3-methoxybenzoic acid) and iso v an ill ic  acid (3-hydroxy- 
4-methoxybenzoic acid) by ra t  caecal microorganisms was carried  
out. When 10 mg samples of each were incubated with ra t  caecal 
contents, both decarboxylation and déméthylation reactions were 
observed as verif ied  by t . l . c .  with authentic standards (Table 2 .1 ) .  
The results were in agreement with those of Scheline (1966a) and 
are also relevant to the in vivo metabolism of shikimic acid 
since the origin of urinary catechol in vivo (Chapter 5) may 
conceivably involve microbial decarboxylation of protocatechuic 
acid.
Metabolism of [^^C]shikimic acid by ra t  caecal microorganisms
Incubation of [^^C]shikimic acid with samples of ra t  caecal 
contents led to the production of less polar m ateria l, extractable  
with diethyl ether. This rad ioactiv ity  was considered as being 
metabolised shikimic acid since the la t te r  does not extract (< 1%) 
from water under these conditions. I t  was found that under suitable  
conditions of substrate concentration and incubation time, >98% 
conversions of shikimic acid to extractable material could be 
obtained (Fig. 2 .1 ) .  Furthermore, t . l . c .  (system b ) -  autoradio-
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graphy of incubate extracts showed the formation of one product 
only, which was not further metabolised within 6 days (Fig. 2 .3 ) .
The metabolism of [^^C]shikimic acid in the incubations described 
was verif ied  as being of microbial origin by the use of controls 
designed to in h ib it  microbial metabolism. Thus, whereas normal 
incubations led to 95-100% conversions of shikimic acid, those carried 
out in the presence of antib iotics or with caecal extract omitted 
gave negligible conversions (Table 2 .2 ) .  Such controls also 
prevented the decarboxylation and déméthylation of protocatechuic 
acid and v a n i l l ic  acid described above.
Id en tif ica tion  of the shikimate microbial metabolite
The i . r . ,  n .m .r . ,  and mass spectra of the microbial metabolite 
were consistent with the structure of cyclohexanecarboxylic acid.
This was further confirmed by reference to the spectra of authentic 
m aterial. The spectra are summarised in Table 2.4 but a fu l l  account 
of th e ir  in terpretation is given in Chapter 6. Elemental analysis 
supported the structure; %C, 64.95, %H, 9.77, (required for  
%C, 65.40, %H, 9.45) and reverse isotope d ilu tion  (via the S-benzyl- 
thiuronium sa lt )  of incubate extracts showed that > 98% of the 
rad ioactiv ity  was present as cyclohexanecarboxylic acid.
The incubations between [^^C]shikimic acid and ra t  caecal 
extracts were normally performed under s t r ic t ly  anaerobic conditions 
and the isolation of caecal samples carried out with a minimum 
contact with a i r .  Such precautions were not essential however.
When incubations were performed a fte r  an in i t ia l  flushing fo r
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Table 2.1 Metabolism of aromatic carboxylic acids by ra t  caecal 
microorganisms
compound incubationsperformed metabolites produced
protocatechuic 3 catechol in 3/3
acid
v a n i l l ic  acid 3 catechol in 3/3
protocatechuic acid in 3/3
iso v an ill ic  acid 3 catechol in 3/3
Table 2.2 Incubation of [^^CJshikimic acid with ra t  caeca! 
microorganisms
incubation incubation
details
% conversion of 
shikimic acid
test normal incubation 95-100%
control 1 caecal extract omitted < 0.5%
control 2 medium + caecal extracts 
boiled before substrate 
addition
< 0.5%
control 3 chloramphenicol present 
(250 yg/ml)
1%
control 4 gentamycin present (500yg/ml) 1%
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Fig. 2.1 Metabolism^ of [ shikimic acid by ra t  caeca! contents
100
(/)
0.1 mgml 
0.2 mgml 
0.5 mgml 
1.0 mgml
00
964824 72
Incubation time (h)
14,t  , determined by the amount of C extracted by diethyl ether 
(3 X 10 ml) at pH 1.
t  14
Fig. 2.2 Metabolism of [ CJshikimic acid in isolated ra t  caecae
50
"O
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Incubation time (h) 
f ,  determined by the amount of[^^C]extracted by diethyl ether (3 x 10 ml) 
at pH 1. Shikimic acid was incubated at a dose level of 1 mg per kg 
original body weight.
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Fig.2.3 T.l.c. - autoradiography showing the formation 
of the shikimate microbial metabolite.
Fig.2.4 T.l.c. - autoradiogram showing the formation of
cyclohexanecarboxylic acid by faecal microorganisms 
isolated from various species. a,mouse; b,rat; 
c,rabbit; d,hamster; e,man; f,ferret; g,guinea 
pig; h,hen.
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1 min with a i r ,  no e ffec t on the metabolism was observed from which 
i t  was presumed that the main organisms responsible were not 
oxygen-sensitive, obligate anaerobes.
Metabolism by gut microorganisms of other animal species
The microbial degradation of shikimic acid to cyclohexane- 
carboxylic acid in v itro  was not confined to the microorganisms 
Isolated from ra t  caecae. The microflora present in the faeces 
or in testinal contents of a variety  of animal species brought 
about the same reaction (Table 2 .3 ) .  The only exception 
observed was the case of the fe r r e t ,  the faeces of which (from 
3 separate animals) did not produce any ether-extractable  
metabolites upon incubation. The e ffec t  is i l lu s tra te d  by the 
t.l .c .-autoradiogram  (Fig. 2,4) of extracts from incubations 
between [^ \]s h ik im ic  acid and various sources of gastrointestinal 
microorganisms. In a l l  cases (except the fe r re t )  the only 
observable product was cyclohexanecarboxylic acid, confirmed 
in each case by reverse isotope d ilu tion .
Microbial metabolism of benzoate
The incubation of [^^CJshikimic acid with in testina l micro­
organisms produced no observable aromatisation products. Isotope 
dilu tion  studies for ( i ) ,  benzoic acid; ( i i )  phenol; ( i i i ) ,  p-hydroxy- 
benzoic acid ( i v ) ,  m-hydroxybenzoic acid; (v ) ,  protocatechuic
acid; ( v i ) ,  p-hydroxybenzaldehyde; (v ii)m  -hydroxybenzaldehyde
14showed <0.5% incorporation of C at any stage of incubation.
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Table 2.3 Metabolism of shikimic acid to cyclohexane­
carboxylic acid by gastrointestinal microorganisms from various 
animal species.
species source of microorganisms
a b i l i t y  to 
metabolise
ra t faeces ++
ra t caecum ++
mouse faeces ++
mouse caecum ++...
mouse stomach
■' +  ■■ ■
rabbit faeces ++
hamster faeces ++. ,
gerbi1 faeces ++
guinea pig faeces ++ .
hen faeces ++ .
man faeces ++
fe rre t faeces -
++, complete conversion within 2 days; + , partia l conversion 
within 2 days; - ,  no metabolism observed. All incubations were 
performed in culture medium (10 ml) with [^^CJshikimic acid (2 mg) 
and a 10% (w/v) suspension of faeces or in testina l contents (0.5 ml)
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The absence of benzoate was most interesting and the po ss ib il i ty
that benzoate may be produced, but further metabolised to
cyclohexanecarboxylic acid, was investigated. Incubation of 
14[ring-U- CJbenzoic acid (in t r ip l ic a te )  with ra t  caecal contents 
however showed no conversion to cyclohexanecarboxylic acid and 
reverse isotope d ilu tion  showed the f in a l product to be->98% 
unchanged benzoate.
Metabolism of shikimic acid in isolated ra t  caecae
The p o ss ib ility  remained that the in v itro  conversion of  
shikimate to cyclohexanecarboxylate, rather than to benzoate, 
may be due to a change in environment or nature of the microflora  
during isolation and subsequent incubation. However, the 
incubation of [^^CJshikimic acid in isolated ra t  caecae led to the 
formation of extractable (metabolised) material (Fig. 2 .2 ) .  After  
3 h, 40% of a lmg(Kg body wt)"^ dose of[^^C]shikimic acid was 
metabolised, 60% of which was confirmed as cyclohexanecarboxylic 
acid by reverse isotope d ilu t io n . Additional isotope d ilu t io n  
studies showed that no detectable amounts of benzoate had been 
formed.
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Tab! G 2,4 Spectral data of the gut microbial metabolite of shikimic acid and authentic 
T^lohexanecarboxylic acid
mje, mass-to-charge ratio (decreasing order of abundance); m*/e, important metastable 
transitions; n.m.r. (nuclear magnetic resonance) chemical shifts are in <5; s, singlet; m, 
multiplet; i.r. absorbances are in cm"\
Spectrum 
I.r. (film)
Metabolite
2930
2860
1705
1450
1300
1260
Authentic 
cyclohexane­
carboxylic acid
2930
2860
1705
1450
1310
1255
Mass spectrum
N.m.r. spectrum
mje m*je mje m*le
73 94.5 73 94.5
41 76.7 55 76.6
55 61.1 41 61.2
29 41.6 83 41.6
128 128
83 56
10.9 (s) 11.6(s)
2.0-2.3 (m) 2.0-2 .4 (m)
1.0-2.0 (m) 1.0-2 0(m )
CO,H
Fig. 2.5
HO
CO,H
Flora
HO 'OH
HO
(II)
Flora
CO2H
CO—NH—CHj—CO,H ÇO2H
Conjugation
Tissues
( I I I )
Tissues
Other aromatic 
products
Probable pathway of shikimic acid aromatization in the rat and the involvement 
of the gastrointestinal flora
(I), Shikimic acid; (II) dihydroshikimic acid; (III)  cyclohexanecarboxylic acid; (IV) 
benzoic acid; (V) hippuric acid.
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DISCUSSION
The in testinal and faecal f lo ra  of a variety  of animal 
species, including man, have the a b i l i t y  to hydrogenate and 
dehydroxylate shikimic acid in v i t r o . The product is cyclo­
hexanecarboxyl ic acid and this is contrary to e a r l ie r  be lie fs  
that a microbial aromatisation of shikimic acid to benzoic 
acid accounts fo r the observed production of urinary hippuric 
acid in vivo. The resu lt however s t i l l  provides an explanation 
of the fac t that shikimic acid is aromatised in vivo but 
inhibited when the gut f lo ra  are suppressed with an tib io t ics .
I t  would seem that the gastrointestinal microflora are responsible 
for  an in i t i a l  reduction and dehydroxylation of shikimic acid 
to cyclohexanecarboxylic acid which may then be absorbed and 
aromatised by the mammalian tissues. The aromatisation of 
cyclohexanecarboxylic acid by mammalian tissues has been known 
for  some time (Friedmann 1911, Beer e t ^  1951, Mitoma e t  al 
1958, Babior and Bloch 1966).
The isolation and subsequent incubation of gastrointestinal 
microorganisms may lead to a considerable modification in the 
nature of the f lo ra  and i t  is wise to exercise caution when 
attempting to correlate such in v itro  work with the in vivo 
s ituation. However, the incubation of shikimic acid in iso lated , 
but in ta c t ,  ra t  caecae led to the formation of cyclohexanecarboxylic 
acid and i t  is l ik e ly  therefore that the reaction occurring in 
v itro  also occurs in v ivo. Furthermore, the p o ss ib il i ty  that 
cyclohexanecarboxylic acid arises from an in i t i a l  aromatisation
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of shikimate to benzoate, which is then further hydrogenated, 
can be discounted as benzoate was recovered unchanged a f te r  
incubation with ra t  caeca! microorganisms.
The metabolic pathway il lu s tra te d  in F ig . 2.5 would appear 
to be the most l ik e ly  way in which oral shikimic acid is f in a l ly  
excreted as urinary hippuric acid. L i t t le  is known of the 
metabolism of cyclohexanecarboxylic acid other than i ts  conversion 
to hippuric acid and here therefore may be a source of other, 
possibly aromatised, metabolites of shikimic acid yet to be 
observed. A complete metabolic study of cyclohexanecarboxylic 
acid is obviously desirable not only to learn more about the 
metabolism of shikimic acid but to confirm that cyclohexane­
carboxylic acid is indeed the key intermediate that these results  
suggest. I t  is highly unlikely that cyclohexanecarboxylic acid 
could be a carcinogenic metabolite of shikimic acid, indeed i f  
shikimic acid does possess carcinogenic properties this  
microbial degradation could be viewed as an important detoxicative  
process.
Although the present work has been restricted to the microbial 
metabolism of shikimic acid, i t  is l ik e ly  that a sim ilar fa te  is 
met by its  close re la t iv e  qui n ic acid since the la t te r  also 
increases the urinary excretion of hippuric acid a f te r  oral 
administration (Adamson et al_ 1970, Cotran £ t  ^  1960). Furthermore, 
whilst free shikimic and quinic acids are abundant in both plants
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and f ru its  (Bohm 1965) various estereal conjugates of these
compounds have also been observed, some of which have been characterised.
Thus d a c ty l i f r ic  acid (5-0-caffeoylshikimic acid. I I I )  is
COOH
HO'
HD
( I I I )
OH
OH
(IV) R
OH (V), R =
obtained from dates, Phoenix d a c ty life ra  (Maier £ t  1964), 
chlorogenic acid (5-0-caffeoylquinic acid, IV) (Herrmann 1956) 
is obtained from coffee beans, theogallin (5 -0-galloy lqu in ic  
acid V) is present in Camellia simensis (Roberts and Meyers 1958) 
and the pentagalloyl derivative of quinic acid is a princip le  
constituent of the vegetable tannin from Caesalpi nia spinosa 
(Haslam e t£ l_  1962). These conjugates, upon ingestion, may 
provide free shikimic and quinic acids a fte r  hydrolysis by bacterial 
esterases in the gut. The hydrolysis and further metabolism of 
chlorogenic acid to m-hydroxyphenylpropionic acid in the r a t ,  
clearly demonstrate that this reaction can occur (Booth ^  ^  1957, 
Scheline 1973). The production of cyclohexanecarboxylic acid by
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gut microorganisms may therefore arise from various ingested 
conjugates of shikimic and quinic acids in addition to the 
parent. acids and i t  is tempting to suggest that these microbial 
pathways may be major contributors to the natural, daily  
excretion of hippuric acid observed in mammals.
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SUMMARY
1. Shikimic acid is hydrogenated and dehydroxylated by gastro­
in testinal microorganisms of a variety  of animal species to 
cyclohexanecarboxylic acid.
2. The metabolic pathway does not involve benzoate since this  
compound has been shown not to be metabolised by gut micro­
organisms.
3. The conversion of shikimic acid to hippuric acid in vivo 
probably proceeds via an in i t ia l  microbial reduction to cyclo­
hexanecarboxyl ic acid followed by an aromatisation of the la t te r  
in the mammalian tissues. This is contrary to e a r l ie r  be lie fs  in 
which a microbial aromatisation of shikimic acid to benzoic acid 
had been postulated.
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CHAPTER 3
Metabolism of cyclohexanecarboxylic acid in the ra t
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INTRODUCTION
As early as 1911 i t  was shown that in jection of cyclohexane- 
carboxylic acid into dogs increased the urinary excretion of 
hippuric acid (Friedmann 1911). Subsequent investigations have 
verif ied  that cyclohexanecarboxylic acid is indeed aromatised and 
conjugated with glycine (Baltes et ^  1952) and that the process 
occurs in both the l iv e r  and kidney (Beer et £]_ 1951). Experiments 
in v itro  have shown that the l iv e r  is the most active tissue for  
aromatisation (Beer et £]_ 1951) and that the overall enzyme system 
fo r  this oxidative process is localised in the mitochondria 
(ilitoma e_t £]_ 1958, Babi or and Bloch 1966). Evidence has been 
presented (Chapter 2) to show that the gastrointestinal microflora  
of a variety  of animal species are capable of hydrogenation and 
dehydroxylation of shikimic acid to cyclohexanecarboxylic acid.
Tne formation of the la t te r  would seem to account for the observed 
urinary excretion of hippurate which follows oral administration 
of shikimic acid (Asatoor 1965, Adamson et ^  1970, Brewster et al 
1976). Apart from the formation of hippuric acid no other metabolic 
products of cyclohexanecarboxylic acid have been described but any 
which do exist should in turn be metabolites of shikimic acid.
A more detailed study of the metabolism of the former was thus 
undertaken in order to provide further information on the metabolism 
of shikimic acid.
Biotransformation studies of chemical compounds usually require 
the analysis of animal excreta (such as daily  samples of urine and 
faeces) which are collected in standard metabolism cages.
Examination of such samples is often hampered by various inherent
74
ü if f ic u l  ties such as cross contamination of urine and faeces
during collection, contamination by food and the sheer quantity
of excreta that may contain the metabolites of in teres t. I t
was considered that re la t iv e ly  non-polar cyclohexanecarboxylic acid
should be rapidly absorbed from the gut ( i ts  s ite  of
formation from shikimic acid) and its  metabolites rapidly
excreted in the urine. With such points in mind anaesthetised
rats received radiolabelled cyclohexanecarboxylic acid by
intraduodenal administration and urine and b ile  was collected by
cannulation of both ureters and the common b ile  duct. The
analysis of urine and b ile  was then confined to those samples in which
rad ioactiv ity  was s t i l l  being eliminated (often this was for less than
3 hours) and therefore reduced considerably the problems outlined
above.
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MATERIALS AND METHODS 
Chemi cals
Cyclohexanecarboxylic acid was obtained from the Aldrich
Chemical Company, Gillingham, Dorset, U.K. and was d is t i l le d
twice before use. Benzoic acid and Adam's catalyst were obtained
from the British Drug Houses L td ., Poole, Dorset, U.K. and 
14[ring-U- CJbenzoic acid (specific  a c t iv ity  339 mCi/mmole) from 
the Radiochemical Centre, Amersham, U.K.
Materials
Cannulae tubing (PP120, PP25, PPIO) was obtained from Portex 
Ltd ., Hythe, Kent, U.K. Polystyrene collection tubes (LP3) were 
obtained from Luckham Ltd ., Burgess H i l l ,  Sussex, U.K. and poly- 
propelene analysis tubes (0.4 ml capacity) for  urine collection  
from Sarstedt L td ., Leicester, U.K.
Synthesis of [ring-U-^^Clcyclohexanecarboxylic acid
Cyclohexanecarboxylic acid was prepared by the ca ta ly t ic  
hydrogenation of benzoic acid. Sublimed benzoic acid (200 mg) 
was dissolved in absolute ethanol (20 ml) and transferred to a 
flask containing Adam's catalyst (platinum dioxide, 40 mg). The 
solution was washed into the pressure vessel of a Baskerville  
and Lindsey hydrogenator with a further volume of ethanol (10 ml) 
and the contents then hydrogenated at room temperature overnight 
under a pressure of 80 - 100 atmospheres of hydrogen. The solution  
was f i l te re d  and evaporated. Small amounts of unchanged benzoic 
acid were occasionally observed in such preparations and
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consequently the above residue was purified by preparative layer
chromatography using acetone-petroleum ether, b.p. 40 -  60°
(1 : 2, by v o l . )  as solvent. The cyclohexanecarboxylic acid and
benzoic acid ( i f  any) were visualised by spraying a narrow section of
the plate with 0.04% (w/v) bromocresol green in ethanol and the
benzoate band iden tif ied  by i ts  quench of short wave (254 nm) u.v.
l ig h t .  The required band was removed and the material obtained
by elution of the powdered s i l ic a  with acetone (25 ml) in a small
chromatography column. The f in a l y ie ld  by this method was usually
between 120 -  180 mg (60 - 90%) m.p. 29 -  31° ( l i t  31 °).  For
14the preparation of [ring-U- C]cyclohexanecarboxylic acid the
above procedure was repeated except with the inclusion of 
14[ring-U- C]benzoic acid (200 pCi) in the hydrogenation. The 
method afforded radiolabelled cyclohexanecarboxylic acid (specific  
a c t iv ity  0.95 yCi/mg) which was stored as an aqueous solution of 
the sodium s a lt  at -40°C. The radiochemical purity of the product 
was determined by reverse isotope d ilu tion  analysis (cyclohexane­
carboxylic acid as described in Chapter 2 and benzoic acid as in 
Chapter 4) which.showed the purity to be greater than 98% and 
the benzoate content as less than 0 .8%.
Animals
Male Wistar albino rats (220 -  250 g) were used throughout 
and were dosed according to the ir  weight on the day of the 
experiments.
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Animal surgery
Animals were anaesthetised using Nembutal and the abdominal 
viscera exposed for cannulation of the common b ile  duct as 
described in Chapter 4. Cannulation of the b i le  duct was 
completed using Portex PP25 tubing. The righ t ureter was located, 
cleared of mesentary and ligated followed in turn by sim ilar  
treatment of the l e f t  ureter. Both ureters were then cannulated 
(PPIO tubing) when s u ff ic ie n t ly  dilated with urine to enable this  
operation to be completed (usually about 10 minutes a f te r  l ig a t io n ),  
To allow intraduodenal dosing of the animals, a short length of 
cannula tubing(PP25) was introduced into the duodenum via a small 
incision and then secured to the wall of the duodenum by a single  
l iga ture . In la te r  experiments i t  was found easier to co llec t  
urine d ire c t ly  from the bladder. A short (PP120) cannula was 
introduced via a small incision and tied  into the bladder wall 
by a single liga ture . The collapsed bladder was then tied  f irm ly  
to the cannula, the urethra ligated , and the cannula adapted to 
PP25 tubing for urine collection. Cannulation of the ureters, 
bladder and duodenum is i l lu s tra te d  in Fig. 3 .1 . A ll cannulae 
were exteriorised before suturing, with the duodenal cannula 
exteriorised via the righ t side body wall. The end of a length 
of PP25 tubing was l e f t  amongst the intestines to allow infusion 
of extra saline or anaesthetic during the experiment. The exterior  
arrangement of cannulae for both sample collection and dosing 
is i l lu s tra te d  in Fig. 3.2 . B il ia ry  cannulae were normally 25 cm 
in length and ureter cannulae as short as possible (8 -  10 cm).
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PPIO
URETERS
PP25
PP120
Urethra
BLADDER
DUODENUM
Bile duct
PP25
Fig. 3.1 Cannulation of ureters, bladder and duodenum
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Dose
PP25
PP25
Bile
PPio
Saline
Urine
Fig. 3.2 bxterior arrangement of cannulae for urine and b ile  
collection
80
Animals were not allowed to recover from these experiments, l i f e  
being terminated by an overdose of Nembutal.
Collection of urine and b ile
Bile was collected in weighed polystyrene LP3 tubes and urine 
in weighed 0.4 ml capacity polypropelene analysis tubes (see 
Fig. 3.2) at th ir ty  minute intervals for upto 7 h. Samples were 
stored at -40°C until required for analysis.
Administration of dose
[^^C]cyclohexanecarboxylic acid (5 -  6 yCi, 0.5 -  200 mg/kg) was 
administered as the sodium sa lt  in 0.5 ml water via the duodenal 
cannula and flushed through with a further 0.25 ml 0.9% saline.
Aliquots of the dosing solution were taken to determine the precise 
quantity of administered.
Measurement of rad ioactiv ity
Urine aliquots (5 p i)  and b ile  aliquots (50 y l )  of a l l  th i r ty  
minute samples were dissolved in 0.4 ml water and 4 ml of a 
Synperonic NXP/toluene/2,5-diphenyloxazole s c in t i l la n t  according 
to the method of Wood et ^  (1975). Radioactivity was measured 
in an LKB 1210 l iq u id -s c in t i l la t io n  counter and the excretion of 
rad ioactiv ity  in the urine and b i le  calculated as a percentage of 
the administered dose. Counting e ff ic iencies were obtained by 
internal standardization using e ither [^^C]toluene or £^^C]hexadecane,
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Solvent extraction of urine and b ile
Radioactive samples of urine and b ile  were separately 
combined, diluted with an equal volume of water and ac id ified  
to pH 1 with 5 M HCl. The solutions (2 -  3 ml) were extracted 
with 5 X 6 ml volumes ethyl acetate in small (10 ml) screw- 
capped glass tubes and the layers separated by centrifugation  
(2,000g for 30 s ). Extracts were combined, evaporated and 
dissolved in methanol (100 -  200 y l ) for examination by th in -  
layer chromatography.
Chromatography
Thin-layer chromatography was carried out using 0.25 mm 
thick plates of s i l ic a  gel GF2g^(Schleicher and Schull, Anderman 
and Co. L td ., London) and preparative-layer chromtography on 
s i l ic a  gel OOFg^  ^ plates of 2 mm thickness (E. Merck, Darmstadt, 
Germany). The following solvent systems were used (a) acetone- 
petroleum ether (b.p. 40 - 60°) -  acetic acid (40 : 80 : 2, by 
v o l . ) ;  (b) n-propanol-ammonia soln. (sp. gr. 0.88) (7 : 3, by v o l . ) ;  
(c)n-butanol-acetic acid - water (4 : 1 : 1, by v o l . ) .  All solvents 
used in the purif ication  of metabolites for e ither mass spectrometry 
or p.m.r. spectrometry were of AnalaR quality .
System (a) separated a l l  metabolites observed, systems (b) and 
(c) were used as means of further purif ication  of the metabolites 
from endogenous impurities. Carboxylic acids were detected by 
spraying the dried plates with 0.04% (w/v) bromocresol green in 
absolute ethanol (Lugg and Overall, 1948) and glucuronic acid
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conjugates with 1% (w/v) napthoresorcinol in acetone -  10%
(v/v ) phosphoric acid (4 : 1, by v o l . )  followed by heating at
100° for 10 min. (Bridges et 1965).
Autoradiography
Autoradiographs of th in -layer chromatograms were produced 
on medical X-ray films (BB54, 18 x 24 cm, Kodak L td .,  Hemel 
Hempstead, Herts., U.K.) by contact exposure. Films were 
developed (Kodak Universal Developer, diluted 1 + 7) fo r  3 min., 
rinsed in d ilu te  ( 2%) acetic acid for several seconds and then 
fixed (Kodafix, 1 + 3 d i lu t io n , Kodak Ltd.) for 3 - 4  min. Films
were washed in moving water for 30 min. and a i r  dried.
Mass Spectrometry
Electron impact mass spectra were recorded on an A .E . I .  MS 12 
mass spectrometer equipped with temperature programming f a c i l i t y .  
Spectra were run a t 70 eV using d irect sample insertion. Urine 
or b i le  extracts were applied to th in -layer plates as 1 -  2 cm 
bands and developed in solvent system (a ) .  For the id en t if ic a t io n  
of metabolites 1 -  3, the plates were then sprayed with 7 M 
aqueous ammonia, located by autoradiography (see f ig .  3 .6 ) and then 
removed, eluted with methanol and chromatographed separately in 
solvent system (b ). Radioactive zones were eluted with methanol 
(AnalaR grade) according to the techniques described by Rix e t al 
(1969) and the f in a l eluates transferred to small, washed melting 
point tubes. The methanol was evaporated by a stream of nitrogen 
from a f in e ly  drawn cap illa ry  and the tubes used as sample probes
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for d irect insertion mass spectrometry. For the id en tif ica t io n  of 
metabolites 4 and 5, urine or b ile  extracts were applied as 10 cm 
bands to th in -layer plates and developed in solvent system (a ).
The compounds were 1 coated and then eluted and described above 
and chromatographed as short (2 cm) bands in solvent system (c ).  
Radioactive zones were removed and eluted with methanol into small 
conical glass v ia ls  (conveniently prepared from the conical section 
of a Pasteur p ipette). The methanolic solutions were f i r s t  treated  
with excess ethereal diazomethane (Vogel 1956), evaporated by a 
stream of nitrogen and then stood overnight with acetic anhydride 
(AnalaR grade, 15 y l )  and re d is t i l le d  pyridine (15 y l ) .  Excess 
reagents were removed under high vacuum and the resulting t r ia c e ty l - 
methyl glucuronates prepared for d irect insertion mass spectrometry 
as described above.
Proton magnetic resonance spectrometry
P.m.r. spectra were recorded on a 90 MH^  Bruker WH-90 Fourier 
transform n.m.r. spectometer operating a t ambient temperature. 
Hexadeuterodimethylsulphoxide was used as solvent and tetramethyl- 
silane (TMS) as internal standard. Chemical sh ifts  ( 6 ) are expressed 
in p.p.m. downfield from IMS. For the purif ication  of metabolites 
1 and 2 the urine of 3 animals which received radiolabelled  
cyclohexanecarboxylic acid (200 mg/kg) was combined and extracted  
as described e a r l ie r .  The extracts were chromatographed on 
preparative layer (2 mm thick) s i l ic a  plates using solvent system 
(a ) ,  the metabolites located and eluted with methanol then further  
purified in sequential fashion on th in -layer plates using solvent
84
system (a) then system (b). The metabolites were recovered as 
free acids by elution with methanol, evaporation, ac id ifica tion  
with 0.1 M HCl (1ml) and f in a l ly  extraction into ethyl acetate 
(5 X 5 ml).
Quantitative determination of urinary metabolites
Urinary metabolites were separated by t . l . c .  of urine 
extracts using solvent system (a) and located by autoradiography. 
Radioactive zones (see f ig .  3 .5) were removed and the powdered 
s i l ic a  suspended in 4 ml of the described s c in t i l la n t  to which 
4% (w/v) Thixotropic gel (Packard) had been added. Radioactive 
metabolites were determined as a percentage of the tota l a c t iv i ty  
recovered from the plates and converted to percentage of administered 
dose by reference to the degree of b i l ia ry  excretion at that dose 
leve l. All determinations were carried out in t r ip l ic a te  which were 
to within 5% of each other, and then meaned.
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RESULTS
14Following intraduodenal administration of C-cyclohexane- 
carboxylic acid rad ioactiv ity  was rapidly eliminated in the urine 
and b i le .  Extraction with ethyl acetate at pH 1 removed between 
97 - 98% of the rad ioactiv ity  present in the urine and 91 -  92% of 
the rad ioactiv ity  in the b i le .  The figures were taken as representing 
complete extraction since the non -extractable a c t iv i ty  in total 
represented no more than 2 - 3 % of the administered dose.
Urinary and b i l ia ry  excretion of rad ioactiv ity
14Intraduodenal administration of C-cyclohexanecarboxylic acid 
at a dose level of 200mg/kg led to a quite rapid elimination of 
rad ioactiv ity  both in the urine and the b i le ,  the results of 3 such 
experiments is i l lu s tra te d  in f ig .  3.3 . At lower dose levels the 
rate of elimination of the dose was very rapid indeed. Fig. 3.4. 
shows the urinary and b i l ia ry  excretion of rad ioac tiv ity  in 5 animals 
at dose levels between 0.5 -  200 mg/kg. Two important points 
emerge from f ig .  3.4. The rate of excretion of the administered 
dose increases with decreasing dose level and the extent of b i l ia r y  
excretion fa l ls .  At the lowest level studied (0.5 mg/kg) about 
95% of the administered dose was excreted within the f i r s t  90 
minutes.
Metabolites of cyclohexanecarboxylic acid
Examination of the ethyl acetate extracts of urine and
14b ile  from animals which received C-cyclohexanecarboxylic 
acid (200 mg/kg) showed the presence of 5 d if fe re n t  metabolites.
The metabolites were visualised by autoradiography of th in - lay er
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Fig. 3.3 Urinary and b i l ia ry  excretion of rad ioactiv ity  following 
intraduodenal administration of [ring-U-^^C]Cyclohexane- 
carboxylic acid to rats.
100
80
•o
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M-
Q-
^  20
time (h)
^^C-cyclohexanecarboxylic acid (200 mg/kg, 5-6 yCi) was administered as 
the sodium sa lt  in 0.5 ml water, o ,  urinary excretion; v ,  b i l ia r y  
excretion. Points represent the means of 3 animals ± S.E.M. shown by 
vertical bars. Flow rates ± S.E.M. : urine, 320 ± 26 p l /h ;  b i le ,
1.13 ± 0.11 ml/h.
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Fig. 3.4 Urinary and b i l ia ry  excretion of rad ioactiv ity  following
14intraduodenal administration of [ring-U- C]cyclohexanecarboxyli 
aciu tu ra ts .
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80
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20
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time (h)
Cyclohexanecarboxylic acid (5-6 yCi) was administered as the sodium 
saTt in 0.5 ml water. □ ,  200 mg/kg; ©, 100 mg/kg; O, 35 mg/kg;
V ,  5 mg/kg; a ,  0.5 mg/kg. Larger symbols represent urinary excretion, 
smaller symbols represent b i l ia ry  excretion. Mean flow rates 
respectively : urine, 280, 210, 250, 140, 170 y l /h ;  b i le ,  1 .22, 1.00,
0 .80, 1 . 20, 0.82 ml/h.
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chromatograms developed in solvent system (a) and are i l lu s tra te d  
by the example shown in f ig .  3.5 . Referring to the numbering 
system of f ig .  3.5 the metabolites were iden tif ied  by t . l . c .  -m .s .  
and p.m.r. as follows: ( 1) ,  hexahydrohippuric acid; ( 2) ,
3,4,5,6-tetrahydrohippuric acid; (3 ) ,  hippuric acid; (4 ) ,  cyclo- 
hexylcarbonyl“3“D-glucuronide; (5 ) ,  benzoyl-g-D-glucuronide.
The mass spectra of metabolites 1 -  5 and the p.m.r. spectra of  
metabolites 1 and 2 are l is ted  in tables 3.1 and 3.2 respectively. 
Complete details of the in terpretation of spectra is given in 
Chapter 6 . All 5 metabolites were present in urine extracts and 
gave an acidic reaction with ethanolic bromocresol green. Hippuric 
acid gave strong quenching and tetrahydrohippuric acid weak 
quenching of the fluorescence of short wave (254 nm) u l t ra -v io le t  
l ig h t .  Glucuronic acid conjugates of cyclohexanecarboxylic acid 
and benzoic acid were the major products observed in the b i le  
(see f ig .  3.5) and gave positive colour reactions with napthoresorcinol
Metabolism cage experiments in which animals received oral ^^C- 
cyclohexanecarboxylic aci d (100 mg/kg) showed a sim ilar metabolic 
pattern. Almost a l l  (> 98%) the administered dose was recovered 
in the urine  and negligible amounts (< 1%) in the faeces and 
expired a ir .  The metabolic pattern in the urine was q u a lita t iv e ly  
the same as outlined above which suggests that the animal surgery 
described e a r l ie r  did not influence the metabolism to any great 
extent.
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Fig.3.5 Fig.3.6
Figs.5.5 - 3.6 T.l.c. - autoradiography of urine 
extracts fUE) and bile extracts (BE)
i
» mg/Kg
Fig. 3.7 T.l.c. - autoradiography of urine extracts after 
various dose levels of cyclohexanecarboxylic acid
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Effect of dose on metabolic p ro fi le
Marked changes in the metabolic pattern occurred when 
cyclohexanecarboxylic acid was administered through a dose range 
of 0.5 -  200 mg/kg. Table 3.3 shows the percentages of 
metabolites excreted from animals which received 0 .5 ,  5, 35, 100 
and 200 mg/kg. What is most apparent, is the decrease in the 
percentage of benzoyl and cyclohexylcarbonyl glucuronides with 
decreasing dose level and the proportionate increase in the 
percentage of hippuric acid. The e ffec t is i l lu s tra te d  by the 
autoradiogram ( f ig .  3.7) of urine extracts chromatographed 
twice on th in -layer plates in solvent system (a ) . The ra tio  
between the urinary cyclohexylcarboxyl and benzoyl glucuronides 
changes with dose (see f ig .  3 .7 ) ,  at the higher level (200 mg/kg) 
the ra tio  is in favour of the cyclohexanecarboxylic acid glucuronide 
(determined as approximately 2 : 1) whereas a t lower levels they 
appear to be formed in equal (but very small) amounts. The fa c t  
that glucuronide formation is greater a t the higher dose levels  
seems to account for the fac t that b i l ia r y  excretion although 
a minor route of excretion of cyclohexanecarboxylic acid is  
greatest at the higher dose levels ( f ig  3 .4 ) .
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DISCUSSION
Intraduodenal administration of cyclohexanecarboxylic acid 
to rats equipped for d irect collection of urine and b i le  results  
in a rapid absorption and elimination of metabolites from the 
animals. Hippuric acid was always the major metabolite and was 
excreted in the urine along with hexahydrohippurate, 3 ,4 ,5 ,6- te t r a -  
hydrohippurate and benzoic acid and cyclohexanecarboxylic acid 
glucuronides (see f ig  3 .8 ) .  A small percentage (3 -  8%) of material 
was b i l ia ry  excreted and shown to be mainly the la t te r  mentioned 
glucuronides. Of the f ive  metabolites observed and id e n t if ie d ,  
only hippuric acid has been reported previously (Friedmann 1911,
Beer et ^ 1 9 5 1 ,  Baltes et_a^ 1952, Mitoma et ^  1958, Babior 
and Bloch 1966). The metabolism of cyclohexanecarboxylic acid is 
very dependent upon dose. At higher levels (100 -  200 mg/kg) 
considerable,amounts of benzoic and cyclohexanecarboxylic acid 
glucuronides are formed which probably explains why b i l ia r y  
excretion is greatest at these levels. At low doses (0 .5  and 5 mg/kg) 
the metabolic pattern s im plifies. B il ia ry  excretion of benzoic and 
cyclohexanecarboxylic acid glucuronides becomes very low, th e ir  
presence in urine insignificant and a proportionate increase in 
hippurate formation occurs. In addition the rate of elimination  
of urinary metabolites (as % dose) is extremely rapid with greater 
than 95% being excreted within 90 rnin. This dose dependence of 
cyclohexanecarboxylic acid metabolism raises important considerations 
in the metabolism of shikimic (and possibly quinic) acids.
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Shikimic, acid is metabolised slowly in the gut by bacterial 
action to cyclohexanecarboxylic acid which is absorbed and 
metabolised by the tissues. At 100 mg/kg about 30 - 40% of an 
oral dose of shikimic acid can be estimated as being urinary 
excreted by this pathway over 24 h (see chapter 5). This is 
equivalent to the production of some 30 -  40 mg/kg/day of 
cyclohexane carboxylate or about 1 -  2 mg/kg/hour. Clearly  
the lower dose levels of cyclohexanecarboxylic acid (e .g . 0 .5  mg/kg) 
would appear to be the most informative as fa r  as the metabolic 
fa te  of shikimic acid is concerned. In addition, the rapid 
rate at which low doses are eliminated from the animal would imply 
that the rate determining step in the overall excretion of urinary  
hippuric acid from shikimic acid is the microbial reduction of the 
la t te r .  The formation of the hexa and tetrahydrohippurates was 
not quite so dependent upon dose although the percentages o f such 
appeared to decrease with decreasing dose, especially the hexa- 
hydrohippurate. From the results outlined above one may predict 
that in the metabolism of shikimic acid, the terminal products of 
the microbial-dependent pathway involving cyclohexanecarboxylic 
acid should be; urinary hippuric acid as major metabolite, urinary
3,4,5,6-tetrahydrohippurate and somewhat less hexahydrohippurate 
as minor metabolites, and negligible amounts of benzoic and 
cyclohexanecarboxylic acid glucuronides. These predictions were 
substantiated in subsequent metabolism studies with shikimic 
acid (see Chapter 5).
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The novel metabolites of cyclohexanecarboxylic acid described 
above provide further information on the mechanism of aromatisation 
of cyclohexanecarboxylic acid to hippuric acid. I t  has been established 
that the isomeric cyclohexenecarboxylic acids notably 1-cyclohexene- 
carboxylic acid are aromatised to hippuric acid in the rabbit but the 
isomeric hydroxycyclohexanecarboxylates are not (Beer et al 1951).
I t  would seem therefore, that aromatisation follows a pathway of 
dehydrogenation rather than sequential hydroxylation and dehydration- 
I t  has been demonstrated (Mitoma et ^  1958) that fo r t i f ie d  mammalian 
l iv e r  mitochondria aromatise cyclohexanecarboxylate but not hexahydro­
hippurate and thus i t  would seem that glycine conjugation does not 
proceed aromatisation. In incubations with un fo rtif ied  mammalian 
l iv e r  mitochondria cyclohexanecarboxyl-CoA but not cyclohexane­
carboxylic acid was aromatised to hippuric acid (Mitoma et ^  1958) 
from which one would conclude that the formation of cyclohexane- 
carboxyl-CoA occurs before dehydrogenation and conjugation with 
glycine. Subsequently i t  was shown that a Guinea pig l iv e r  mito­
chondrial enzyme system converted cyclohexanecarboxyl-CoA to benzoyl-CoA 
via an intermediate cyclohexene-1-carboxyl-CoA (Babior and Bloch 1966).
0 3
Although the isomeric A and the A -cyclohexenecarboxyl-CoA derivatives  
were also converted to benzoyl-CoA, trapping experiments showed 
these compounds did not partic ipate in the aromatisation pathway.
For the f in a l stage in the formation of hippuric acid, benzoyl-CoA 
has been shown to be the active intermediate in the conjugation with 
glycine (Schachter and Taggart 1953). Fig. 3.9 i l lu s tra te s  the overall 
aromatisation pathway of cyclohexanecarboxylic acid to hippuric acid 
formed by a combination of the results of the workers mentioned above
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and i t  can be seen how the in vivo formation of the hexahydro 
and 3,4,5,6-tetrahydrohippurates substantiates the pathway.
I f  cyclohexanecarboxyl-CoA and cyclohexene-1-carboxyl-CoA are 
indeed intermediates and glycine conjugates with benzoyl-CoA 
one may expect that some conjugation of glycine with the former 
should occur. The in vivo formation of the hexa and tetrahydro­
hippurates suggests that this is indeed the case.
No evidence was obtained to suggest that any of the possible 
isomeric dihydrohippurates (cyclohexadienylcarbonyl glycines) were 
produced. I t  may be these compounds, i f  formed, are read ily  aromatised 
by the animal tissues and therefore are not detected. I t  is unlikely  
that they are actually excreted and then undergo further chemical 
transformation due to the ir  in s ta b i l i ty ,  since no other products 
were observed and the recovery of iden tif ied  metabolites was about 
98%.
The s im ila r ity  of stages 1 and 2 in the aromatisation pathway 
( f ig .  3 .9 ) ,  to the 3-oxidation of fa t ty  acids has already been 
pointed out (Mitoma £ t  ^  1958). The two pathways do seem to be 
related both in location of the enzyme system responsible and in the 
geometrical isomerism produced by the dehydrogenase ( i . e .  trans).
I t  may be that the cyclohexene-1-carboxyl-CoA is produced in this  
manner but that the r ig id  conformation of the a l ic y c l ic  r in g , or 
the substituted nature of the a-carbon, prevents further progress 
through the 3-oxidation pathway.
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Fig. 3.8 Metabolism of cyclohexanecarboxylic acid in the ra t
CONHCHXOOH
(2)
O 
COOH II
CONHCHXOOH
(minor)
(minor)(major) COOH
OH
HO
OH
COOH
pH
HO
(1 ) ,  hippuric acid; (2) 3,4,5,6-tetrahydrohippuric acid; •
(3 ) ,  hexahydrohippuric acid; (4 ) ,  benzoyl-g-D-glucuronide;
(5 ) ,  cyclohexylcarbonyl-g-D-glucuronide.
these pathways are dose dependent and are important only a t  
higher dose levels.
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SUMMARY
1. In the ra t ,  cyclohexanecarboxylic acid is metabolised and excreted 
(mostly in the urine) as hippuric acid, hexahydrohippuric acid,
3,4,5,6-tetrahydrohippuric acid and benzoyl and cyclohexylcarbonyl-  
g-D-glucuronides.
2. The metabolism is dose dependent. At low dose levels e.g. 0.5 mg/kg
the metabolic pattern sim plifies to a rapid excretion of hippuric
acid (major product) and hexa and tetrahydrohippuric acids (minor 
products).
3. The metabolic pattern at low dose levels should bear re la tio n  to
the urinary metabolites of shikimic acid a f te r  oral administration.
This has subsequently been found to be the case (Chapter 5 ).
4. The observed formation of hexahydrohippuric acid and 3 ,4 ,5 ,6 - te t r a ­
hydrohippuric acid substantiates the proposed mechanism of aromatisation 
of cyclohexanecarboxylic acid. I t  would appear that these compounds 
arise via side reactions (glycine conjugation) of the active  
intermediates in the aromatisation process.
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CHAPTER 4
The metabolism of cyclohexanecarboxylic acid in 
the isolated perfused ra t  l iv e r
102
INTRODUCTION
In recent years attention has been given to investigations  
into the metabolism of chemical compounds using isolated perfused 
l ive rs . Such techniques have very d e fin ite  benefits which are 
generally worthy of the practical e f fo r t  involved. There are 
three main advantages in the use of l iv e r  perfusion studies 
(Bartosek ^  al_ 1974, Garattin i £]_ 1973).
( i )  Although the l iv e r  is generally regarded as the princip le  
s ite  of drug metabolism, i t  is frequently of in terest to establish  
the actual contribution of the l iv e r  to particu lar metabolic 
transformations without the interference of other organs. Perfusion 
studies therefore not only indicate the role of the l iv e r  in the 
metabolism of compound A to metabolite B but also, when results
are compared with those obtained from whole animals studies, they 
help assess the role of extrahepatic tissues in such processes.
( i i )  A fundamental feature of the perfused l iv e r  system is the 
in teg r ity  of the organ. Although the use of various in v it ro  
systems such as tissue homogenates, microsomal preparations and 
slices have the ir  value in studying single stage processes such as 
hydroxylation or conjugation, the isolated perfused l iv e r  enables 
the overall metabolism of the compound by the l iv e r  to be followed. 
In addition, the re la t iv e ly  straightforward kinetics experienced
in perfusion studies help overcome some of the d i f f ic u l t ie s  
encountered in vivo with problems of drug d istr ibution  and tissue 
binding.
( i i i )  Metabolism studies in vivo are usually dependent upon the
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examination of animal excreta. Unfortunately, the metabolic 
products thus observed are usually the terminal products of 
the reactions and are often less interesting than the intermediates 
of the metabolic pathway. The detection of metabolic intermediates 
in vivo presents various problems. The detection of minor 
metabolites in the blood may be impossible since levels may be 
below the detection l im i t  of the assay and i t  may be d i f f i c u l t  to 
increase such levels because of toxic side effects . The perfused 
l iv e r  offers a means of increasing drug leve ls , often without 
adverse e ffec ts , and thereby improving the chances of detecting  
the more minor metabolic intermediates. The la t te r  point was well 
i l lu s tra te d  by the example of the tran qu ilize r  Diazepam whose 
metabolites in whole ra t  blood could not be detected by a sensitive  
gas chromatographic technique (Marcucci and Mussini 1968, Garattini 
et ^  1970), but which were readily  observed in the isolated  
perfused ra t  l iv e r  (Kvetina et £]_ 1968).
There are various methods of perfusing the l iv e r .  The 
technique of M il le r  £ t  (1951), with modifications to medium 
composition (Schimassek 1962),has received the most a tten tion .
Other methods of perfusion include in situ techniques (Mortimore 
and Tietze 1959, Hems £ t ^  1966), reverse perfusions (Trowell, 
1942) and hepatic artery perfusions in which the organ perfusion 
takes place via both the hepatic artery  and hepatic portal vein 
rather than the portal vein only (Ross et ^  1967, Powis 1970).
Shikimic acid has been shown to be hydrogenated and 
dehydroxylated by ra t  gastrointestinal microorganisms (Brewster
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^  i l  1976)to cyclohexane carboxylic acid (see chapter 2) and i t  
has been proposed that the aromatisation of the la t te r  by the 
mammalian tissues accounts for the observed urinary excretion 
of hippurate which follows oral administration of shikimic 
acid. Although in v itro  studies have already established that  
cyclohexanecarboxylic acid is aromatised to benzoic acid (and 
f in a l ly  hippuric acid) by the l iv e r  (Beer et ^  1951, Mitoma et ^  
1958, Babior and Bloch 1966) i t  was thought of in terest to examine 
further the contribution of the l iv e r  in this aromatisation 
process and what other products, aromatised or otherwise, may be 
formed. I t  v/as f e l t  that the isolated perfused ra t  l iv e r  offered  
the most suitable means of carrying out such an investigation.
TECHNIQUE OF ISOLATED LIVER PERFUSION
The technique of isolated l iv e r  perfusion involves removal 
of the l iv e r  from the in tact animal followed by a continuous 
perfusion with a suitable medium such as to replace the usual 
venous supply. The perfusion is normally carried out in a temperature 
controlled cabinet in which oxygenation of the c irculating perfusate 
may be maintained.
In isolated l iv e r  perfusion studies there are essentia lly  
two methods of perfusion; one employing diluted animal blood as 
perfusate (M il le r  et ^  1951) and the other using a semisynthetic 
and defined perfusate which may be easier to prepare and handle 
(Schimassek 1962). The following experimental procedure uses the 
la t te r  method with the further modification of an infusion of the 
l iv e r  with c e l l - f re e  perfusate during completion of the hepatectomy.
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Operative principles
The surgical steps involved in preparing the ra t  l iv e r  
fo r  perfusion may be better understood by referring to Fig. 4.1 
which outlines the pathways by which drugs may be transported 
to and from the l iv e r .  Thus for perfusion, the portal vein 
is cannulated to receive perfusate which is collected a f te r  
passing through the l iv e r  by e ither cannulation or simple 
scission (and perfusate collection) of the in fe r io r  vena cava. 
Although not widely practised by e a r l ie r  workers, the b i le  
duct may be cannulated for a more complete study. This is 
especially important when examining compounds which are l ia b le  
to undergo extensive b i l ia ry  excretion. The hepatic artery  
which arises from the coeliac axis , a branch of the aorta ,  
constitutes the remaining supply of blood to the l iv e r  but is 
not normally cannulated for perfusion since the major proportion 
of blood is supplied via the portal vein. In the ra t  about 
75-80% of the blood supply to the l iv e r  is carried by the portal 
vein (Abraham £ t  ^  1968, Powis 1970) and provides an oxygen 
supply in excess of the requirements of the l iv e r .  Since the 
usual perfusion of the l iv e r  is without a r te r ia l  supply the l iv e r  
perfusion is a low pressure system which w il l  perfuse s u ff ic ie n t ly  
well at inflow pressures of only 20 cm of water.
Apparatus and cabinet .
The l iv e r  perfusion apparatus designed by M il le r  e t ^  (1951) 
has been adopted by most workers in the f ie ld .  Finer deta ils  
of the apparatus vary between research groups but the general
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arrangement seems to have been universally adopted. Liver 
perfusions are usually performed in a temperature controlled  
cabinet which is often constructed from perspex. Along with 
thermostatically controlled heating elements in the cabinet 
is a fan to ensure an even distr ibution of warmed a i r .  The 
perfusion apparatus used in the present study is i l lu s tra te d  
in Fig. 4 .2 .
Surgery
Figure 4.3 shows the anatomy of the ra t  pertinent to the 
surgical aspects of l iv e r  perfusion and Fig. 4.4 i l lu s tra te s  
the points of l ig a t io n , cannulation and scission during the 
hepatectomy.
Male Wistar albino rats (220 -  250 g) were anaesthetised 
using an intraperitoneal in jection of sodium pentobarbital 
(Nembutal, 60 mg/kg). With the animal on i ts  back, the limbs 
were restrained, the abdomen s te r i l is ed  with alcohol and a midline 
ventral incision made through the skin. This was followed by a 
sim ilar cut through the peritoneum (linea alba) to expose the 
abdominal viscera. A la te ra l extension to thé incision was made 
and a l l  flaps of skin clamped and fixed with Spencer-Wells a r te r ia l  
forceps. The intestines were displaced to the animals l e f t  and 
wrapped gently in saline-soaked cotton wool swabs. Using a clamped 
spatula (or with the aid of an assis tan t), the l iv e r  was retracted  
to expose the b ile  duct and hepatic portal vein. The b i le  duct 
was cleared of mesentary and two loose ligatures placed in position
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GUT
m.v.
s.v.p.p.v.
a.p.v.
fAorta
Hepatic portal vein 
, jjdo% Bile ductHeart
Lungs Hepatic
arteryL I VER 20%
Inferior vena cava
Fig. 4.1 Blood supply to and from the l iv e r .
Li.v ., anterior and posterior mesenteric veins; s .v . ,  splenic 
vein; p .p .V . , posterior pancreaticoduodenal vein; a .p .v . ,  
u.icerior pancreaticoduodenal vein; p .v . ,  pyloric vein*
Fig. 4.2
LIVER PERFUSION APPARATUS
O :  CO. Tr
C .H .
P .M . H .E .
O poo
CXD
R: reservoir, M; magnetic s tirre r , P: peristaltic pump, 
II . E; heat exchanger, W, water hath, Lg; a rtific ia l lung, 
H: humidifier, C .H : constant head device, t; tap,
pre-perfusion system, L: liver, F .M . flow meter, 
V: bile collecting vial, H: heating bars, T h : thermostatic  
control device, F: e lectric fan, A and B: perfusate 
sampling parts.
Iü 3
Hepatic veins 
Sinusoids
Aorta
To right 
atrium
Right 
kidney
Inferior 
vena cava
Hepatic portal vein
Liver
Hepatic artery
Diaphragm 
Pyloric vein 
Stomach
Spleen
Duodenum 
Pancreas 
Bile duct
Anterior pancreatico­
duodenal vein
Fig. 4.3 Abdominal viscera of the rat relevant to l iv e r  perfusion 
surgery.
Right atrium
Inferior vena cava
Liver
Bile duct
Portal vein
„^^Pre-infusate
3-way tap
Perfusate
Fig. 4.4 Points of l ig a t io n , cannulation and scission involved 
in l iv e r  perfusion surgery.
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around i t  and the ligature proximate to the duodenum tied o f f .
The duct was cannulated using polypropylene tubing (Portex, PP25) 
a fte r  making a small incision with iridectomy scissors, the 
cannula being fixed in position by tying o ff  the remaining 
l iga tu re . The pancreaticoduodenal vein was ligated proximate 
to the portal vein (this section of the former is Often referred  
to as the pyloric vein, see Fig. 4 .3 ) to ensure complete perfusion 
of the l iv e r .  Two loose ligatures were then located around both 
the hepatic portal vein and the in fe r io r  vena cava ( ju s t  above the 
r igh t renal vein). At the portal vein the d ista l ligature  was 
tied and the vein cannulated with heparinised PP60 tubing and 
secured with the remaining ligature . The cannula was allowed 
to f i l l  completely (until dripping) with blood, connected to 
a piston-type infusion pump and an infusion of the l iv e r  with c e l l -  
free perfusate (10 ml min ^) began. The following operations 
were then carried out as rapidly as possible. The loose ligatures  
around the in fe r io r  vena cava were t ied  and the thorax opened by an 
extension of the midline incision. The in fe r io r  vena cava was 
quickly severed beyond the diaphragm (to avoid pressure in the l iv e r )  
and the hepatectomy completed by severing ( 1) the in fe r io r  vena cava 
between the two ligatures ( i i )  the pancreatico-duodenal vein 
(pyloric vein) beyond its  ligature ( i i i )  the hepatic portal vein 
distal to the cannula and f in a l ly  ( iv )  the remaining connective 
tissue. The l iv e r  was then placed carefu lly  onto a perforated 
porcelain support in the perfusion cabinet and connected to the 
c ircu la tin g , equilibrated perfusate by means of a three-way tap 
attached to the venous cannula (Fig. 4 .4 ) .  Portal pressure was
no
adjusted to a head of 25 - 30 cm of perfusate and the flow rate  
to 1 ml min  ^ g l iv e r  \  Note i t  is most important to ensure 
that a ir  does not enter the l iv e r  during connection of e ither  
the infusate or whole perfusate. Failure to do so results in 
blockage of the hepatic cap il la ry  system and therefore incomplete 
perfusion of the organ.
Pre-infusion and perfusion media
The basic c e l l - f re e  medium used for the in i t ia l  infusion of 
the l iv e r  consisted of the following:
component name manufacturer quantity
medium/buffer medium 199 
without 
phenol red
Difco Laboratories 100 ml
plasma substitute B.S.A.
(type V)
Sigma Chemical Co. 2.5%
anticoagulant heparin B.D.H. Chemicals 500 units
an tib io tic gentamyci n Flow Laboratories 0.075%
The resulting medium was always gassed (O2/CO2 J 95/5) before use.
Of the 100 ml of prepared medium, 65 ml were mixed with washed 
caprine red blood cells  to a total volume of 100 ml fo r use as the 
whole perfusate (haematocrit in the range 33 -  35%). Remaining 
medium was used for the pre-infusion of the l iv e r .  Blood was collected  
from the jugular vein of female Swiss Alpine goats (125 ml per experiment) 
into glass collection flasks moistened with heparinised saline (500 units)  
and the cells  separated by centrifugation ( 2,000 g for 4 min) and
mthen washed three times with isotonic saline. Preparation of the
red blood cells  was usually carried out the evening prior to the
experiment and the washed cells  stored under isotonic saline at  
04 C overnight.
Pre-infusion of the l iv e r
The pre-infusion of the l iv e r  with c e l l - f re e  medium in the 
manner already described is not widely practised by research workers 
but has certain d is t in c t  advantages.
( i )  The technique ensures that an adequate supply of oxygen and 
nutrients are available to the l iv e r  during the f in a l stages of 
the hepatectomy a fte r  the portal vein has been cannulated.
( i i )  The infusion of c e l l - f re e  perfusate clears the l iv e r  of blood 
to leave the organ a pale flesh colour. At this point, the degree 
to which colour is removed from the extreme margins of the l iv e r  
affords a good indication of the success of the operation i . e .  the 
extent to which the l iv e r  is being perfused.
( i i i )  On connection of the l iv e r  to the c irculating whole perfusate, 
an additional check on the extent of perfusion is obtained by 
observing the degree to which the red colouration spreads rapidly  
through to the extremities of the organ.
Sequence of operations
Washed goat erythrocytes were prepared the day prior to the 
perfusion and stored overnight a t  4°C. Whole perfusate was 
circulated in the apparatus under the conditions of an actual 
perfusion for about 1 h prior to the experiment. This allowed both
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the apparatus and perfusate to equilibrate  to the desired 
temperature and the system to be bled of small a ir  bubbles. I t  
was convenient to carry out the surgery during the la te r  
stages of this equilibration period such that a l l  was ready for  
connection of the l iv e r  immediately following completion of the 
hepatectomy.
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MATERIALS AND METHODS
Chemicals
Benzoic acid and hippuric acid were purchased from BDH
Chemicals L td . ,  Poole, Dorset, cyclohexanecarboxylic acid from
the Aldrich Chemical Company L td . ,  Gillingham, Dorset and 
14[ring-U- C] benzoic acid (specific a c t iv i ty  108 mCi/mmol) from 
The Radiochemical Centre, Amersham, Bucks.
[ring-U-^^C]Cyclohexanecarboxylic acid (specific a c t iv i ty  
0.95 pCi mg ^) was prepared by the ca ta ly tic  hydrogenation of 
[^^C] benzoic acid as described in Chapter 3. Reverse isotope 
dilu tion  analysis showed the purity to be > 98% (as determined 
via the s-benzylisothiuronium s a l t .  Chapter 2) and the benzoate 
content as < 0 . 8%.
Perfusion Media
A medium, comprising of 100 ml tissue culture medium 199 
(Table 4 .1 ) without phenol red (Difco Laboratories, D e tro it ,  
Michigan, USA), 2.5 g bovine serum albumin, fraction V (Sigma 
Chemical Company, St. Louis, Minnesota, USA), 500 units heparin 
(BDH Chemicals L td . ,  Poole, Dorset) and 75 mg gentamycin 
(Flow Laboratories L td . , Irv in e , Ayrshire) was prepared and 
65 ml of this made up to 100 ml with washed red blood ce lls  . 
to give the perfusion medium. The remaining ce ll free medium 
(35 ml) was used as the pre-perfusion medium.
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Animal s
An adult female Swiss Alpine goat was used as the donor of 
red blood cells  and male Wistar albino rats (220 - 250 g) as the l iv e r  
donors. All animals were allowed to feed and drink ad libitum  
prior to experiments.
Perfusion techniques
The techniques of isolated l iv e r  perfusion has already been
-1  -1described in d e ta i l .  Livers were perfused a t  a rate o f 1 ml min g 
under a constant head of 30 cm perfusate a t 37° and the system 
allowed to equilibrate  for 30 min before the addition o f the 
substrate (cyclohexanecarboxylic acid, 25 mg, 6 - 10 pCi).
The amount of substrate used in each perfusion was equivalent 
to 100 mg/kg liver-donor body weight.
Collection of samples
Perfusate samples were collected from sampling ports ju s t  
before (1 ml) and just a f te r  (0.2  ml) the l iv e r  a t various time 
intervals during the perfusion. Bile was collected as half-hourly  
samples in preweighed LP3 plastic tubes (Luckham L td ., Burgess 
H i l l ,  Sussex). A fter weighing the fu l l  tubes i t  was possible 
to determine the b i l ia ry  flow rate .
Measurement of Radioactivity
Total rad ioactiv ity  in the b i le ,  perfusate, erythrocytes and 
l iv e r  was determined by a liqu id  s c in t i l la t io n  technique. Following 
solubilisation of insoluble samples (see below), aliquots were
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suspended in (a) Synperonic NXP-toluene (1 : 2, by vol) 
containing 2,5-diphenyl oxazole (Wood et a^ 1975) or 
(b) Insta gel (Packard). Counting was achieved using 
s c in t i l la t io n  spectrometers (e ither Packard Tricarb, 3320 
or LKB 1210), and effic iencies  determined using e ither [^^C] 
toluene or [^^C] hexadecane as the internal standard.
(1) B ile (e ffic iency 78-82%): aliquots of b ile  (10 -  50 p i ,  
depending upon the a c t iv i ty )  were diluted with water (0 .5  ml) and 
suspended in s c in t i l la t io n  f lu id  (a) (4.0 ml).
( i i )  Whole perfusate (e ffic iency 72-75%) : whole perfusate 
(50 p i)  was digested by heating with 60% perchloric acid (100 p i )  
a t 55° for 2 h in loosely capped glass s c in t i l la t io n ' v ia ls .
The resulting solutions were decolourised by the addition of 
30% hydrogen peroxide (200 pl)and heating fo r  a further 1 -  2 h.
The colourless digests were then suspended in s c in t i l la t io n  
f lu id  (a) (10 ml).
( i i i )  Washed erythrocytes (e ffic iency 72-75%) : whole perfusate 
(1.0 ml) was centrifuged at 2,000 g for 10 min in an MSE bench 
centrifuge and the cell free perfusate drawn o f f  fo r  further  
analysis. The erythrocytes were washed with 0.9% saline ( 5 x 4  vols) 
F in a lly ,  the washed cells  were resuspended in saline (to a to ta l  
volume of 1.0 ml) using a vortex mixer and aliquots (50 yl ) digested 
and counted as above.
( iv )  Liver (effic iency 60-65%) : upon termination of the 
perfusion, the l ivers  were washed and 10% homogenates in 0.9% sàline  
prepared. Aliquots (100 y l ) were heated with 3 ml Hyamine (Packard)
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in loosely capped glass s c in t i l la t io n  vials for 2 h at 55° 
and decolourised by standing overnight with 30% hydrogen 
peroxide (250 p i ) .  F in a lly , the solution was neutralised 
with conc. HCl (250 p i) and the resulting solution suspended 
in s c in t i l la t io n  f lu id  (b) (7 .0  ml) for counting.
Preparation of samples for analysis
Determination of rad ioactiv ity  in both b ile  and whole 
perfusate has already been described. Bile samples were 
stored at -  40° until required. Perfusate samples, including 
the f in a l reservoir perfusate, were centrifuged soon a f te r  the 
experiment and the supernatants (c e l l - f re e  perfusates) trans­
ferred to 4 ml capacity septum vials and either freeze-dried  
or deep frozen ( -  40°C) until further use. The separated 
erythrocytes from such samples were washed with saline and 
contents determined as already described.
Extraction of Cell Free Perfusate and Bile
Aliquots of cell free perfusate or b ile  (2 .0  ml) were
ac id ified  to pH 1 with 5 M HCl and extracted with ethyl acetate
(5 X 5 ml). When necessary, separation of layers was aided 
by centrifugation (1000 g for 1 min) in an MSE bench centrifuge  
The extracts were combined, evaporated to dryness under reduced 
pressure and the residue redissolved in methanol (200 pT) for  
examination by thin layer chromatography.
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Isotope dilu tion
Hippuric acid : ethyl acetate extracts of c e l l - f re e  perfusate 
(1 ml) were evaporated to dryness and redissolved in methanol 
(10 ml). T r ip lica te  aliquots (50 y l ) of this solution were counted 
for rad ioactiv ity . An exact volume (usually 5.00 ml) of the 
solution was mixed with an exact weight (2 g) of AnalaR hippuric 
acid and the mixture warmed to bring about solution. A fter  
evaporation, the residue was recrystalised to constant specific  
rad ioactiv ity  from either methanol or ethanol. Accurately weighed 
samples of dried crystals (50 mg) were counted in 10 ml of 
s c in t i l la n t  (a ) .
Benzoic acid: benzoic acid was quantitated as described 
for  hippuric acid. Benzoic acid was f i r s t  recrystalised from water 
and then sublimed to constant specific read ioactiv ity .
Cyclohexanecarboxylic acid: the cyclohexanecarboxylic
acid content of perfusate extracts was carried out using the method 
described in Chapter 2.
Chromatography
Thin layer chromatography of the methanolic extracts was 
performed on 0.25 mm plates of s i l ic a  gel G.F.gg^ (E. Merck, 
Darmstadt, Germany) using (a) acetone-petroleum ether (b .p t .  40-60°) 
acetic acid (20:40:1 , by volume) and (b) n-butanol-acetic acid/»- 
water (4 :1 :1 , by volume) as the solvent systems.
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Autoradiography
Autoradiograms of the chromatograms were produced on 
"Blue Brand" medical X-ray film  (BB 54, 18 x 24 cm, Kodak L td . ,  
Hemel Hempstead, U .K .). After suitable contact exposure the 
films were developed in Kodak Universal Developer (d iluted 1 in 8 ) 
for 3 mins, rinsed in d ilu te  acetic acid for several seconds, 
and then fixed (Kodafix, 1 in 4 d ilu tion) fo r 3 - 4  min. The 
films were washed in running water for at least 30 min and a ir  
dried. Contact prints of the developed autoradiograms were then 
obtained.
Mass Spectrometry
Electron impact mass spectra were recorded on an AEI MSI2 
mass spectrometer at 70 eV using direct sample insertion. Small 
amounts of metabolites (separated by t ic )  or the ir  derivatives,  
were prepared fo r analysis by the method of Rix et ^  (1969).
For the id en tif ica tio n  of glucuronide conjugates,extracts 
of perfusate or b ile  were applied as 10 cm bands to th in - la y er  
s il ic a  plates and developed in solvent system (a ). The compounds 
were located by autoradiography, eluted from the s i l ic a  with 
methanol in small chromatography columns and then chromatographed 
as 2 cm bands in solvent system (b ). Radioactive zones were 
removed and eluted with methanol into small conical glass v ia ls  
(conveniently prepared from the conical section of a Pasteur 
p ipette ). The methanolic solutions were f i r s t  treated with excess 
ethereal diazomethane (Vogel 1956), evaporated by a stream of
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nitrogen and then stood overnight with acetic anhydride 
(AnalaR grade, 15 y l ) and re d is t i l le d  pyridine (15 y l ) .  Excess 
reagents were removed under high vacuum and the resulting t r ia c e ty l -  
methyl glucuronates prepared for d irect insertion mass spectrometry.
Quantitative determination of Metabolites
Methanolic solutions (200 y l ) of ethyl acetate extracts of 
the cell free perfusate samples were prepared as described e a r l ie r  
and aliquots of known volume (ty p ica lly  50 yl ) applied onto thin  
layer chromatography plates as narrow (2 cm) bands. The chromatograms 
were then developed using solvent system (a) and the radioactive  
metabolites located by autoradiography. Each radioactive zone, apart 
from zone 1 (see Fig. 4 .8 ) was removed and counted in s c in t i l la t io n  
f lu id  (a) containing 4% thixotropic gel (Packard). As cyclohexane- 
carboxylic acid (zone 1) is s l ig h t ly  v o la t i le ,  i t  could not be 
quantitated in this way. Instead, i t  was necessary to determine 
the tota l rad ioactiv ity  applied to each plate (measured by counting 
aliquots of the original methanolic solution) and to substract from 
this the summated counts recovered from the plate (apart from zone 
1). Once the percent composition of the cell free perfusate had 
been established i t  was possible to convert the values to percent 
of the original dose by taking into account the b i l ia ry  excretion 
of rad ioactiv ity  and the extent of binding of ra d io a c tiv ity  to the 
red blood ce lls . .
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RESULTS
Distribution of Radioactivity
Fig. 4.5 shows the d istribution of rad ioactiv ity  during a 
typical perfusion study with cyclohexanecarboxylic acid. As may 
be seen, there was comparatively l i t t l e  active uptake of the 
substrate from the perfusion during the f i r s t  pass through the 
l iv e r  and a fte r  15 min 90% of the administered a c t iv i ty  was s t i l l  
present in the perfusate medium. Also, the levels of a c t iv ity  
in perfusate samples taken from before and a fte r  the l iv e r  
were very sim ilar throughout.
Closer examination of the perfusate showed most of the 
radiolabel to be associated with the c e l l - f re e  frac t io n , but is 
is interesting to note that a s ign ificant amount was associated 
with the erythrocytes, and that this could not be eluted with 
physiological saline. What is more, the amount gradually increased 
with time so that a f te r  5 h 7 -  9 % of the original dose could be 
accounted for in the erythrocyte fraction (Fig. 4 .6 ) .  This 
phenomenon was not further investigated.
Perhaps surprisingly for such a low molecular weight compound, 
16-18 % of the original dose was excreted in the b ile  (Fig. 4 .7 ) .
Id en tif ica tion  of Metabolites
The ethyl acetate extraction procedure adopted proved to be 
very e f f ic ie n t .  Of the total a c t iv ity  present, 98% was extracted 
from the cell free perfusate and 91% from the diluted b ile
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Table 4.1 Composition of medium 199 (Difco) used in the construction 
of whole perfusate.
Ingred ien ts  per l ite r
70 mg Calc ium  P an to th en ate 0 .0 1  rag
20 mg B io tin 0 .01  rag
70 mg F o lic  Acid 0 .0 1  rag
40 mg. C h o line 0 .5  mg
20 mg In o s ito l 0 .0 5  rag
50 mg p-A m inobenzoic  A cid 0 .0 5  rag
20 mg V itam in  A 0 .1  rag
30 mg C a lc ife ro l 0 .1  rag
50 mg Menadione 0 .0 1  rag
60  mg a-Toco phero i Phosphate 0 .0 1  rag
1?0 mg A scorbic A c id .0 .0 5  rag
40 mg G lu tath ione 0 .0 5  rag
50 mg C h oleste ro l 0 .2  rag
150 mg L -G lu tam in e 100 rag
60  mg A d enosinetriph osphate 1 rag
50 mg A d enylic  A c id 0 .2  rag
4 0  mg Ribose 0 .5  rag
10 mg D csoxyribose 0 .5  rag
50 mg B a c to - D extrose 1 g
0 .1  mg T w een  80 5 rag
10 mg Sodium A c eta te 50 rag
0 .3  mg Iron (as F e rr ic  N it ra te ) 0 ,1  rag
0 .3  rag Sodium C h lo rid e 8 g
0 .3  rag Potassium  C h lo rid e 0 .4  g
0 .3  rag C a lc ium  C h lo rid e 0 .1 4  g
0 .3  rag M agnesium  S u lfa te 0 .2  g
0 .0 1  mg D isod ium  Phosphate 0 .0 6  g
0 .0 1  mg M onopotassium  Phosphate 0 .0 6  g
0 .0 2 5  mg Sodium B icarbo nate 0 .3 5  g
0.025 mg
0 .0 2 5  rag Carbon D io x id e to  p H  7 .2
0 .0 2 5  rag T r ip le  D is t i l le d  Water 1000 m l
!.-A rg in in e
L -H is t id in e
L -L y s in e
L -T y ro s in e
D L -Tryp tophane -
IJ l .-P h c n y la la n in e
L -C y s tin e
O L-M eth ion ine
D L 'S e rin e
D L -T h re o n in e
D l.-L e u c in e
D L -Is o le u c in e
D L -V a lin e
D L -G lu ta m ic  Acid
D L -A s p a rt ic  Acid
D L -A la n in e
L -P ro lin e
L -H yd ro xyp ro lin e .
G ly c in e
l.-C y s tc in e
Adenine
G uanine
X a n th in e
H ypoxan th ine
Thym ine
U ra c il
T h ia m in e  H ydroch loride  
R ib o fla v in
P y rid o x in e  H ydrochloride  
P y rid o x a l H ydroch loride  
N ia c in  
N ia c in a m id e
Table 4.2 Ethyl acetate extraction of perfusate and b ile
Cell-free perfusate Bile
Extractions % Extracted Extractions % Extracted
1 19 0 1 5 6
2 5 1 2 1 5
pH 5 3 2 0 3 1 0
Total 26 1 Total 8 1
1 511 1 33 2
2 13 8 2 22-8
3 4 0 3 14 0
p H l 4 2 1 4 8  1
5 1 0 5 4  9
Total 72 0 Total 83-0
................................... ......... - 1
Sum total 98 1 Sum total 91 1
Aq ueous 2 3 Aqueous 7 0
■aeu+jn3
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Fig. 4.6 Erythrocytic uptake of during the metabolism of [^^C] 
cyclohexanecarboxylic acid in the isolated perfused ra t  
l iv e r .
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Points represent the means of 4 isolated l iv e r  perfusions 
± S.E.M. shown by vertica l bars.
Fig. 4.7 B ilia ry  excretion of C during the metabolism of[ C] 
cyclohexanecarboxylic acid in the isolated perfused 
rat l iv e r .
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-a
+->
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perfusion time (h)
Points represent the means of 3 isolated perfused 
ra t livers ± S.E.M. shown by vertica l bars.
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(see Table 4 .2 ) .  This meant that only <3% of the radiolabel 
was not recovered.
Thin-layer chromatography of these extracts on s i l ic a  
using solvent system (a) showed the presence of 6 discrete  
compounds visualised by autoradiography (see Fig. 4 .8 ) .
Three of these, namely cyclohexanecarboxylic acid, benzoic 
acid and hippuric acid, the presence of which had been 
anticipated, were f i r s t  confirmed as being present by reverse 
isotope d ilu tion  procedures. They were then iden tif ied  as 
spots 1, 2 and 5 (see Fig. 4 .8 ) by comparison with Rf values 
obtained for authentic compounds run in the same solvent 
system. As a f ina l check, electron impact mass spectra of 
each of these bands were obtained (M^\ ^/e 128, 122 and 179 
respectively). Figure 4.8 shows a developed tlcrautoradiogram 
of both perfusate and b ile  extracts a fte r  the l iv e r  perfusion 
of cyclohexanecarboxylic acid for 4| h. The metabolic pattern  
is seen compared to the pattern present in urine extracts (UE) 
and b ile  extracts (BE) of rats which received introduodenal 
cyclohexanecarboxylic acid as described in chapter 3 (Fig. 4 .9 ) .  
By comparison of chromatograms in this way, metabolites 3 and 4 
were iden tif ied  as hexahydrohippuric acid and 3 ,4,5,6-tetrahydro-  
hippuric acid respectively.
Metabolite 6 (see Fig. 4 .8 ) was suspected as being a 
glucuronide as i t  gave a blue spot on a pink background a f te r  
being sprayed with naphthoresorcrnol reagent (Bridges, Kibby 
and Williams, 1965) and i t  was therefore decided to prepare the 
tr iace ty l methyl ester of this compound for mass spectrometry.
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Fig.4.8
I I
Fig.4.9
Fig.4.8 T.I.e. - autoradiography of perfusate and bile 
extracts after 4|h.
Fig.4.9 In vivo metabolites of cyclohexanecarboxylic acid 
(UE) , urine extracts ; (BE), bile extracts.
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The mass spectra obtained (M*, '^ /e 444) from both urine and b ile  were 
consistent with the structure of the triacetyl-methyl ester of 
cyclohexylcarbonyl glucuronide (see Chapter 6 for a f u l le r  in te r ­
pretation). There was no evidence in the spectra for the presence 
of any derivatised benzoyl glucuronide (metabolite 7 in Figure 
4 .9 ) .
Pharmacokinetics
After 6 h, only 10% of the original dose of cyclohexanecarboxylic 
acid remained unchanged with the rate of elimination from 
the perfusate being shown to be a f irs t -o rd e r  process ( i . e .  =
-k[CCA] or In [CCA]^ = In [CCA]^ - kt by plotting ln[CCA]^ against
time (see Fig. 4 .10 ). Linear regression yielded the equation 
InlCCAJ^ = 5 .52-0 .377t, the correlation coeffic ien t being 0.999.
Thus, for cyclohexanecarboxylic acid in this system, the elimination
Defin ition of terms (N otari, 1971)
[CCA] = cyclohexanecarboxylic acid concentration
[CCA]g = cyclohexanecarboxylic acid concentration a t  time 0
[CCA]^ = cyclohexanecarboxylic acid concentration at time t  
t  = time k = elimination constant
-1constant (k) was determined as being 0.377 h  ^ , the apparent
concentration at time zero ([CCA]^) as 249.6 mgl  ^ (actual, 250 mgl )
the apparent volume of d istr ibution (Vd = 100.0 ml
0 1 
(actual, 100.0 ml) and the clearance rate (Vd x k) as 37.7 ml h
(0.063 ml min  ^ g liver ^).
Vù!
6 0
5-5
5-0
<oc:> 4-5
4-0
3-5
time (h)
Fig. 4.10 Plot of ln[CCA]+ against time for the metabolism of
'14 ^
[ Cjcyclohexanecarboxylic acid in the isolated  
perfused rat l iv e r .
[CCA].; cyclohexanecarboxylic acid concentration in 
- 1mgl at time t .  Linear regression gave the function 
In[CCA]^ = 5.52 - 0.377t (correlation c o e ff ic ie n t ,  0.999)
IZÜ
Metabolites of the substrate appeared in the perfusate 
almost immediately and within § h a l l  were c learly  v is ib le  
on the autoradiogram. After 6 h the original substrate was 
present as unchanged cyclohexanecarboxylic acid (10%), 
hippuric acid (50%), benzoic acid (1%), hexahydrohippuric 
acid (2%), 3,4,5,6-tetrahydrohippuric acid (2%) and cyclo­
hexyl carbonyl glucuronide (2-3%). I t  is interesting to note 
that levels of cyclohexylcarbonyl glucuronide , hexahydrohippuric 
acid, tetrahydrohippuric acid and benzoic acid were greatest 
a fte r  2| h (10-12%, 3%, 3% and 2% respectively) a f te r  which a 
decline was noticed. Perfusate levels of cyclohexylcarbonyl 
glucuronide in particu lar were reduced dramatically over the 
f in a l period of perfusion. These effects are i l lu s tra te d  in 
Fig. 4.11 in which a kinetic study of perfusate composition
has been compiled from the results of 3 isolated l iv e r  perfusions.
14
An a lternative  way of viewing the metabolism of [ CJcyclohexane- 
carboxylic acid is provided by Fig. 4.12 which summarises a typical 
isolated l iv e r  study and combines the progress of perfusate 
components with both b i l ia ry  excretion and erythrocytic uptake 
of rad ioactiv ity .
The major metabolite in the b ile  was the glucuronide of 
cyclohexanecarboxylic acid but minute quantities of hippuric 
acid, hexahydrohippuric acid and tetrahydrohippuric acid were 
also observed. Benzoyl glucuronide could not be detected in 
the b ile  or the perfusate.
I c :j
Fig. 4.11 Levels of perfusate metabolites during the perfusion
of isolated ra t livers with jcyclohexanecarboxylic 
acid.
100 50
40
-a
CO
4-J 60
o
•4->
40 20
10 -20
^ -^--4—-A
: I________ I____ I___________ I_____I 3
2 4 66
time (h)
cuU)
o•a
time (h)
cu
CO
o-a
fO4->
o
2 4
time (h)
^— 4-—
2 4
time (h)
Points represent the means of 3 isolated l iv e r  perfusion experiments 
-  S.E.M. shown by vertical bars.
©; cyclohexanecarboxylic acid, □; hippuric acid, O; benzoic acid, 
t ; cyclohexylcarbonyl glucuronide, v; hexahydrohippuric acid ,  
3,4,5,6-tetrahydrohippuric acid.
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Fig. 4.12 [^^C]Cyclohexanecarboxylic acid metabolism and product
formation during perfusion of an isolated ra t  l iv e r .
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cyclohexanecarboxylic acid; b , hippuric acid; o, b i l ia r y  
excretion*, v , cyclohexylcarbonyl glucuronide? □, associated 
with perfusate erythrocytes*, v ,  hexahydrohippuric acid; 3 ,4 ,5 ,6 -  
tetrahydrohippuric acid; o , benzoic acid; ® t o t a l  component 
levels.
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DISCUSSION
Cyclohexanecarboxylic acid was metabolised rapidly by 
isolated perfused ra t  l ivers  and eliminated from the perfusion 
medium by a f i r s t  order process. The id en tity  of the metabolites 
in the perfusate and b i le ,  and the kinetics of th e ir  formation 
and excretion, were consistent with the metabolic pathway 
proposed in chapter 2. Moreover, the results of this present 
study not only add considerably to the understanding of this  
pathway, but also highlight important differences between 
in vivo and in v itro  (perfusion) experiments.
The results described show that when a considerable quantity  
of cyclohexanecarboxylic acid (25 mg) is presented to an isolated  
ra t  l iv e r  i t  is a t f i r s t  detoxicated by 2 pathways. I t  is e ither  
glucuronidated or aromatised and conjugated with glycine to form 
hippuric acid (probably via the carbonyl-coenzyme A derivatives  
of cyclohexanecarboxylic acid, A'-cyclohexenecarboxylic acid and 
benzoic acid, see chapter 3 ). Whilst the cyclohexanecarboxylic 
acid is present in the perfusion medium at concentrations above 
about 100 mgl these pathways are of approximately equal importance 
This was deduced by the finding that a f te r  2| h, of the in i t ia l  
dose, 30% was present as glycine conjugates (predominantly 
hippuric acid, 23%) and 23% as cyclohexanecarbonyl glucuronide.
As the molecular weight of the la t te r  (289) is ju s t on the threshold 
l im i t  for b i l ia ry  excretion in the ra t  (Smith 1973), i t  was not 
surprising to find i t  being released into the b ile  and perfusate 
at similar ra tes , and i t  is probable that the fraction found in
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the perfusate a f te r  2|  h (11% dose) would normally ( i . e .  in v ivo) 
be urinary excreted (this correlates very well with the in vivo 
s ituation , see chapter 3 ). However, as this route of excretion 
was not available to the isolated l i v e r ,  the glucuronide was taken 
back into the l iv e r  and subsequently b i l ia ry  excreted. After  
2gh when only about 35% of the substrate remains in c ircu lation  
the hippuric acid pathway takes over completely, apparently with 
no fu rther  glucuronide or minor glycine conjugates being formed.
The metabolism of cyclohexanecarboxylic acid in the 
isolated perfused ra t  l iv e r  has been shown to correlate well with 
the in vivo s ituation. Certain major differences were observed 
however. In the perfused l iv e r  no benzoyl glucuronide was detected 
and the levels of hexahydrohippuric and tetrahydrohippuric acids 
were low (2%). In the in vivo situation however, a comparable 
dose of cyclohexanecarboxylic acid (100 mg/kg, ^ 25 mg) afforded 
cyclohexylcarbonyl and benzoyl glucuronides in s im ilar amounts 
(10 - 11% ) and levels of urinary hexahydro and tetrahydro- 
hippurates (10% of each) were much higher than in the perfused 
l iv e r .  Why such differences with the in vivo s ituation occur 
remain to be explained but other tissues (e.g. kidney) are almost 
certa in ly  involved.
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SUMMARY
1. The metabolism of cyclohexanecarboxylic acid has been 
examined in the isolated perfused ra t  l iv e r .  The elimination of 
this compound from the perfusate follows f i r s t  order kinetics.
2. The results presented show that the l iv e r  is an important 
organ in the metabolism of cyclohexanecarboxylic acid (a gut- 
microbial metabolite of shikimic acid ) by mammals.
3. Liver perfusion of cyclohexanecarboxylic acid produced benzoic 
acid, hexahydrohippuric acid, 3 ,4,5,6-tetrahydrohippuric acid , 
hippuric acid and cyclo hexylcarbonyl glucuronide.
4. Certain observed qu alita tive  and quantitative differences  
from the in vivo situation supported the b e lie f  that other 
mammalian tissues may contribute to the metabolism of this  
compound.
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CHAPTER 5
Metabolic fate of shikimic acid in 
the rat
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INTRODUCTION
Although a considerable amount of information has been 
compiled on the biochemistry of shikimic acid in the plant 
kingdom (Haslarn 1974), very l i t t l e  is known of the ways in which this  
naturally  abundant compound and its  close re latives (such as quinic 
acid) are metabolised in mammalian systems. The claim (Evans and 
Osman 1974) that shikimic acid may possess carcinogenic and 
mutagenic properties has added to the need for a closer examination 
of this compound, p articu larly  with regard to its  metabolic fate  
since the compound i t s e l f  does not appear to satis fy  the chemical . 
requirements of the more common groups of compounds known to produce 
cancer in experimental animals.
When shikimic or quinic acids are administered o ra lly  to 
animals an increased urinary excretion of hippuric acid is observed 
(Adamson £ t  aj_ 1970, Asatoor 1965, Cotran et 1960, Scheline and 
Indahl 1973, Brewster et £l_ 1976) which may be prevented by 
suppressing the gut f lo ra  of the animals with an tib io t ics . These 
observations have been explained by the finding (see Chapter 2) 
that shikimic acid is metabolised by gastrointestinal microorganisms 
to cyclohexancarboxylic acid and that the la t te r  is aromatised 
by the mammalian tissues (see chapters 3 and 4 ) .  Taking note of 
a possible major contribution by the gut f lo ra  to shikimic acid 
metabolism, the experimental procedures adopted have been designed 
to establish metabolism that is of microbial or tissue o r ig in .
The metabolism of shikimic acid by mammalian tissues has therefore  
been examined using ( i )  isolated perfused rat livers and ( i i )  in t ra -
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peritoneal administration of the compound. The metabolism of 
shikimic acid a fte r  oral administration to both normal and 
antib io tic  treated animals has been investigated in an attempt 
to assess the importance of any microbial involvement in vivo.
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MATERIALS AND METHODS
Chemicals
Shikimic acid (m.p. 188-190°) was obtained from the Sigma
Chemical Co., London, U.K., and Cambrian Chemicals L td . ,  Croydon,
England. [^^Cjshikimic acid was purchased as D-[G-^^C]shikimic
—1
acid (specific a c t iv ity  20.7 mCi mmole ) from New England Nuclear, 
Dreieichenhain, W. Germany and as D-[2,3,4,5(n)-^^C]shikimic acid 
(specific a c t iv ity  64 mCi mmole ^)from The Radiochemical Centre, 
Amersham, U.K. All samples of shikimic acid, radiolabelled or 
otherwise were shown to co-chromatograph on manufacturers 
recommended t . l . c .  systems. Neomycin and tetracycline were obtained 
from Sigma, and trimethyl s i ly l  derivatising reagents such as 
trimethylchlorosilane (TMCS), hexamethyldisilazane (HMDS) and 
N,0-bis-(trim ethyls ily l)-acetam ide (BSA) from the Pierce Chemical 
Co., Rockford, I l l in o is ,  USA.
Animals
Male Wistar albino rats (220 - 250 g) were used in a l l  the 
experiments described. For the in vivo experiments in which 
i t  was necessary to suppress the gastrointestinal m icroflora, 
animals were administered a solution of Neomycin (40 mg) and 
tetracycline (20 mg) in 0.25 ml of water twice daily  fo r  4 days, 
and once on the f i f t h  day 1 - 2 h before the experiment.
Cannulation experiments
Cannulation of the ureters and b ile  duct to permit the
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direct collection of urine and b ile  was carried out as 
described in Chapter 3. Anaesthetised animals subsequently 
received shikimic acid (50 - 100 mgKg \  4 yCi) in 0.5 ml 
water e ither by intraperitoneal in jection or (in one experiment) 
intraduodenal administration. Urine and b ile  was collected  
(see Chapter 3) for 7 h.
Liver perfusion
The metabolism of shikimic acid in the isolated perfused 
ra t  l iv e r  was carried out according to the methods described 
in Chapter 4. Shikimic acid (12.5 mg, 5 -  6 yCi) was added to 
the c ircu la tin g , equilibrated whole perfusate in 1 ml of water 
and the livers  perfused for 5 h.
Animal experiments
For the collection of radioactive excreta during in vivo 
metabolism studies, animals were maintained in glass metabolism 
cages (Metabowls, Jencons S c ien tif ic  Ltd.) and urine and faeces 
collected separately for 24 h. Expired carbon dioxide was ‘ 
collected by drawing through a series of ethanol amine-2-ethoxy- 
ethanol (1 :4 , by v o l . )  solvent traps at a rate of approximately 
200 cm^min \  Animals received [^^Cjshikimic acid (100 mgkg ^ , 
6-15 yCi) throughout.
Preparation of excreta for determination of rad ioactiv ity
Faeces : Aliquots (0.5 ml) of an approximately 5% (w/v)
aqueous homogenate of 24 h Faecal samples were dispensed into  
glass s c in t i l la t io n  vials and heated with 3 ml hyamine hydroxide
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(Packard Ltd.) a t 55-60° for 5 h. After cooling, 30% 
hydrogen peroxide (0.25 ml) was added and the solutions 
allowed to decolourise overnight. Digests were neutralised  
with 0.25 ml conc. HCl before determination of in 
s c in t i l la n t  (3 ).
Urine : Urine samples were diluted to 50 or 100 ml and
aliquots (100 y l ) determined in s c in t i l la n t  (2 ).
Expired carbon dioxide: To trapping medium (5 ml)
was added AnalaR methanol (4 ml) and the solution counted in 
s c in t i l la n t  (2) .
S c in t i l la t io n  counting
Determination of rad ioactiv ity  was carried out using 
either an LKB 1210 or Packard 3320 liquid s c in t i l la t io n  
counter. Three s c in t i l la t io n  systems were used, (1) 0.55% 2 ,5 -  
diphenyloxazole in Synperonic NXP - toluene (1 :2 , by v o l . ) ,
(Wood et ^  1975), (2) 0.55% 2 ,5-diphenyloxazole in toluene 
containing 4% thixotropic gel (Packard L td . ) ,  (3) Insta Gel ‘ 
(Packard L td .) .
Solvent extraction of samples
C ell-free  perfusate: Whole perfusate was centrifuged
(2,000 g, 2 min) and cell free perfusate aliquots (5 ml) freeze-  
dried. Dry residues were ground with 1 g s i l ic a  and transferred  
to a small glass chromatography column and eluted with methanol
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(40 ml). Extracts were evaporated and redissolved in 0.5 ml 
of aqueous methanol (1 :1 , by v o l. )  for  analysis by th in -layer  
chromatography.
Urine: Two methods of extraction were employed.
(1 ) for examination of metabolites formed via the microbial- 
dependent cyclohexanecarboxylic acid pathway, 5 ml diluted urine 
(1 :1 , by v o l . )  was ac id ified  to pHl and extracted with ethyl 
acetate (5 x 6 m l), the extracts evaporated and redissolved
in methanol (200 y l )  for analysis by t . l . c .  on system (a ) .
(2) for analysis of whole urine, 5 ml of diluted urine (1 :1 ,  by v o l . )  
was freeze-dried then suspended in methanol (10 m l). The suspension 
was transferred to a small chromatography column containing 1 g 
s i l ic a .  The clear eluate was collected and the s i l ic a  eluted with
a further volume (10 ml) of methanol. Extracts were combined, 
evaporated and redissolved in methanol (300 y l )  for  analysis 
by t . l . c .
Faeces: Aliquots (10 ml) of 5% (w/v) homogenates of the
24 h faecal samples were freeze-dried and then suspended in ’ 
methanol (10 ml). Suspensions were transferred to small 
chromatography columns containing 1 g s i l i c a ,  the eluates collected  
and the s i l ic a  eluted with a further aliquot of methanol (20 m l). 
Methanolic extracts were combined and decolourised with activated  
charcoal (100 mg). After f i l t e r in g ,  the extracts were evaporated 
and redissolved in methanol (200yl ) for  analysis by t . l . c .
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Before reducing to low volume aliquots of a l l  extracts were 
counted for rad ioactiv ity  to determine the extraction e ffic iency  
of each procedure adopted.
Chromatography
Thin-layer chromatography was carried out using 0.25 mm 
thick plates of s i l ic a  gel G.Fgg^ (Schleicher and Schull, 
distributed by Anderman and Co. Ltd .) and preparative-layer  
chromatography on s i l ic a  gel GOFgg^  plates of 2 mm thickness 
(E. Merck, Darmstadt, Germany). The following solvent systems 
were used (a) acetone-petroleum ether (b .p .40-60°)- acetic  
acid (20:40:1, by v o l . ) ;  (b) n-propanol-ammonia soln. (sp.gr. 0.88) 
(7 :3 , by v o l . ) ;  (c) n-butanol-acetic acid-water (4 :1 :1 , by v o l . ) ;
(d) toluene-ethyl acetate-methanol-ammonia soln. (sp. gr. 0 .88 ) 
(1 :5 :2 :1 , by v o l . ) ;  (e) ethyl acetate-methanol-ammonia soln.
(sp.gr. 0.88) (3 :2 :1 , by v o l . ) ;  ( f )  Methanol-chloroform (1 :6 , by 
v o l . ) .
Acidic compounds were detected by spraying the developed 
chromatograms with 0.04% bromocresol green in ethanol (Lugg and 
Overall 1948). Shikimic acid and other 1,2-dio ls were detected 
by spraying chromatograms l ig h t ly  with 0.01 M sodium metaperiodate 
followed (a fte r  5 min) with a solution containing 0.9% soluble 
starch, 0.8% potassium iodide and 0.9% boric acid in saturated sodium 
tetraborate (Metzenberg and Mitchell 1954). Compounds which were 
oxidised by periodate thus gave a white spot against a blue 
background.
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Autoradiography
Autoradiography of th in -layer chromatrograms was carried out 
as described in chapter 2 .
Incubations with ra t  caecal microorganisms
The in v itro  metabolism of compounds by ra t  caecal micro­
organisms was performed as described in chapter 2 .
Quantitative determination of metabolites
Hippuric ac id : this was determined by reverse isotope
d ilu tion  of ethyl acetate extracts of urine according to the 
method outlined in chapter 4. ,
Catechol : diluted 24 h urine (5 ml) was heated with an
equal volume of 4M HCl at 90-95° for 30 min. The solution 
was cooled and then extracted with ethyl acetate(3 x 10 ml). 
Extracts were evaporated under reduced pressure and redissolved 
in methanol (5 ml). An accurately weighed sample of pure 
catechol (1 -  2 g) was added and the solution warmed to bring 
about solution. After evaporation, the residue was recrystalised  
(m.p. 103-5°) to constant specific rad ioactiv ity  from toluene. 
Alquots of the original urine were counted for ^^ C to determine 
the amount of rad ioactiv ity  analysed.
Shikimic acid and other metabolites: these were determined
by quantitative radioassay a f te r  separation by t . l . c .  Radioactive 
metabolites werelocated by autoradiography of the developed
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chromatograms, the areas removed and then counted for in 
s c in t i l la n t  (2 ).
Mass spectrometry
Electron impact mass spectra were recorded on an AEI MS 12 
mass spectrometer using direct sample insertion. Spectra were 
recorded at 70 eV and a source temperature of 200 -  250° except 
where otherwise stated. Small samples separated by th in -layer  
chromatography were prepared for analysis by modifications of 
the method described by Rix e^ ^  (1969).
For analysis of metabolites 1 - 3 ,  ethyl acetate extracts  
of urine were chromatographed on solvent system (a ) ,  the 
metabolites located by autoradiography, removed and eluted with 
methanol, then chromatographed separately on system (b).
Derivatisation of samples for mass spectrometry
Derivatisation of samples was carried out in small, 
conical glass v ia ls  -  conveniently prepared from the conical 
sections of Pasteur pipettes.
Shikimic acid: Methanolic extracts of freeze-dried
urine or c e l l - f re e  perfusate were chromatographed as 5 cm bands 
in solvent system (b). The required bands (located by autoradiography) 
were removed, eluted with methanol in small glass columns (e.g. 
shortened pasteur p ipettes), ac id ified  with methanolic HCl and 
chromatographed in system (c). Shikimic acid bands were 
removed, eluted with methanol, evaporated and then derivatised
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with hexamethyldisilazane (HMDS, 20 yl ) and trimethylchloro- 
silane (TMCS, 10 yl ) in acetone (300 y l ) .  After 10 liiin 
the solution was separated from a precipitate  of ammonium 
chloride and the tetra-(trimethyl s ily l)-sh ik im ate  prepared for  
mass spectrometry as described above. Trimethyl s i ly l  ethers of  
other metabolites were prepared in a s im ilar fashion a f te r  in i t i a l  
purification  by t . I . e .
E s té r if ic a t io n : Methanolic solutions of carboxylic
acids were es ter if ied  by the addition of excess ethereal 
diazomethane (Vogel 1956) and the resulting esters purified  
by t . l . c .  on system ( f ) .
Acetonide formation: suspected c is -1 ,2 -d io ls ,  purified
from faeces, were es ter if ied  as described above and purified  
by t . l . c .  on system ( f ) .  The esters were recovered from the 
s il ic a  by elution with methanol and evaporated by a nitrogen 
stream. Diol-esters (50 - 200 yg) were stood for 24 h in acetone 
(300 y l )  containing p-toluenesulphonic acid (p-TsOH) in c a ta ly t ic  
amounts (10 -100 yg).  The acetone solution was subjected to 
thin layer chromatography in solvent system ( f ) ,  suspected 
acetonide bands eluted from the s i l ic a  with acetone and the 
samples prepared for d irect insertion mass spectrometry.
Purification of metabolite 4 from ra t faeces
Metabolite 4 was the major faecal metabolite of shikimic 
acid and was also present to a small extent in urine. The
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metabolite was purified for further analysis as follows:
The 24 h freeze-dried faeces of 3 rats which received oral 
[^^C]shikimic acid (100 mgKg ^) were extracted with methanol 
and the extracts decolourised with activated charcoal as 
described e a r l ie r .  The extracts were f i r s t  subjected to 
preparative layer chromatography using system (b ), the metabolite 
located by autoradiography, removed and eluted from the s i l ic a  
with methanol. A fter ac id ifica tio n  with conc. HCl (5 y l )  the 
extracts were further chromatographed on th in -layer plates 
in sequential fashion using systems (c ) ,  (d) and (e) respectively. 
The purified material was f in a l ly  ac id ified  with conc. HCl 
(5 y l ) in d is t i l le d  water (1 ml) and freeze-dried.
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RESULTS
Administration of [^^C]shikimic acid to rats resulted in an 
elimination of the dose in the urine, faeces and as expired 
carbon dioxide with over 95% being recovered within 24 h (see 
Table 5 .1 ) .  After intraperitoneal administration, a l l  of the 
dose was excreted in the urine whereas a f te r  oral dosing approximately 
equal amounts were recovered in both the urine and faeces. In 
animals pretreated with a combination of Neomycin and te tracyc lin e ,  
the urinary excretion of oral shikimic acid was greatly reduced and 
indicated a suppression of reductive microbial metabolism (see 
Table 5 .1 ) .
Metabolism of shikimic acid a f te r  intraperitoneal administration
Intraperitoneal administration of [^^Cjshikimic acid to 
anaesthetised ra ts , cannulated for d irect collection of urine and 
b i le ,  resulted in a rapid and complete elimination of the dose in  
the urine (see Fig. 5 .1 ) .  A very small degree of b i l ia r y  excretion  
was observed (Fig. 5.2) which was not further investigated.
Methanol extraction of freeze-dried urine was highly e f f ic ie n t ,
> 98% of the urinary being recovered by such means. Analysis 
of these extracts by t . l . c .  (system b) followed by autoradiography 
of the developed chromatograms showed the presence of one component 
only (equivalent to 95-98% of the recoverable ^^C) in 3 separate 
experiments and which co-chromatographed with authentic shikimic 
acid ( I ) .  The urinary component was confirmed as shikimic acid 
by mass spectrometry of the te tra - tr im e th y ls ily l  derivative ( I I )
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prepared using hexamethyldisilazane (HMDS) and trim ethyl-  
chlorosilane (TMCS). The mass spectrum (M^, e 462) was 
consistent with the required derivative and identical to
COOH C00Si(CH3)3
HMDS/TCMS
HO
OH
(CHgjgSiO
(I)
OSIfCHg)]
t
bsi(CH3)3 ( I I )
(m.wt., 462)
the spectrum of authentic shikimic acid derivatised in s im ilar  
fashion (see Table 5 .2 ) .  A fu l le r  in terpretation of these mass 
spectra in given in Chapter 6 .
Metabolism of shikimic acid in the isolated perfused ra t  l iv e r
The perfusion of isolated ra t  livers  with [^^C]shikimic acid
14(12.5 mg, 5 yC i) resulted in no active uptake of C from the 
perfusate and only a very small degree of b i l ia ry  excretion of 
^^C (see Figs 5.3 and 5 ,4 ) .  B il ia ry  rad ioactiv ity  (< 0,8% dose 
a fte r  5 h) was not investigated further but the c e l l - f re e  
perfusate in 3 experiments was freeze-dried and separately 
extracted with methanol, releasing 95-98% of the associated 
rad ioac tiv ity . Examination of these extracts by t . l . c .  (system b)
followed by autoradiography of the developed chromatograms showed
the presence in each case of only one component (equivalent 
to >95% of the recoverable ^^C) which co-chromatographed with 
authentic shikimic acid. The material was confirmed as shikimic
Fig. 5.1 Urinary excretion of rad ioactiv ity  following intraperitoneal 
administration of [^^Cjshikimic acid to rats
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^ 40
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time (h)
Points represent the means of 3 experiments ± SEM _-| 
represented by vertical bars. Shikimic acid (50 mgKg , 4 yCi) 
was administered in 0.5 ml water.
Fig. 5.2 B il ia ry  excretion of rad ioactiv ity  following intraperitoneal 
administration of shikimic acid to rats
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% 0 75
-a
o 0-254->
time (h)
Points represent the means of 3 experiments ± SEM 
represented by vertical bars. Shikimic acid (50 mgKg , 4  yCi) 
was administered in 0.5 ml water.
14.Fig. 5.3 Perfusate C levels during perfusion of an isolated ra t  
l iv e r  with I^^C]shikimic acid.
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Shikimic acid (12.5 mg, 4 yCi) was added to the perfusate 
reservoir in 1 ml water. ▼, before l iv e r ;  a ,  a f te r  l iv e r ,
Fig. 5.4 B il ia ry  excretion of rad ioactiv ity  during perfusion of an 
isolated ra t l iv e r  with [^^CJshikimic acid.
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Shikimic acid (12.5 mg, 4 yCi) was added to the perfusate 
reservoir in 1 ml water.
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Table 5.1 Excretion of following administration of [^^C]shikimic 
acid to ra ts .
Percentage of dose excreted
route animal faeces urine expi red
COg
24h
recovery
oral normal rats (7) 45-63 40-57 4-7 95-97
oral an tib io tic  treated 
rats (3)
75-81 12-16 + 93-96
i .p. normal rats (3) < 1 97-100 < 0.8 98-100
In a l l experiments shikimic acid was administered at a dose level of
100 mgKg"'. Numbers of individual animal experiments are given in 
parenthesis. +, not determined.
Fig. 5.5 . Urinary excretion of rad ioactiv ity  following intraduodenal 
administration of [^^C]shikimic acid.
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Shikimic acid (100 mgKg"^, 4 yCi) was administered in 0.5 ml water.
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acid by analysis of the mass spectrum of the te tra - tr im e th y ls ily l  
derivative (M^, "^ e^ 462) which was identical to that of authentic 
te tra -(tr im e th y ls ily l)-sh ik im ate  (see Table 5.2 and Chapter 6 ) .
The experiments described above indicated that shikimic 
acid is not metabolised by mammalian tissues and that the 
metabolism of this compound may be to ta l ly  dependent upon gastro­
in testinal microorganisms. Extensive microbial metabolism of 
shikimic acid was considered quite possible since such a highly 
polar compound would be expected to be poorly absorbed from the 
gut. This was confirmed by examining the urinary excretion 
of a f te r  intraduodenal administration of [^^C]shikim1c acid 
(see Fig. 5 .5) and was indeed found to be considerably slower 
(excretion rate approx. 2% h"^) than by the intraperitoneal 
route. Furthermore, of the material absorbed and excreted, 
a considerable proportion of this was probably due to microbial 
degradation to cyclohexanecarboxylic acid (see Chapter 2 ) .
B il ia ry  excretion (< 0.4% dose over 5 h) was a very minor route 
of excretion of the dose and was not investigated fu rther .
Subsequent experiments were confined to oral administration  
of shikimic acid and the metabolism compared to that of animals 
in which the gut f lo ra  had been suppressed with a combination 
of Neomycin and te tracycline. This combination a n tib io t ic  
offers advantages over the use of Neomycin alone which is in e ffec tive  
against Bacteroides, a major group of gastrointestinal microorganisms 
(Finegold et al 1965).
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Metabolism of shikimic acid a f te r  oral administration 
Urinary metabolites
Urine was analysed i n i t i a l l y  by extraction with ethyl 
acetate a t pH 1. This procedure has been shown (see Chapter 
3) to recover the metabolic products of cyclohexanecarboxylic 
acid and does not extract very polar compounds such as shikimic 
acid. In an tib io t ic  treated animals only 19-23% of the 
urinary rad ioactiv ity  (2-3% dose) was removed by this procedure 
but the urine of normal animals furnished some 72-79% (35-40% 
dose) of the urinary ^^C. The e ffec t was attributed to the 
production of less polar, urinary metabolites of shikimic acid 
which are prevented when the gut f lo ra  are suppressed.
T . l . c .  (system a) of normal urine extracts followed by auto­
radiography of the developed chromatograms showed the presence 
of hexahydrohippuric acid, 3,4,5,6-tetrahydrohippuric acid 
and hippuric acid (metabolites 1 -  3 respectively, see Fig. 5 .6)  
which were iden tif ied  both by comparison with the metabolites 
of cyclohexanecarboxylic acid .{see chapter 3) and by mass 
spectrometry (M^, ^Ye 185, ^/e 183, ^/e 179 respectively) a f te r  
suitable purif ication  (see Table 5 .2 ) .  In normal rats hexahydro* 
hippuric acid and tetrahydrohippuric acid constituted some 
0.8-1.3% and 2.0-3.5% of the dose respectively and hippuric 
acid (see Fig 5.9) between 25-30% of the dose. More important 
however, the ratios between the amounts produced was approx. 
3:9:80 respectively which correlates well with the ratios  
observed in the metabolism of cyclohexanecarboxylic acid 
(see Chapter 3) a t low dose levels (0.5 mgkg“^), and therefore
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Fig.5.6
Fig.5.6 T.l.c. - autoradiography of ethyl acetate 
extracts of urine.
Fig.5.7
• •••
AR NR
AR NR
SA SA SA
Fig.S.7 T.l.c. - autoradiography of whole urine.
AR, antibiotic treated rats; NR, normal rats; 
SA, i"^C-shikimic acid.
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provides additional support for the microbial production of the 
la t te r  from shikimate.
Analysis of whole urine was carried out by extraction of
freeze-dried material with methanol. The procedure proved
to be very e f f ic ie n t ,  extracting between 95-100% of the
rad ioactiv ity  contained in a l l  urine samples analysed. T . l . c .
(system b) of normal urine extracts followed by autoradiography
of the chromatograms showed, in addition to the hippurates
described above (metabolites 1 -3 ),  the presence of two additional
components(4 and 5)one of which (component 5) co-chromatographed
with authentic [^^CJshikimic acid (see Fig. 5*7). The urine of
an tib io t ic  treated rats contained one major component (component 5)
14which also co-chromatographed with authentic [ C]shikimic acid, 
and only traces of the metabolites observed in the urine of normal 
rats (see Fig. 5 .7 ) .  Component 5 was confirmed as unchanged 
shikimic acid by mass spectrometry of the te tra -tr im e th y ls ily l  
derivative (M^, ^/e 462) which was identical with authentic 
te tra -( tr im e th y ls ily l)-s h ik im ate  (see Table 5 .2 ) .  Unchanged 
shikimic acid was present in similar amounts (8 -  12% dose) in 
the urine of both normal and an tib io t ic  treated animals (see 
Fig. 5.7 and Fig. 5*11) consistent with f i r s t  a slow absorption 
and then urinary excretion of the substrate from both groups of 
animals. Metabolite 4 however was barely detectable in the 
urine of a n tib io t ic  treated animals (see Fig. 5 .7 ) and was taken 
as arising through microbial metabolism although presumably, in 
l ig h t  of the results of chapter 3, by a pathway separate to that
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involving the in i t i a l  production of cyclohexanecarboxylic acid.
This metabolite w il l  be discussed shortly.
Acid hydrolysis of urine released catechol as id en tif ied  
by co-chromatography (system f )  with authentic m ateria l, i ts  
spontaneous darkening through oxidation by a i r  and f in a l ly  
by reverse isotope d i lu t io n . Levels of released catechol which 
were normally low (0 .3 -1 *8%) were barely detectable in the urine 
of an tib io t ic  treated rats indicating an additional, although 
minor, microbial pathway (see Fig. 5 .10).
Faecal metabolites
The extraction o f freeze-dried faeces with methanol proved 
to be very e f f ic ie n t  also. Between 95-98% of the rad ioac tiv ity  
was released in this way and with due care no additional losses 
were incurred upon decolourisation of the extracts with activated  
charcoal. T . l . c .  (system b) of the decolourised methanolic 
extracts of normal ra t  faeces followed by autoradiography of the 
developed chromatograms showed the presence of one major component 
(see Fig. 5 .8 ) ,  less polar than shikimic acid and which was 
subsequently shown to co-chromatograph with the unidentified  
metabolite (metabolite 4) of normal urine. Small amounts o f at  
least two unknown metabolites were also observed (see Fig. 5 .8 ) which 
together represented between 5 - 9% of the original dose. In 
antib io tic  treated rats most of the rad ioactiv ity  in the faeces 
was present as unchanged shikimic acid (confirmed by mass spectrometry
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SA SA
Fig.5.8 T.l.c. - autoradiography of rat faecal extracts 
AR, antibiotic treated rats; NR, normal rats; 
SA, l-^C-shikimic acid.
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Fig. 5.9 Urinary excretion of hippuric acid following oral 
administration of [^^CJshikimic acid to ra ts .
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jnm fiïïl
Fig. 5.10 Urinary excretion of conjugated catechol following  
oral administration of [^^C]shikimic acid to ra ts .
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Fig. 5.11 Urinary excretion of unchanged shikimic acid a f te r  
oral administration to rats .
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F ig .  5 .1 2 Urinary excretion of isomeric dihydroxycyclohexane- 
carboxylic acids a fte r  oral administration of shikimic acid
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Fig, 5.13 Faecal excretion of isomeric dihydroxycyclohexane-
carboxylic acids a fte r  oral administration of shikimic acid
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Fig. 5.14 Faecal excretion of unchanged shikimic acid a f te r  oral 
administration to rats .
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of the te tra -tr im e th y ls ily l  derivative) as compared to normal 
faeces in which only small amounts remained (see Fig. 5o8 and 
Pig. 5 .14).
Id en tif ica tion  of metabolite 4
Metabolite 4 was the major metabolite present in the 
faeces of normal rats and also occurred (but to a lesser extent) 
in urine. Purification of the faeces of 3 animals gave 3 mg 
of 4 for further experiments. T . l . c .  (system b) showed 
the material to be acidic (by i ts  reaction with ethanolic 
bromocresol green), fu l ly  saturated (by i ts  fa i lu re  to 
quench the fluorescence of 254 nm u.v. l ig h t )  and to contain a 
1 , 2-d io l grouping (by i ts  reaction with the periodate/iodide  
spray reagent). On this basis the material was assigned the 
basic structure ( I I I )  or ( IV ) .  For analysis the material was
COOH COOH
HO HO
OH
( I I I )  ( IV )
e s te r if ied  with ethereal diazomethane in methanol. The product 
was purified by t . l . c .  in system ( f )  upon which i t  resolved into  
2 discrete components 4a and 4b (approx. ra tio  2:1) with Rf values 
of 0.52 and 0.47 respectively. These were carefu lly  separated
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and eluted from the s i l ic a  with methanol for further examination.
Both 4a and 4b indiv idually  gave the reactions described above 
for the mixture (4) and in addition although in su ff ic ien t  
material was available to obtain interpretable n.m.r. spectra, the 
spectra obtained showed quite c learly  the absence of any signals 
corresponding to aromatic or o le f in ic  resonances. Both 4a and 
4b showed almost identical mass spectra under electron impact 
and were consistent with the methyl dihydroxy-cyclohexanecarboxylate 
structure ( I I I ) .  Parent ions of the compounds were not observed, 
and ions of highest mass (^ /e , 156) in both spectra corresponded 
to (M-HgO)*' an e ffec t also observed in the spectrum of 
underivatised shikimic acid (see Table 5 .2 ) .  The s p e c if ic ity  
of acid catalysed condensations between acetone and c is -1 , 2-d io ls  
to acetonide derivatives was employed for further characterisation  
of 4a and 4b. Thus, treatment with acetone and p-toluenesulphonic 
acid converted 4a to an acetonide derivative with reduced 
chromatographic po larity  on system ( f )  and from which 4a was 
iden tif ied  as methyl 3,4-(cis)-dihydroxy cyclohexanecarboxylate (V). 
Metabolite 4b did not form an acetonide derivative under the 
above conditions,being recovered unchanged and was thereby 
iden tif ied  as methyl 3,4-(trans)-dihydroxycyclohexanecarboxylate(VII). 
The mass spectrum (see Table 5.2) of acetonide (V I) showed the 
peak of highest'^/e as (M-15)^ representing the d irect loss of 
CHg' to give the resonance-stabilised i o n ( V I I I ) .  Parent ions are 
not observed in acetonide spectra and molecular weights are 
normally calculated from the value of the M-15 peak (Budzikiewicz 
^  1967a). A fu l le r  interpretation of the mass spectra of V -  V I I
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CÜOMe COOMe
HO
OH
(VI)Me "
COOMe
ÔH
(V I I )
is given in Chapter 6 .
The isomeric dihydroxycyclohexanecarboxylates which o r ig in a l ly  
constituted component 4 (see Figs. 5.7 and 5.8) were apparently 
microbial dependent products of shikimic acid since th e ir  appearance 
in both faeces and urine was prevented in animals pretreated  
with antib iotics  (see Fig. 5.12 and Fig. 5 ,13).
COOMe
Me"
Me
COOMe
Me
COOMe
Me
( V I I I )
("Ve 199)
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DISCUSSION
Previous workers have shown that shikimic and quinic 
acids are metabolised and excreted in the urine as hippuric 
acid (Adamson et ^  1970, Asatoor 1965, Cotran e t ^  1960,
Scheline and Indahl 1973, Brewster £ t  ^  1976), that gastro­
in testinal microorganisms play an important ro le , probably 
in the aromatisation to benzoic acid and that the metabolism 
(in the case of quinic acid) shows considerable species 
variation (Adamson ^  ^  1970). The urinary excretion of 
small amounts of conjugated catechol have also been observed 
(Booth et ^  1960, Scheline and Indahl 1973, Brewster e t  al 
1976). The present results using shikimic acid show that the 
metabolism is somewhat more involved than was f i r s t  thought.
The in a b i l i ty  of the ra t to metabolise intraperitoneal 
administrations of shikimic acid and the fa i lu re  to observe 
metabolic products of shikimic acid a f te r  continuous perfusion 
through isolated ra t livers  indicate that shikimic acid is not 
metabolised by mammalian tissues. In addition, oral administration  
of shikimic acid to an tib io tic  treated animals resulted mainly 
in the excretion of unchanged shikimic acid and à considerable 
reduction of the metabolites observed in normal animals (see 
Figs. 5 .9 -5 .1 4 ) . This would indicate that although the tissues 
may be involved in subsequent reactions, the metabolism of 
shikimic acid is e n tire ly  dependent upon various in i t i a l  
microbial transformations.
The observed formation of urinary tetrahydro- and hexahydro­
hippuric acids (together with hippuric acid) confirmed the
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prediction (see Chapter 3) that i f  cyclohexanecarboxylic 
acid is produced in the gut by microbial action, then these 
compounds would appear as urinary metabolites of shikimic 
acid. This follows from the metabolism of cyclohexanecarboxylic 
acid in the ra t  (see chapter 3 ) .  Furthermore the s im ila r ity  
between the ratios of the hippurate derivatives produced from 
shikimic acid and from intraduodenal administration of low 
doses (comparable with the rate of the microbial production) 
of cyclohexanecarboxylic acid confirmed the la t te r  as the 
precursor of urinary hippurates. The production of benzoyl 
and cyclohexylcarbonyl glucuronides was not observed and is  
consistent with a slow (although continuous) production of 
cyclohexanecarboxylic acid in the gut since these conjugates 
are not produced from the la t te r  at low dose levels (see 
Chapter 3 ).  Since shikimic acid occurs widely in plants 
and f ru its  (Bohm 1965) and is converted to cyclohexanecarboxylic 
acid by a variety  of animal faecal microflora (see Chapter 2) 
then hexahydro- and 3 ,4 ,5 ,6 -te trahydro- hippuric acids should 
occur naturally  in the urine of animals as does hippuric 
acid which has been well documented. Hexahydrohippuric acid 
has in fac t recently been detected in the urine of c a t t le  
(Suemitsu et ^  1971) and therefore the microbial conversion 
of dietary shikimate to cyclohexanecarboxylate followed by 
metabolism in the animal tissues would appear to o ffe r  a viable  
explanation for this observation. This mechanism is an 
alternative  to the pathway suggested by Rho and Evans (1975) 
that hexahydrohippuric acid may arise from a microbial 
reduction of benzoate or hippurate and is strengthened by the
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fact that ra t  gastrointestinal microorganisms do not appear to 
reduce benzoate e ither in v itro  or in vivo (see chapter 2) .
The presence of 3,4,5,6-tetrahydrohippuric acid in animal urine 
has yet to be reported but almost certa in ly  exists.
There are other microbial pathways operating however. Both 
the 3 ,4 - (c is )-  and 3 ,4 - ( t ra n s )-  dihydroxy cyclohexanecarboxylic 
acids (IX and X) must arise via pathways other than that 
involving the formation of cyclohexanecarboxylic acid since 
neither are converted to the la t te r  by ra t  caecal microorganisms 
The formation of IX and X ind iv idually , may represent separate 
pathways which involve the removal of e ither the 3-hydroxyl 
or 5-hydroxyl of shikimic acid prior to hydrogenation. 
A lternatively  the formation of IX and X may be envisaged 
as arising from a single non-steriospecific dehydroxylation
COOH
COOH
3
I
tiH _3
(X)
(X I)
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of dihydroshikimic acid (X I) .  Carr e t ^  (1957) have shown 
that a variety  of lactobacillus pastorianus has the a b i l i t y  
to convert both shikimic and quinic acid into (X I) with the 
same configuration a t C, as ( - )  quinic acid.
Yet another microbial-dependent pathway operating f in a l ly  
results in the elimination of conjugated catechol. A microbial 
aromatisation of quinic (or shikimic) acid to protocatechuic 
acid (3,4-dihydroxybenzoic acid) followed by decarboxylation 
has been proposed to account for this observation (Scheline 
and Indahl 1973) although an aromatisation of the hexahydro- 
protocatechuates IX or X in the mammalian tissues appears to 
o ffe r  a second possible explanation. Protocatechuic acid 
produced in this way would be expected to furnish catechol upon 
b i l ia r y  excretion into the gut since this decarboxylation is 
carried out by gastrointestinal microorganisms (Scheline 
1966a, Booth and Williams 1963). An outline of the microbial 
pathways operating in the metabolism of shikimic acid is  given 
in Fig. 5.15. The in vivo formation of microbial metabolites 
other than cyclohexanecarboxylic acid (the only microbial 
product in v itro  -  see chapter 2 ) is a clear example of a 
qualita tive  difference between in vivo and in v itro  studies in 
microbial metabolism.
167
mammalian 
t is s u e ^  
/
COOH/
excretion
flo ra
COOH
-OH \  mammal Ian tissues?
flo ra
flo ra
flo ra
\
\ COOH
HO
COOH
flora
HO
excretion
I
metabolites produced by 
mammalian tissues
Fig. 5.15 Possible microbial pathways operating during the 
metabolism of shikimic acid in the ra t
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SUMMARY
1. Shikimic acid does not appear to be metabolised by mammalian 
tissues.
2. Shikimic acid is converted to hexahydrohippuric acid, 
3,4,5,6-tetrahydrohippuric acid and hippuric acid via an in i t i a l  
microbial conversion to cyclohexanecarboxylic acid which is then 
metabolised in the mammalian tissues.
3. By microbial pathways separate to that which produces cyclo­
hexanecarboxylic acid, shikimic acid is also converted to 3 ,4 - (c is )  
dihydroxycyclohexanecarboxylic acid and 3 ,4-(trans)-d ihydroxy-  
cyclohexanecarboxylic acid.
4. The origin of urinary conjugated catechol probably involves 
the production and subsequent decarboxylation of protocatechuic 
acid (3,4-dihydroxybenzoic ac id ). The la t te r  may be formed
by a microbial aromatisation of shikimic acid or possibly by an 
aromatisation of the above hexahydroprotocatechuates in the 
mammalian tissues. This reaction would be analogous to the 
aromatisation of cyclohexanecarboxylic acid.
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CHAPTER 6
,m.r. and mass spectra of shikimic acid 
and metabolites
170
INTRODUCTION
Too often in the past, id en tif ica tio n  of the metabolites of 
foreign compounds has been based upon such c r i te r ia  as Rf values 
and also the reactions produced by various colour-generating 
reagents. I t  is important however that chemical id en tif ica t io n  
be based on stronger techniques especially those of n.m.r. and 
mass spectrometry the sens it iv ity  of which w i l l  now permit 
analysis of compounds at the levels normally experienced in 
metabolic studies.
The more important n.m.r. and mass spectra of compounds and 
metabolites examined in the metabolic study of shikimic acid are 
now compiled and more important aspects in th e ir  in terpretation  
are discussed.
SPECTROSCOPY
Proton n.m.r. spectra were recorded using a 90 MHz Bruker 
WH-90 Fourier transform n.m.r. spectrometer operating at ambient 
temperature. All chemical shifts  (6 ) are expressed in p.p.m. 
downfield from tetramethylsilane (TMS).
Electron impact mass spectra were recorded on an A .E .I .  MSI2 
mass spectrometer equipped with a temperature programming f a c i l i t y .  
Spectra were obtained by direct insertion of samples at an 
acceleration voltage of 8KV and ionisation voltage of 70 eV. The 
samples were prepared for analysis as described e a r l ie r  (see chapters 
2 -5 ). Assignment of parent-daughter ion transitions to important
metastable ions was aided by the use of a computer programme 
(University of Surrey multi access system) designed to select 
and record observed transitions which satis fied  Equation 6 .1 .
*
"’/e  = ("2/ e )2
Equation 6.1
*
(^Ve), mass to charge ra tio  of metastable ion of apparent mass
m ; (' 2^/ e ) ,  mass to charge ra tio  of daughter ion of mass m 
(^^ /e), mass to charge ra tio  of parent ion of mass m].
SPECTRA
Microbial metabolism of shikimic acid
The incubation of shikimic acid in v itro  with animal caecal 
and faecal microorganisms gave rise to a complete(almost 
quantitative) conversion to what was subsequently id en tif ied  
as cyclohexanecarboxylic acid (see chapter 2 ). The in fra -red  
spectrum obtained (below) was typical of an a lip hatic  carboxylic 
acid, was identical to the spectrum of authentic cyclohexane­
carboxylic acid (Aldrich Chemical Co. L td .) and requires no 
further explanation.
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The n.m.r. spectrum of the metabolite (see Fig. 6 .1) showed 
a low f ie ld  s inglet at 6 11.65 due to the carboxyl proton, a one 
proton m ultip let at 6 2.0 -  2.5 (a -  proton) and an 11 proton 
m ultip let (6 1.0 -  2 . 0 ) corresponding to the remaining ring 
protons.
The mass fragmentation pattern (see Fig. 6 .5) v;as the same 
as that of an authentic sample and was consistent with the 
proposed structure. The parent ion ( I )  was c learly  v is ib le  
and lost carboxyl by simple fission to the cyclohexylium ion 
( I I )  a t 83 which subsequently eliminated ethylene to give 
the ^Ye 55 ion ( I I I ) .  The base peak in the spectrum (^ /e , 73) 
arose via 1,4 hydrogen transfer in ( I )  to give the resonance 
stabilised ion IV at ^/e 73.
(I)
OOH
( I I )
m/e 83
“CH2=CH2
( I I I )  CHz 
m/e 55
m*/e obs.36.5,calc.36.46
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COOH
XH
CH, COOH
CH,
m/e  73
HO
CH, ^  CHg"- CH?
(IV)
*
Ve obs. 41.6, 
calc. 41.63
Metabolism of cyclohexanecarboxylic acid
The metabolic fate of cyclohexanecarboxylic acid was 
examined in order to determine the role of mammalian tissues 
in the subsequent metabolism of this microbial product of 
shikimic acid. In the r a t ,  cyclohexanecarboxylic acid was con­
verted to hippuric acid, hexahydrohippuric acid, 3 ,4 ,5 ,6 - te t r a -  
hydrohippuric acid and benzoyl- and cyclohexylcarbonyl 
glucuronides (see Chapter 3 ). In the isolated perfused l i v e r ,  
a ll  but benzoyl glucuronide were observed.
Hippuric acid was iden tif ied  by isotope d ilu tion  and mass 
spectrometry. The mass spectrum was quite simple the important 
features being a small parent ion at *^ e^ 179, ions corresponding
to PhCO* (^/e 105) and Ph  ^ (‘“/e  77), with ions a ttr ibu tab le  to 
loss of COOH and CO^  at ^/e 134 and /^e 135 respectively (see Fig. 6 . 6 )
Hexahydrohippuric acid and 3 ,4,5,6-tetrahydrohippuric acid 
were iden tif ied  both by n.m.r. (see Figs. 6.2 and 6 .3 ) and mass 
spectrometry. The n.m.r. assignments have been given in 
Chapter 3 (Table 3 .2 ) .  In the spectrum of the tetrahydrohippurate
.+ /m
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the low f ie ld  o le f in ic  signal at 66.57 integrated to 1 proton 
compared to the 2 proton doublet (6 3.74) of the methylene 
protons in the glycine moiety. This can only be consistent 
with the -isomer (see f ig .  6 .3 ) .  The hexa- and tetrahydro- 
hippurates showed sim ilar fragmentation modes under electron 
impact, the main decompositions resulting from the parent ions
co'^
(V) m/e 83
- glycine  ^ wVe 185
+CO
(VI)
CH,
m/e  110
+
'/e 109
7 e 81
( V I I I )Ve 183
glycine
Ve 108
+ M/e 55
(V and VI) a t ^/e 185 and M/e 183 respectively (see Figs. 6.7 and 
6 . 8 ) .  Thus respective parent ions lost the substituent grouping 
to leave the corresponding cyclohexenylium (^Ve 81) ion V llland
175
Fig. 6.1 H n.m.r. of cyclohexanecarboxylic acid in COCl^
J__________I__________L J_____ I
12 11 10 9 8 7 6 5 4 3 2 1 0 £
Fig. 6.2 H n.m.r. of hexahydrohippuric acid in DMSO-d^
T
11
T9 10Tà T6 T1—r‘I T2T4
T"
10 7 3
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Fig. 6.3 H n.m.r. of 3,4,5,6-tetrahydrohippuric acid in 
üMSO-df
0 511 7 19 8 6 510 3 24
Fig. 6.4 H n.m.r. of shikimic acid
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V II ,  The ion V II eliminated a molecule of ethylene to leave 
at ^/e 55, the transition being characterised by the 
accompanying metastable at ^Ve 36.46. Both V and VI eliminated 
a neutral molecule of glycine to present fragments at /^e 110 and
m/e  108 respectively.
Benzoyl glucuronide and cyclohexylcarbonyl glucuronide 
could not be analysed d irec t ly  by mass spectrometry and the 
te tra - tr im e th y ls ily l  derivatives did not exhibit parent ions. 
The methyl-triacetylglucuronates however gave excellent spectra 
(see Figs. 6.9 and 6.10) and were prepared by the action of 
ethereal diazomethane followed by acetic anhydride in pyridine 
(see Chapter 3 ). Although parent ions were c learly  v is ib le ,  
most of the ion current was carried by species derived from the
aglycones. Thus IX fragmented to ions equivalent to CO
rm( /e  111) whereas a-fission (at carboxylate) and the loss of
AcO
COOMe
OAc
O' 
il 
0-C
OAc
(IX)
COOMe
OAc
AcO
OAC
"'/e 444 (i-f ) ■"/e 438 (M+)
a molecule of acetic acid provided ions of only minor abundance 
at ^/e 385 (M^-59) and "Ve 384 (M^-60) respectively. In the
spectrum of derivatised benzoyl glucuronide the parent ion (X)
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furnished the benzoylium ion CgH^ CO**" (^Ye 105) which dominated 
the spectrum above "Ve 43 and again, the M^-59 (" /^e 379) and 
M*-GO ("Ve 378) peaks were of minor importance. The spectra 
of both derivatives showed an abundant acetylium ion 
(CHgCO*, "Ve 43) due to a -fiss ion  in the acetate groupings.
RO - C - CH^  --------------- >  RO + CH. -  C = 0^11 d ■ d
0 *+
" /^e 43
Metabolism of shikimic acid in the ra t
The iden tity  of the commercially obtained shikimic acid 
used in a l l  studies v;as checked by m.p. and by n.m.r. The 
n.m.r. spectrum (see Fig. 6.4) v;as consistent with 
previously interpreted spectra Hall (1964) and w il l  therefore  
not be discussed here.
Intraduodenal administration of [^^Cjshikimic acid to 
rats led to a rapid and complete recovery of in the urine 
(see Chapter 5) which co-chromatographed with authentic 
shikimic acid. For mass spectrometry the po larity  of shikimic 
acid and the urinary component was reduced by derivatisation  
with hexamethyldisi 1azane and trimethylchlorosilane in 
dry acetone. The resulting spectrum (see Fig. 6.11) of the 
urinary component was identical to that of the authentic 
te tra -(tr im e th y ls ily l)-s h ik im ate  (see Fig. 6 .12). Most of 
the ion current was. carried by the ions XI (base peak) and
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X II at * /^e 204 and "Ve 73 respectively, the former seemingly 
providing an excellent example of the retro-D ie ls-A lder  
reaction which also appears to be operating in the genesis
TMSG
COOTMS
TMSG
GTMS
GTMS
mVe 462
GGH
HG'
HG
GH
CGGTMS
4-
'SifCHg)]
(X I I )
)TMS
OTMS
(X I)  
■"/e 204
m/e  73
CGGH 
+ H
H ^  /
■GH
TMS = -SifCHg)]
GH ( X I I I )
m/e  60
of the base peak ion X I I I  (^Ve 60) in the spectrum of 
underivatised shikimic acid (see Fig. 6 .15). The th ird  major 
ion in the spectra at 147 occurred via the sequential 
expulsion of methyl radical and a neutral epoxide analagous 
to the formation of this ion from ethylene g lyco l-b is -tr im ethy l-  
s i ly l  ether (Budzikiewicz et ^  1967b) and other s te rio -  
chemically suitable d io l -b is - ( t r im e th y ls i ly l ) ethers (Havlicek
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et al 1971). Parent ions exhibited typical s ilicon isotopic
COOSiMe
- CH
'OSiMe
Si
\
Me
Me Me
'^Si^
II
+05iMe2
("/e 462 (M ) ""/e 447 (M+-15) m/e  147
clusters and calculation (Biemann 1962) of the theoretical 
M/M + 1 ra tio  (1 : 0.42) showed good agreement with the 
observed value (1 : 0 .41).
Oral administration of shikimic acid to rats led to the 
urinary excretion of hippuric acid, hexahydrohippuric acid 
and 3,4,5,6-tetrahydrohippuric acid the mass spectra of which 
have been discussed e a r l ie r  (see Figs. 6 .6 - 6 . 8 ) .  Shikimic 
acid was also excreted and id en tif ied  by mass spectrometry as 
above. The faeces of these animals contained small amounts 
of shikimic acid and an unidentified major component (present 
also as a minor urinary product) which on méthylation with 
diazomethane and subsequent th in -layer chromatography 
yielded two separate compounds with almost identical mass 
spectra. The spectra were each consistent with the structure  
of methyl- 3 , 4-dihydroxycyclohexanecarboxylate. The ester of 
greater Rf on t . l . c .  (see chapter 5) was converted to an acetonide
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derivative on treatment with acetone and p-toluenesulphonic 
acid and was therefore iden tif ied  as methyl-3,4-(cis)-dihydroxy* 
cyclohexanecarboxylate (XIV). The accompanying ester did not
COOMe COOMe
HO (XlV)« (XV)
OH
derivatise under these conditions and was thereby id en tif ied
as methyl- 3 ,4 - (trans)-dihydroxycyclohexanecarboxylate (XV).
The mass spectra of XIV and XV (see Figs. 6.13 and 6.14) did
not exhibit parent ions, the highest ion in the spectra (*^/e 156) 
+corresponding to M -HgO an e ffec t s im ilar ly  observed in the 
spectrum of shikimic acid i t s e l f  (see Fig. 6 .15 ). The M^-18 
ions suffered a -fiss ion to give rise to the stabilised ^/e 97 
peak (XVI) and 1,4-hydrogen transfer reactions s im ilar to that  
in cyclohexanecarboxylic acid (Fig. 6.5) produced the stabilised  
ion XVII at "^ "/e 87. The intense * /^e 44 peaks in the spectra 
may be attributed to the electron defic ien t vinyl alcohol 
species (XIX) which is produced by e ither of 2 pathways depending 
on the hydroxyl which bears the in i t i a l  charge. The magnitude 
of the peaks observed (in  the trans isomer 44 is the base 
peak) re flects  the driving force that the expulsion of neutral 
molecules (vinyl alcohol and methyl acrylate) presents.
186
-  H.O
COOMe
-COOMe
(XVI)
Benz and Biemann (1964) Ve 156 m/e  97
COOMe
HO
OH
COOMe
CHg-CHg
(XVII)
OOMe
HO
O^H
HO
COOMe
OH
+
OH
+
m/e  44
(XIX)
The mass spectrum of the acetonide derivative of XIV 
(see Fig. 6.16) was readily  interpreted and thereby confirmed 
the id en tity  of XIV as methyl- 3 , 4 - (c is)-dihydroxycyclohexane- 
carboxylate. Parent ions are not observed in acetonide spectra 
(Budzikiewicz 1967a) and the highest peak true enough
corresponded to the expected loss of methyl radical to the
stabilised ion XX at /e  199. Such ions usually expel ket.ene
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COOMe COOMe
Me
Me
(XX)
^/e 199 (M+-15)
OOMe
! H
CH
COOMe
X
CHpCO
/  + (XXI)
m7e 157
COOMe CO
/
-MeOH -CO
(XXII)
m/e  125 m/e  97
(McCloskey and McClelland 1965) and this was indeed the case 
but in addition the resulting oxirani urn ion (XXI) suffered 
sequential losses of methanol (for which a desired metastable 
at ^/e 99.6 added firm evidence) and carbon monoxide to provide
the peak at /e  97 (X X II) .  The base peak in the spectrum
19o
(^/e 43) was attributed to the release of the acetylium ion
(XX)
Me Ve 199
+
(X X II I )
"’/e  43
(X X II I )  which together with protonated acetone {^ /e 59) are 
ubiquitous in a l l  acetonide spectra (De Jongh and Biemann 
1964, McCloskey and McClelland 1965).
Summary
The n.m.r. and mass spectra of the metabolic products 
observed in the previous chapters were a l l  fu l ly  consistent 
with the structural assignments concluded. In a l l  cases only 
the more important features of the mass spectra have been 
discussed and although a more complete in terpretation of 
each was available excessive detail has for s im plic ity  been 
omitted.
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CHAPTER 7
General Discussion
192
Shikimic and quinic acids have been regarded as classic  
examples of compounds which are aromatised by gastrointestinal 
microorganisms. Such hypotheses are now in need of some degree 
of modification and expansion. An in v itro  examination of the 
metabolism of shikimic acid by microorganisms present in the 
faeces or in testinal contents of a variety  of animal species 
has shown that shikimic acid is converted completely to 
cyclohexanecarboxylic acid. This finding is contrary to e a r l ie r  
beliefs that an aromatisation to benzoic acid would explain the 
observed metabolism to hippuric acid in v ivo. The observed 
formation of cyclohexanecarboxylic acid s t i l l  permits explanation 
of the fact that the conversion of o ra lly  administered shikimic 
acid to urinary hippuric acid is dependent on the involvement 
of gastrointestinal microorganisms since cyclohexanecarboxylic 
acid is aromatised by mammalian tissues to hippuric acid.
In the present studies, closer examination of the metabolic 
fa te  of cyclohexanecarboxylic acid provided further evidence 
to the pathway discussed above and also further knowledge 
therefore on the metabolism of shikimic acid. In the ra t  
cyclohexanecarboxylic acid was not only metabolised to hippuric 
acid in accord with previous l i te ra tu re  findings but also to 
smaller amounts of hexahydrohippuric acid, 3 ,4 ,5 ,6 -te trahydro -  
hippuric acid and benzoyl- and cyclohexylcarbonyl glucuronides. 
The metabolism is dose dependent however since a t low dose 
levels (equivalent to the rate of microbial production of 
cyclohexanecarboxylic acid from shikimic acid in the gut )
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glucuronide formation is absent and the levels of hexahydrohippuric 
acid and tetrahydrohippuric acid are reduced. Predictably, oral 
administration of shikimic acid to rats resulted in the urinary 
excretion of hippuric acid together with small amounts of 
3,4,5,6-tetrahydrohippuric acid and hexahydrohippuric acid. The 
urinary excretion of these metabolites therefore represented a 
series of reactions occurring mainly in the l iv e r  but dependent 
upon an in i t ia l  microbial conversion of shikimate to cyclohexane­
carboxylate. Liver perfusion studies confirmed the b e lie f  that  
the l iv e r  is a major organ responsible for the metabolism which 
occurs in the tissues although quantitative differences in the 
metabolites produced, p articu larly  the hexahydro- and tetrahydro- 
hippurates, suggest that other tissues such as the kidneys may 
be involved.
Other microbial-dependent pathways appear to be operating 
in the metabolism of o ra lly  administered shikimic acid. In the 
ra t ,  both c is-3,4-dihydroxycyclohexanecarboxylic acid and trans- 
3 ,4-dihydroxycyclohexanecarboxylic acid were observed as major 
faecal and minor urinary metabolites whose formation was 
suppressed by an tib io tic  treatment of animals. Their formation 
may be viewed as a pathway separate to that involving cyclohexane­
carboxylic acid since neither compound was converted to the la t te r  
on incubation with ra t caecal microorganisms in v i t r o . The urinary  
excretion of small amounts of conjugated catechol represents a 
further microbial pathway although the p o ss ib ility  exists that 
dihydroxycyclohexanecarboxylic acids may be aromatised to proto- 
catechuic acid by the mammalian tissues. The production of catechol
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in the gut would then arise by microbial hydrolysis and 
decarboxylation of b i l ia ry  excreted protocatechuic acid 
conjugates* A d irect production of catechol may be envisaged 
via an aromatisation of shikimate to protocatechuate followed 
by decarboxylation and has been demonstrated anaerobically 
in the case of quinate and shikimate metabolism by Laclobacillus  
plantarum (Whiting and Coggins 1971). This could occur via  
the énolisation of 3-dehydroshikimic acid to 3 ,4 ,5 -tr ihydroxy-  
cyclohexa-1j3“dienecarboxylic acid (see Fig. 7 .1 ) .
Since shikimic acid does not appear to be metabolised by 
mammalian tissues the ultimate fate  of the compound is dependent 
upon various in i t i a l  microbial transformations. The metabolites 
are e ither excreted d ire c tly  or subsequent to further metabolism 
in the tissues such as in the case of the cyclohexanecarboxylic 
acid pathway (see Fig. 7 .1 ) .  Closer examination of the l i te ra tu re  
has revealed examples of the production of metabolites of shikimic 
acid, sim ilar to those observed in the r a t ,  by isolated strains  
of bacteria. Aerobic incubation of ^^C-shikimic acid with an 
acidophilic thermophilic bacillus isolated from hot springs 
(Bacillus acidocaldarius) led to an incorporation of ^^C into the 
Cy (cyclohexylmethyl) unit of the fa t ty  acids 11-cyclohexylundecanoate 
and 13“cyclohexyltridecanoate (De Rosa ^  ^  1972). The 
microorganism also incorporated cyclohexanecarboxylic acid and 
cyclohexene-1-carboxylic acid (but not benzoate) into the same 
fa t ty  acids and a microbial reduction of shikimate to cyclohexane­
carboxylic acid (via cyclohexene-1-carboxylic acid) followed by 
side chain extension was postulated (De Rosa et al_ 1974). Evidence
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for the formation of dihydroxycyclohexanecarboxylic acids has 
been described by Whiting and Coggins (1974) who purified an 
NAD-dependent hydroaromatic dehydrogenase of Lactobacillus 
plantarum (isolated from apple ju ice) capable of reducing 
(-)-quinate  and (-)-shikimate to ( - ) t - 3 ,  t-4-dihydroxycyclo- 
hexane-r-l-carboxylic acid ( i . e .  with the same configuration 
as ( - ) -q u in ic  ac id). This observation suggests that the 
configuration at in the dihydroxycyclohexanecarboxylates 
isolated from rat faeces may well be the same as that in ( - ) -q u in ic  
acid. The further metabolism of (-)t-3,t-4-dihydroxycyclohexane- 
r - 1-carboxylic acid to cyclohexanecarboxylic acid by the enzyme 
system was not observed (analogous to the properties of the faecal 
dihydroxycyclohexanecarboxylates). In addition, this reductive 
degradation was accompanied by an oxidative pathway leading to 
the formation of catechol (Whiting and Coggins 1971). Strains 
of Lactobacillus pastorianus isolated from apple ju ice also 
metabolise shikimic acid and qui n ic acids but the metabolism in 
this case proceeds no further than dihydroshikimic acid 
(Carr et al 1957).
Shikimic acid is a re la t iv e ly  stable compound and to exert 
a carcinogenic action by covalent binding to DNA or RNA would 
probably require prior metabolic activation. Since mammalian 
tissues do not appear to metabolise shikimic acid in vivo or 
in v itro  this po ss ib ility  is un like ly . Pretreatment of animals 
with intraperitoneal injections of shikimic acid did not induce 
cytochrome P-450 and enzymes of the hepatic microsomal mixed- 
function oxidase system to any appreciable extent nor enhance 
in v itro  the levels of normal hepatic microsomal biphenyl- 2-
196
hydroxylase. The p o ss ib ility  of metabolic activation by the 
gastrointestinal microflora has not been supported by the 
metabolites id en tif ie d . Although certain metabolic intermediates 
and products are capable of lactone formation under suitable  
chemical conditions and that such products could be of considerable 
importance (Dickens 1964) this is most unlikely to occur in the 
gut and no evidence has been obtained to suggest this may occur 
in the mammalian tissues.
To summarise (see Fig. 7 .1) i t  would seem that shikimic acid 
and quinic acid are metabolised in the gastrointestinal t ra c t  
via a m u lt ip l ic i ty  of microbial pathways a ttr ibu tab le  to certain  
groups of microorganisms which constitute the normal in testina l  
f lo ra .  In the case of the production of cis-3,4-dihydroxy- 
cyclohexanecarboxylic acid this reaction is probably carried out 
by certain anaerobic lac to b ac il l i  (b ifidobacteria) which represent 
a major group of gastrointestinal microorganisms. Whilst shikimic 
acid i t s e l f  is not metabolised by the mammalian tissues the 
microbial metabolites may be more amenable to such transformations 
and this has been demonstrated in the case of the microbial-dependent 
production of urinary hippurate derivatives. The metabolic products 
of shikimic acid in the ra t has not supported the p o s s ib il i ty  that  
the compound gives rise to toxic products upon ingestion.
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